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A b st r a c t
African trypanosomes, such as Trypanosoma brucei, are single celled eukaryotic 
parasites of mammals and are the causative agents of sleeping sickness 
(trypanosomiasis) in humans and nagana in cattle. To avoid being eliminated by the 
host’s immune response trypanosomes undergo a process termed antigenic variation. 
This consists of spontaneous, periodic changes in the Variant Surface Glycoprotein 
(VSG) species that acts as a protective coat on the surface of the parasite.
Only one gene has been identified thusfar to have a role in VSG switching: RADSL 
This encodes the eukaryotic homologue of bacterial RecA and archaebacterial RADA, 
and is central to the catalysis of homologous recombination. radSl-L T  brucei cells 
show increased DNA damage sensitivity, have an impaired recombination and reduced 
levels of VSG switching. However, recombination and VSG switching do still occur, 
meaning that backup pathways must exist for both processes.
The T. brucei genomic databases were searched with T. brucei RAD51, Saccharomyces 
cerevisiae Rad51 and Escherichia coli RecA sequences to define genes with the 
potential to encode strand exchange proteins. Five further iLiD5i-like genes were found 
in this way, and three were chosen for further analysis. The first was named RAD51-3, 
which has homology to the S. cerevisiae RAD51 co-factor Rad57, as well as H. sapiens 
Rad51C, in BLAST searches. The second, named DMCl, encodes a protein that is 
highly homologous to a meiosis-specific form of RAD51 found in many eukaryotes. 
Finally, the most distantly related of the RADSl-likQ genes was examined, this was 
named RADS 1-5 and was identified by searching the T. brucei genome with E. coli 
RecA.
Genetic and biochemical analyses of homozygous mutants of the three genes identified 
no role for DMCl in repair, recombination or VSG switching. In contrast, both RADSl- 
3 and RADSl-S were shown to have roles in repair, recombination and to mediate the 
re-localisation of RAD51 in following DNA damage. Surprisingly, only RADS 1-3 was 
shown to have a role in VSG switching.
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C h a p t e r  l
In t r o d u c t io n
1.1 Introduction
Protozoan parasites cause some of the world’s most prevalent and devastating diseases. 
One such protozoan parasite is Trypanosoma brucei, the causative agent of African 
trypanosomiasis, often called sleeping sickness in humans and nagana in cattle. 
According to the World Health Organisation it is estimated that over 60 million people 
are at risk from the disease, with 300,000 to 500,000 cases annually 
(www.who.int/mediacentre/factsheets/fs259/en/). The numbers of deaths from sleeping 
sickness is estimated at 50,000 annually, although it is considered that this is an 
underestimate. T. brucei is endemic across sub-Saharan Africa and can cause two 
clinically distinct forms of the human disease depending on which morphologically 
indistinguishable sub-species of the parasite is involved. The general symptoms of the 
early phase of the disease are a general malaise, headaches and bouts of fever (Barrett et 
al., 2003)(www.who.int/mediacentre/factsheets/fs259/en/). The second phase of the 
disease occurs after the parasite has crossed the blood-brain barrier invading the CNS. 
This results in confusion, sensory disturbances, poor coordination and sleep disruption 
(the symptom which gives the disease its name) (Barrett et at., 2003). The disease is 
fatal if left untreated and the neurological damage caused after onset of the second 
phase of the disease cannot be reversed by treatment (www.who.int/mediacentre/ 
factsheets/fs259/en/). T. brucei gambiense is endemic to west and central Africa and 
causes a chronic infection in which a person can be infected for months or years before 
symptoms emerge, at which point the disease is at an advanced stage. T, brucei 
rhodesiense, in contrast, is endemic to southern and east Africa and causes a more acute 
form of the disease whose course from infection to death can be weeks or months. A 
third sub-species of the parasite, T. brucei brucei, which is not human infective, affects 
wildlife and cattle, which can also act as reservoirs of the T. b. gambiense and T. b. 
rhodesiense sub-species (www.who.int/mediacentre/ factsheets/fs259/en/).
African trypanosomes are unicellular, flagellated protozoa of the order Kinetoplastida, 
named after the highly unusual organisation of DNA (the kinetoplast) found in the 
single large mitochondrion at the base of the flagellum. A number of further species of 
Trypanosoma, including T. vivax and T. congolense, also affect wildlife and cattle in 
Africa. Moreover, some Trypanosoma have spread beyond Africa, and can infect 
organisms other than mammals (Barrett et at., 2003; Stevens and Gibson, 1999).
T. brucei has been shown to be able to undergo genetic exchange, with all evidence 
suggesting that meiotic division is involved, despite the fact that a haploid stage has not
been defined (Gibson, 2001). The first evidence for genetic exchange in T. brucei was 
the production of hybrid trypanosome strains by the co-transmission of two parental 
strains through tsetse flies (Jeimi et a l, 1986). Whether or not this genetic exchange 
occurs at a significant frequency in natural populations is a matter for debate. However, 
minisatellite analysis of trypanosome isolates from a number of African locations 
suggests that frequent genetic exchange may occur in the field (MacLeod et al., 1999).
ÿ
1.1.1 The life cycle of T. brucei
T. brucei proliferates in the bloodstream, capillaries and tissue spaces of its mammalian 
host and is transmitted between hosts by the tsetse fly {Glossina spp.). As a result, the 
parasites have an intricate life cycle (reviewed in Barry and McCulloch, 2001;
Matthews et al, 2004; Matthews, 2005) with several morphologically distinct life cycle 
stages, each with specific adaptations for growth (Fig 1.1). A major division in the life 
cycle is clear between the mammalian host and tsetse fly vector stages but life cycle 
stages are also distinguishable between growth in the mid-gut and salivary gland of the 
fly. In each life cycle stage replicative forms of the parasite (bloodstream long slender, 
procyciic and epimastigote) can be detected and appear responsible for the 
establishment of the parasite infection. Equally, at each point of transmission between 
stages non-replicative forms (bloodstream short stumpy, mesocyclic and metacyclic) 
can be found (Barry and McCulloch, 2001; Matthews, 2005).
Population growth in the mammalian host is carried out by the long slender form which 
rapidly, mitotically divides. The trypanosome evades the host immune system by 
spontaneous, periodic changes of the variant surface glycoprotein (VSG) present on the 
external surface of the parasite cell membrane; this is a process termed antigenic 
variation and is discussed in section 1.3 (reviewed in Barry and McCulloch, 2001). The 
VSG molecules form a densely packed coat that protects against the host alternative 
complement system and prevents access of the host acquired immune system to 
invariant surface molecules. Immune reactions generated against the VSG, which is 
highly immunogenic, result in destruction of the parasite. However, parasites that have 
switched to expressing an antigenically distinct VSG species survive and proliferate.
This contributes to the fluctuating parasitemia and relapse peaks that are characteristic 
of trypanosome infections (Barry and McCulloch, 2001; Matthews et al, 2004). 
Trypanosome populations at parasitémie peaks differentiate into the non-dividing short
stumpy form, in a process thought to be density-dependent (Tyler et al., 2001). The 
short-stumpy form has a finite life, being destroyed by the host immune system or 
degenerating over the course of a few days if not transmitted to the tsetse fly (Turner et 
al., 1995). Differentiation is thought to result from the release of a pheromone-like 
factor, or catabolite, termed stumpy induction factor (SIF) which, although it remains to 
be identified, appears to act through a cAMP signalling pathway to induce growth arrest 
(Vassella et al., 1997). Short stumpy forms have several pre-adaptations for growth in 
the tsetse fly, including metabolic changes to aid movement fi*om the host bloodstream, 
where glucose is the main energy source, to the tsetse mid-gut, where proline is the 
main energy source (Hendriks et al., 2000).
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Figure 1.1: The Life-cycle of T. brucei. Life-cycle stages are represented as scanning electron 
microscope images, reproduced to scale. The mammalian stages are shaded red and the tsetse stages 
shaded blue, circular arrows represent replicative stages. This diagram was taken from Barry & 
McCulloch (2001).
Upon uptake in the blood meal of the tsetse fly, short stumpy forms differentiate to 
procyciic forms. Differentiation involves cell lengthening, repositioning of the
kinetoplast and the expression of procyclins (reviewed in Roditi et al, 1998), the major 
surface molecules in the fly, which replace the VSG coat. Procyclins are thought to 
protect against digestion by hydrolases in the tsetse midgut and function in tropism 
(Roditi and Liniger, 2002). Procyciic cells are also released from the cell cycle arrest 
imposed on the short stumpy form and are able to proliferate.
Despite pre-adaptation to life in the tsetse fly, the majority of ingested trypanosomes do 
not survive to differentiate (Van den Abbeele et al, 1999). Growth of the surviving 
population within the tsetse midgut is rapid and reaches a maximum density of 5 x 10^  
parasites per midgut (Van den Abbeele et al, 1999). During growth of the trypanosome 
population in the fly there is a migration from the posterior towards the anterior midgut, 
a migration that coincides with the differentiation to the mesocyclic form. In addition, 
there are changes in the form of procyclin expressed on the cells surface (Vassella et al, 
2001). Mesocyclic cells subsequently enter the foregut and the probiscus. During this 
movement the cells elongate, replicate their DNA to become 4N and differentiate to 
become epimastigote cells, the life cycle form that is thought to migrate to the salivary 
glands.
The division of long mesocyclic cells results in the production of a long and a short 
epimastigote cell, both of which are 2N (Van den Abbeele et a l, 1999). The fate of the 
long epimastigote cells is unknown, but presumably they fail to differentiate or survive. 
The short epimastigote cells, however, continue the life cycle by dividing and becoming 
attached to the epithelial membrane of the salivary glands; it is at this stage that meiotic 
exchange is most likely to take place (Gibson and Whittington, 1993; Tait et al, 1989). 
Differentiation of epimastigote cells then occurs to form mammalian-infective 
metacyclic cells, which are characterised by a cessation of cell division, the gaining of a 
metacyclic VSG (MVSG) coat and repression of the mitochondrion (Tetley and 
Vickerman, 1985; Tyler and Engman, 2000).
On entry into the mammalian host via a fly bite trypanosome cells proliferate and 
disseminate from their initial subcutaneous location (chancre) to the vascular system 
(Barry and McCulloch, 2001). The MVSG present on the surface of the parasite remains 
there for the first few days following entry into the host before being replaced with a 
bloodstream form VSG, and the initiation of antigenic variation.
1.2 Phase and Antigenic variation
Many pathogenic organisms have adopted mechanisms to evade destruction by host 
defence systems. Phase and Antigenic variation are two of these mechanisms. Phase 
variation refers to a reversible switch between two distinct states, resulting in many 
altered phenotypes and behaviours, including evasion of host defences. Antigenic 
variation, in contrast, refers to the expression of antigenically distinct versions of a 
functionally conserved moiety, with the specific function of evading acquired 
immunity. A brief summary of examples of phase and antigenic variation are discussed
1.1.2 The genome of J. brucei
T. brucei has a haploid nuclear genome size of approximately 35 Mb, varying between 
isolates by up to 25% (El Sayed et al., 2000). The chromosomes that make up the T 
brucei genome are categorised into three classes according to size: the megabase 'I
chromosomes, the intermediate chromosomes and the mini-chromosomes. The ' 'dmegabase chromosomes are the largest and vary in size from 1 Mb to over 6 Mb. There 
are 11 of these chromosomes, named I to XI in ascending order of size in the TREU 
927/4 strain (Melville et al., 1998). The Megabase chromosomes are diploid, showing 
mendelian inheritance and constitute approximately 53.4 Mb of DNA (Melville et al.,
1998). Only the megabase chromosomes have been shown to be diploid, with the ploidy 
of the intermediate and mini-chromosomes unknown at present.
In the 71 brucei genome there are generally between 1 and 5 intermediate chromosomes 
that range in size from 200 to 900 kb (Ersfeld et al., 1999). Interestingly, none of 401 
cDNA and gene clones tested was found to hybridise to the intermediate chromosomes, 
indicating that they may not contain house keeping genes (Melville et al., 1998).
The mini-chromosomes, present in approximately 100 copies per genome, are linear 
molecules of 50 to 100 kb in length (Ersfeld et al., 1999). The mini-chromosomes 
posses the same telomeric repeats as the other larger chromosomes and are composed 
almost entirely (>90%) of 177 bp repeats (El Sayed et a l, 2000). Despite the presence 
of silent VSGs on the telomeres of mini-chromosomes, none have been shown to posses 
an active VSG expression site (discussed below), suggesting that to be activated a mini- 
chromosomal VSG must be duplicated into an active expression site or be involved in a 
telomere exchange with one (El Sayed et al, 2000; See below).
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below; however, further information can be obtained from the book ‘Antigenic 
Variation’ (Craig and Scherf, 2003), and several recent reviews are also available 
(Allred and A1 Khedery, 2004; Borst, 2002; Galinski and Corredor, 2004; Nash, 2002; 
van der Woude and Baumler, 2004).
Phase variation in bacteria can influence either surface proteins or carbohydrates, and 
can allow switches between distinct forms, or between on and off expression. A number 
of mechanisms can account for this process, including gene transcription, promoter 
inversion, and transcriptional or translational strand slippage. An example of the later is 
provided by Helicobacter pylori, a Gram-negative gastric bacterium present within the 
stomachs of as much as half of the world population. Phase variation in H. pylori is 
generated during the replication of genes containing homopolymeric repeats, one 
particular example being those whose products are involved in lipopolysaccharide 
(LPS) synthesis. DNA polymerase slippage on these C-tracts yields daughter stands 
with either increased or reduced numbers of C residues, resulting in a reversible 
frameshift (Appelmelk and Vandenbrouck-Grauls, 2003). This frameshifting results in 
the fluctuation between functional and non-functional LPS products, causing the 
generation of a heterogeneous population in terms of LPS expression. Changes that are 
advantageous to an individual, such as serum resistance, aid survival and proliferation.
Phase variation appears to be confined to bacteria, whereas antigenic variation is found 
in diverse pathogens, including viruses, bacteria, fungi and protozoan. During host 
infection of mammals, Plasmodium falciparum colonises erythrocytes, causing 
alterations in their surface morphology which target them for destruction in the spleen. 
To counter this, the parasites express proteins on the surface of the erythrocyte which 
cause adherence to the endothelium of the host blood vessels preventing their 
movement to the spleen. P. falciparum achieves this by expression of the var genes, 
which encode the erythrocyte membrane protein 1 (PfEMPl). This also results in the 
generation of an immune target for the host, so to combat this P. falciparum contains 
approximately 50 var genes, of which one is expressed at one time, resulting in the 
ability to produce PfEMPl molecules that are antigenically distinct and adhere to 
different endothelial surface molecules (reviewed by Borst, 2002; Deitsch and Hviid, 
2004). Approximately 18% of the parasite population per generation switch var gene 
expression, much faster than previously thought (Gatton et al., 2003). However, recent 
evidence suggests that variable var transition rates also play a part in P. falciparum 
antigenic variation (Horrocks et al., 2004).
Giardia lamblia is a parasite of the gut and evades the host immune system by 
expression of variant surface protein (VSP) present on the surface of the parasite 
(reviewed by Nash, 2002). There are approximately 150 VSP species encoded by the G. 
lamblia genome and the switching rate is isolate- and VSP-dependent. The exact 
mechanism of the regulation of VSP switching is not known. However, it is probably 
regulated at the transcriptional level (as is var gene switching in P. falciparum), either 
only one VSP is expressed, or all but one repressed, at one time in one cell.
1.3 Antigenic variation in T, brucei
Antigenic variation in T. brucei is probably the best characterised mechanism for 
evasion of the host immune system in protozoans and as a result several reviews are 
available (Barry and McCulloch, 2001; Barry and McCulloch, 2003; Donelson, 2003;
Pays et al., 2004; Vanhamme et al., 2001b). Antigenic variation in T. brucei involves 
the spontaneous, periodic switching of the VSG species present on the surface of the 
parasite. To be expressed a VSG gene must occupy a specialised, telomeric transcription 
unit known as an expression site (ES; see section 1.3.2). There are two types of ES, the |
bloodstream form ES (BES) for expression of VSG during growth within the 
bloodstream of the mammalian host, and the metacyclic ES (MES) that allows
iexpression of VSG in the metacyclic cell as a preadaptation for entry in to the |
mammalian host. Only one ES is active in a single cell at any one time, resulting in a 
single VSG gene being expressed at any one time. Trypanosomes can switch VSG |
expression by one of two apparently distinct mechanisms. They either inactivate 
transcription from the active ES and activate transcription from a previously inactive ES 
{in situ switch), or move a silent VSG into the active ES by DNA recombination. The 
process of VSG switching is spontaneous and is not dictated by the host immune 
response. In addition, the switching rates of different trypanosome isolates varies 
greatly. So-called ‘pleomorphic’ T. brucei lines switch at a rapid rate, around 1 x 10'^  
switches/cell/generation (Turner and Barry, 1989), much greater than the background 
rates of mutation. In contrast ‘monomorphic’ lines, generated through serial syringe 
passaging in mice, switch at a much lower rate of around 1 x 10'  ^ to 1 x 10’^  
switches/cell/generation (Lamont et al., 1986). Pleomorphic lines are distinguished 
from monomorphic lines in that they retain the capacity to differentiate from long- 
slender to short stumpy bloodstream forms, a process lost in monomorphic cells.
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Whether or not there is a connection between this distinction in difïerentiation capacity 
and in VSG switch rate has not been experimentally examined.
1.3.1 The VSG species of T. brucei
Central to antigenic variation in T. brucei is the VSG protein, which forms a densely 
packed layer on the surface of the parasite comprising approximately 10 million VSG 
dimers (Blum et aL, 1993; Carrington et al., 1991)(Fig. 1.2). The tightly packed VSG 
species prevent access of the host immune system to the invariant surface molecules, 
such as receptors for transferrin or lipoproteins and glucose transporters (Borst and I
Fairlamb, 1998; Pays and Nolan, 1998), allowing the parasite to survive in the 
bloodstream. To facilitate the process of antigenic variation, trypanosomes contain a 
large repertoire of distinct VSG species present as predominantly silent genes. Original 
estimates suggested that T. brucei contained around 1000 VSGs (Van der Ploeg et al.,
1982), and subsequent sequence analysis of the genome of T. brucei strain 927 has 
shown that this to be a reasonable estimate, with approximately 900 VSGs currently 
annotated (L. Marcello and J.D. Barry, pers. comm.).
To date, 877 VSGs have been annotated, and all but one are located in sub-telomeric 
domains. A minority are present in the ESs, and the majority are in silent arrays. 
Surprisingly, only 35 (4%) of these VSGs were found to be functional. Of the 
remainder, 576 (66%) were found to be full length pseudogenes, 73 (8%) were Atypical 
and 184 (22%) were shown to be fragments (L. Marcello and J.D. Barry, pers. comm.).
The T. brucei genome sequence does not include the 100 or so mini-chromosomes, 
increasing the size of the repertoire, but all the VSGs characterised to date on this class 
of chromosome appear to be functional (Alsford et al., 2001).
The three dimensional structure of an expressed VSG consists of a 350-400 amino acid 
residue N-terminal region and a 50-100 residue C-terminal region which are separated 
by a hinge (Carrington et al., 1991). The sequences of different VSG proteins show high 
levels of divergence, with the levels of identity between two N-terminal domains as low 
as 20% (Blum et al., 1993). The N-terminal region encodes the antigenic epitopes 
present on the surface of the parasite, and therefore this level of sequence divergence 
results in the generation of a large number of immunogenically distinct epitopes. The 
C-terminal region is attached to the plasma membrane of the trypanosome via a 
glycophosphatidylinositol (GPI) anchor (Boothroyd et al., 1980). The function of the C-
terminal region remains obscure, however, it has been suggested that it acts to lengthen 
the VSG, resulting in a thicker coat (Chattopadhyay et al., 2005).
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Figure 1.2: The surface of T. brucei. (A) A three-dimensional depiction of the tightly packed VSG 
dimers present on the cell surface of bloodstream form T. brucei. (B) A schematic representation of the 
VSGs and the invariant molecules present on the surface of T. brucei. The invariant surface molecules 
present are the Transferrin receptor, which is encoded by ESAGs 6 and 7, and a Hexose transporter. An 
IgG2 antibody is shown for size con^arison. Figure taken from Borst and Fairlamb (1998).
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1.3.2 The expression sites of T. brucei
As stated previously (section 1.3), to be expressed a VSG gene must occupy either a 
BES or MES (Fig. 3). The estimated numbers of BES found in the T. brucei genome 
vary from approximately 30 (Navarro and Cross, 1996) to 42-52 (Vanhamme et al., 
2000), but only one is active at any one time. The BESs are large (~50kb) polycistronic 
transcription units that appear to be exclusively telomeric and contain not only the VSG 
gene but also a number of other genes termed ES associated genes (ESAGs). So far, 12 
ESAGs have been identified (reviewed in Pays et al., 2001), but, their presence or 
absence, order and copy number varies between individual BES (Fig. 1.3). Only ESAGs 
6 and 7 appear to be present in all BES sequenced to date (Berriman et al., 2002) and, as 
a result, are the only ESAGs to be constitutively expressed in the bloodstream. 
Although 12 ESAGs have been identified, the functions of only three of them have been 
defined to date. ESAGs 6 and 7 have been shown to encode a heterodimeric membrane- 
bound transferrin receptor (Ligtenberg et al., 1994; Salmon et al., 1994; Steverding et 
al., 1994), and ES AG 4 has been shown to encode an adenylate cyclase (Alexandre et 
al., 1996). One gene, found in T. b. rhodesiense, was named the serum resistance- 
associated (SRA) gene, before it was shown to that it could also be present as an ESAG 
(De Greef and Hamers, 1994). SRA confers resistance to human serum, encodes a 
VSG-related protein and is present in some, but not all, BES (Xong et al, 1998). More 
recently, SRA has been shown to be a lysosomal protein that confers resistance by 
interacting with the serum protein apolipoprotein L-I (Vanhamme et a l, 2003).
The region in the BES between the ESAGs and the VSG contains a large repetitive 
region, containing many degenerate copies of a single sequence, known as the 70-bp 
repeats (Liu et al, 1983). The 70-bp repeats appear to be exclusively associated with the 
VSGs, both in the ES and in silent copies elsewhere, and often demarcate the boundary 
of recombination (Liu et al, 1983; Matthews et al, 1990). It has been suggested that 
these are a sequence specific element that promotes VSG switching (Barry, 1997), but 
other work in which the 70-bp repeats were deleted fi*om an active BES suggest that 
they are not essential for recombination (McCulloch et al, 1997). The BES promoter is 
well characterised upstream of the ESAG genes and directs RNA polymerase I-mediated 
transcription (Gunzl et al, 2003). Another repeat region, known as the 50-bp repeats, is 
found upstream of the promoter of all known BES, This repeat region can extend for 40 
-  50 kb and is thought to function as a barrier, separating the upstream sequences from 
the regulatory forces of the BES (Sheader et al, 2003).
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Figure 1.3; The expression sites of T. brucei. Schematic representations of the expression sites found in 
T. brucei. A: The BESs shown are AnTat 1.3A, Etat 1.2CR, VSG 10.1, 221 ES, V02 ES and Bn-2 ES. 
The ES promoters are indicated by a white flag, the 50-bp repeats by thickly striped boxes, the 70-bp 
repeats are thinly striped boxes, the ESAGs and the pseudo-jE&lGs (vj/) by black and grey boxes 
respectively, and white boxes represent the VSGs. B: Two MESs are also shown. The ES promoters are 
indicated by a white flag, the 70-bp repeats by striped boxes, the ESAGs and the pseudo-J?&lGs (v|/) by 
white boxes and black boxes represent the VSGs. The BES figure was taken from Berriman et al (2002) 
and the MES figure from Rudenko (2000).
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MESs, in contrast to the BESs, are monocistronic transcription units only a few kb in 
length. It is predicted that as many as 27 MESs may be present in the genome (Turner et 
aL, 1988), and these also appear to have a telomeric location (Alarcon et aL, 1994). The 
VSG within the MES is, like in the BES, located most proximal to the telomere. The 
MES promoter, which is distinct in sequence from the BES promoter (Alarcon et al., 
1994; Ginger et al., 2002), is situated approximately 2 kb upstream of the VSG. The 
region between the promoter and the VSG does not contain any ESAGs, but does contain 
70-bp repeats, although not to the same extent as the BES, as only 1 or 2 repeats are 
normally present (Matthews et al., 1990). The presence of numerous ESAGs and ESAG 
pseudogenes present upstream of the MESs has led to suggestions that they have arisen 
from the BES (Graham et al., 1999; Rudenko, 2000).
Transcription of the ESs is highly unusual in that it is mediated by RNA polymerase I, 
whereas transcription of other protein coding genes is mediated by RNA polymerase II 
(Gunzl et al., 2003). Also, the expression of the VSGs appears to be regulated at the 
transcriptional level (Vanhamme et al., 2000), which is in contrast to other protein 
coding genes, such as the glycolytic enzymes, whose expression is regulated in a 
posttranscriptional manner (Vanhamme and Pays, 1995).
In bloodstream form T. brucei, the ability to regulate transcription so that only one BES 
is active at any one time is almost certainly linked to the discovery of a sub-nuclear 
entity known as the expression site body (ESB) (Navarro and Gull, 2001). The ESB is 
distinct from the nucleolus and may be a discrete proteinaceous structure (Chaves et al., 
1998; Navarro and Gull, 2001). The ESB also appears to contain RNA polymerase I and 
only the active BES, suggesting that it has a role in antigenic variation. This conclusion 
is strengthened by observations that the ESB has only been shown to be present in 
bloodstream form cells (Navarro and Gull, 2001). Exactly how the ESB contributes to 
VSG transcriptional control is not known. However, the localisation of only one BES 
within the ESB may allow it to be fully transcribed, with RNA elongation inhibited at 
all other BES (Vanhamme et al., 2001a). This suggestion has been made in the light of 
observations that the initiation of transcription occurs at the majority of BES (Ansorge 
et al., 1999; Vanhamme et al., 2000) in bloodstream form cells.
Another process that may help explain the full expression of only one BES is the 
discovery of a DNA modification, called base J (Gommers-Ampt et al., 1991; 
Gommers-Ampt et al., 1993; van Leeuwen et al., 1996). p-D-glucosyl- 
hydroxymethyluracil (base J) replaces -0.5-1% of thymine in the T. brucei genome and 
is conserved within the Kinetoplastida and in Euglena (Dooijes et al., 2000; van
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Leeuwen et al., 1998). The function of base J bas not yet been defined, but it has been 
localised to telomeric repeats, other repeated sequences elsewhere in the T. brucei 
genome (van Leeuwen et al., 2000), and in VSG and other BES sequences exclusively 
within the inactive BESs (van Leeuwen et al., 1997). The absence of base J from silent 
VSG arrays and from the active BES have led to the suggestion of a role in BES 
silencing (van Leeuwen et al., 1996). It is possible base J is a direct block to 
transcription and that the ESB is involved in removing the modified base from an 
inactive BES during switching, resulting in its activation. Alternatively, base J might be 
a second layer of transcriptional repression over the absence of an ESB directing 
transcription of the inactive BES. The fact that base J is not limited to T. brucei, or to 
VSG-related sequences within T. brucei, may mean that base J has a function outwith 
BES transcriptional control. It is known that at least one kinetoplastid protein, JBPl, 
binds base J, and elucidating the function of this may clarify the contribution of base J 
to BES control (Cross et al., 1999; Cross et al., 2002).
1.3.3 Mechanisms of VSG switching in T, brucei
The mechanisms employed to mediate VSG switching in bloodstream form T. brucei 
fall into two categories: transcriptional or recombinational. What is known about these 
mechanisms, and their relative significance, is discussed below.
1.3.3.1 Transcriptional {in situ) switching
Transcriptional switching appears to involve the co-ordinated inactivation of full 
transcription of the active BES and switching on full transcription in a previously 
inactive BES (Fig. 1.4). This process differs from all other VSG switching mechanisms, 
as it appears not to involve the movement of a VSG by recombination. Although DNA 
rearrangements have been reported to be associated with in situ switching (Gottesdiener 
et al., 1992; Navarro and Cross, 1996), the fact that no specific DNA rearrangement was 
determined would suggest that it is not a requirement of transcriptional switching.
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Figure 1.4: The VSG switching mechanisms of T. brucei. A schematic representation of the 
mechanisms of VSG switching. See text for an explanation of the switching mechanisms. Horizontal grey 
line; expression site and the VSG array chromosome. Vertical grey line: the end of the telomere. Triangle: 
the expression site promoter. Black arrow: transcription of the expression site. Black and white striped 
box: the 70-bp repeats. Grey and white striped box: the 177-bp repeats. Coloured squares: distinct VSGs. 
Black lines: the extent of sequence copied into the active expression site. GC: gene conversion.
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It is still unknown how in situ transcriptional switching occurs, or might be regulated. A 
degree of regulation of the reaction, or ‘cross-talk’ between the BESs, has been ■suggested by experiments which attempt to select for T. brucei cells expressing two 
BESs (Chaves et a l, 1999). Full transcription of two BESs appears impossible, and 
instead this work uncovered an unsteady state, in which VSG expression appeared to 
rapidly fluctuate between the two BESs (Chaves et al., 1999), possibly indicating an 
intermediate that occurs during in situ switching. The inability to isolate such putative 
intermediates between three BES (Ulbert et al., 2002a) suggests that this ‘cross-talk’ 
can only extend to two BESs, the active site and the site about to be activated. This 
work appears to argue against there being any form of random activation or inactivation, 
as initially postulated by telomeric silencing models (Horn and Cross, 1995; Rudenko et 
al., 1995). However, it is not clear how this relates to the function of the ESB, or base J. 
Moreover, the trans or cis acting elements which mediate such cross-talk are unknown.
1.3,3.2 Recombinational switching
As the majority of VSGs are located outwith ESs, they must be copied or transposed 
into the active ES in order to be expressed. This must occur by recombination, and 
several distinct mechanisms of VSG switching that involve recombination have been 
described.
Duplicative transposition is a gene conversion reaction, which is defined as the non­
reciprocal transfer of genetic information from one DNA molecule to its homologue. 
Duplicative transposition involves the replacement of the VSG within the active 
expression site with a copy made from a silent VSG. This can result in the activation of 
a silent VSG from an array location (array VSG GC; Fig. 1.4), from another ES (ES 
VSG GC; Fig. 1.4), or from a mini-chromosomal location (MC VSG GC; Fig. 1.4). A 
silent VSG can also be recombined into the active ES by using sequences upstream of 
the 70-bp repeats for homology in a process known as ES gene conversion (ES GC; Fig. 
1.5). The last type of gene conversion reaction involves the replacement of sequence in 
the active ES from a telomeric location (telomere conversion; Fig. 1.5).
The length of sequence transposed during gene conversion is variable, compatible with 
the reaction being driven by homologous recombination (Rudenko et al., 1998). To 
achieve the successful recombination of the full VSG, homologous recombination 
utilises sites of homology upstream and downstream of the VSG to direct homologous
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recombination. During VSG gene conversion {VSG GC) the 70-bp repeats normally 
mark the site of 5' homology for transfer of the VSG ‘cassette’ (Liu et al., 1983; 
Matthews et al., 1990). However, deletion or inversion of the 70-bp repeats was shown 
to have no effect on the level of VSG GC (McCulloch et al., 1997). This suggests that 
some gene conversions can use upstream sequences, probably the ESAGs, rather than 
the 70-bp repeats (Donelson et ah, 1983; Kooter et al., 1988; LaCount and Donelson, 
2001; Pays et al., 1985). The 3' region of homology can take the form of the C-terminal 
coding region (Donelson et al., 1983; Liu et al., 1983; Liu et al., 1985; Pays et al., 
1985) of the VSG, or the 3' untranslated region (Timmers et al., 1987).
The transfer of a VSG in to the active ES by a telomeric conversion mechanism can also 
use sites of homology further upstream of the VSG (Kooter et al., 1988; Lee and Van 
der Ploeg, 1987), and has also been shown to extend as far downstream as the telomere 
repeats (de Lange et al., 1983; Scholler et al., 1989). This mechanism of activation, 
however is limited to the silent VSGs located on the telomeres of mini-chromosomes or 
in other BESs.
Reciprocal telomere exchange has also been observed during VSG switching (Rudenko 
et al., 1996). This switch mechanism involves the exchange of telomeres with no loss or 
gain of sequence (Fig. 1.5). However, as is the case for telomere conversion, it is 
limited to the activation of silent VSGs located on the telomeres of mini-chromosomes 
or in other BESs, and it is most likely a less frequent process.
One other mechanism of recombinational switching is mosaic gene formation, which 
involves the creation of a new VSG from fragments of existing genes or pseudogenes 
(Fig. 1.5). Pseudogenes are fragments of VSGs or non-functional VSGs, which can only 
be activated through segmental gene conversion into the active ES, creating a composite 
gene. This event is thought to occur late in infection to prolong chronic infections after 
exhaustion of the intact VSG repertoire, and is therefore considered to be a rare event 
(Kamper and Barbet, 1992; Pays, 1989; Thon et al, 1989). Recent analysis of the 
genome has shown there to be a larger number of pseudogenes than first thought (L. 
Marcello and J.D. Barry, pers. comm.). As a result, it is likely that mosaic gene 
formation may account for a more significant proportion of switching events than 
previously estimated, possibly by increasing the VSG repertoire beyond the physical 
number of VSGs in the genome.
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Figure 1.5: The VSG switching mechanisms of T. brucei (cent.). A schematic representation of the 
mechanisms of VSG switching. See text for an explanation of Üie switching mechanisms. Horizontal grey 
line: expression site and the VSG array chromosome. Vertical grey line: the end of the telomere. Triangle: 
the expression site promoter. Black arrow: transcription of the expression site. Black and white striped 
box: the 70-bp repeats. Coloured squares: distinct VSGs. Coloured rectangles: VSG pseudogenes. Black 
lines: the extent of sequence copied into the active expression site, which can be variable (dotted line).
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1.3.3.3 The relative use of switching mechanisms
■
Monomorphic T. brucei cells, which have been used in the majority of switching studies 
to date, appear to predominantly utilise in situ switching, at least early in infection (Liu 
et al., 1985). This is perhaps due to rapid serial passaging, which may require a reduced 
repertoire of switching compared to chronic cattle infections. However, later in 
infection the use of recombination to activate silent VSGs plays a larger role (Timmers 
et ah, 1987), There is no evidence that trypanosomes can regulate the relative use of in 
situ and recombinational switching, meaning that this is most likely explained by a 
predominance of in situ switching and an uncovering of recombinational switching as 
antibodies are generated against VSG species in the BES. In contrast, VSG gene 
conversion is the switching mechanism that predominates early in infections with 
pleomorphic cell lines (Robinson et al., 1999; L. Morrison, PhD Thesis), Monomorphic 
trypanosomes may have lost or down-regulated the function of a specific factor that 
interacts with the homologous recombination machinery resulting in its ability to 
regulate, initiate or carry out VSG gene conversion. If true, monomorphic cell lines may 
rely on general levels of recombination for VSG switching, and therefore rely upon the 
general recombination machinery.
A hierarchy of the activation of VSGs during an infection has also been described, with 
some genes prone to appear early in infection and some late (Robinson et al., 1999). 
Unpublished work by L. Morrison (PhD Thesis), showed that VSGs contained within 
telomeric locations are preferentially activated; this is possibly due to the close 
proximity of the telomeres within the nucleus and the level of homology between 
telomeres (Freitas-Junior et al., 2000). It could also be that all the VSGs present in 
telomeres are full length functional. Within the group of telomeric VSGs, those located 
on mini chromosomes appear to be activated with slight preference to those on the 
larger chromosomes, probably as a result of their larger copy number. Finally, in the 
hierarchy, VSG activations fi-om array locations (Robinson et al., 1999; L. Morrison, 
unpublished) appeared to be the least frequent. Neither of these studies identified 
mosaic VSGs during switching analysis, suggesting that these remain the latest events in 
the hierarchy.
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1.4 DNA double strand break repair
DNA double strand breaks (DSBs) can be caused by a plethora of potentially mutagenic 
agents. These include free radicals, ionising radiation, chemicals, transposons, blocks to 
DNA replication, and specifically-targeted cellular enzymes. Unrepaired, DSBs could 
result in chromosomal fragmentation, translocations and deletions, with long-term 
consequences including death and cancer (in multicellular organisms) (Jackson, 2001). 
DSB repair is therefore an essential process that acts to maintain genomic integrity. The 
mechanisms of double strand break repair can be divided into two categories: 
homologous recombination (reviewed in Krogh and Symington, 2004; Paques and
Haber, 1999; Symington, 2002) and non-homologous end joining (NHBJ) (reviewed in 
Lieber et al., 2003; Weterings and van Gent, 2004). Homologous recombination repairs 
DSBs through DNA sequence homology and generally repairs DNA accurately. NHEJ, 
on the other hand, ligates the ends of a DSB, often resulting in sequence changes. Both 
mechanisms of DSB repair are discussed below.
More recently, it has become clear that potentially the main role of homologous 
recombination is the repair of stalled replication forks. Stalled replication forks can arise 
due to DNA damage in replication substrates, inhibition of the replication machinery, or 
the blocking of the replication machinery by DNA-protein complexes. Stalled 
replication forks represent a source of genomic instability of potentially lethal 
consequences, and can lead to the creation of DSBs (Michel et a l, 2004), The interplay 
between replication and recombination is still being established, and the mechanism of 
how the homologous recombination machinery is able to restart stalled replication forks 
is beginning to be uncovered. Bacteria appear to have at least two pathways of 
replication fork restart. The GAP repair mechanism restarts forks that have stalled after 
encountering a DNA lesion and forks that stall after encountering a DNA nick are 
restarted by the DSB repair mechanism, in both cases recombination is involved (Cox et 
al, 2000). In eukaryotes the replication fork restart is much less clear, however, 
recombination is still proposed to play a major role (Krogh and Symington, 2004).
1.5 Non Homologous End Joining
NHEJ (reviewed in Lieber et al., 2003; Weterings and van Gent, 2004) is the process of 
ligation of DNA ends formed as a result of a DSB (Fig. 1.6a), often involving very
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small regions of sequence homology (2 to 4 bp). In mammalian cells, NHEJ begins with 
the assembly of the DNA-dependent kinase (DNA-PK) at the DSB. The Ku 
heterodimer, consisting of Ku70 and Ku80, is the first to bind to the ends of the DSB, 
either tethering them (Cary et al., 1997), or providing end protection (Mimori and 
Hardin, 1986). The Ku heterodimer then recruits the catalytic subunit of DNA-PK 
(DNA-PKcs), which is activated by Ku (Hammarsten and Chu, 1998; West et al., 1998). 
DNA-PK has been shown to phosphorylate a number of proteins, including p53, Ku, 
Xrcc4 and DNA-PK^s itself (Smith and Jackson, 1999). How exactly DNA-PK is 
involved in the process of NHEJ is currently a matter of conjecture. Next, the DNA 
ligase IV/Xrcc4 complex is recruited to the DSB forming a tetrameric structure 
(Sibanda et al., 2001), in which ligation of the DNA ends occurs.
The same core proteins appear to be involved in yeast NHEJ, although no DNA-PKcs 
has yet been identified (Pastwa and Blasiak, 2003). Whether another kinase assumes 
this function, or if the reaction proceeds in its absence, is not known. Interestingly, the 
proteins of the MRX complex (see Section 1.6.2) are essential for NHEJ, as disruption 
of the individual genes results in a defect in NHEJ (Moore and Haber, 1996), where as 
the equivalent complex, MRN, is not required in vertebrates (Yamaguchi-Iwai et al., 
1999).
Very recently, it has been suggested that NHEJ might be conserved in bacteria also 
(Weller et al, 2002; Wilson et al., 2003). Several bacterial Ku homologues have been 
identified and have been shown to recruit DNA ligase to DNA ends and promote 
ligation (Weller et al., 2002). The single copy Ku found in bacteria was shown to be 
homologous to the central regions of the eukaryotic Ku70 and Ku80 genes, suggesting 
that a gene duplication occurred to result in the two copies found in eukaryotes (Wilson 
et al., 2003). Also, as is the case in eukaryotes, bacteria were shown to require Ku for 
fully functioning NHEJ (Wilson et al., 2003).
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Figure 1.6: Pathways of double strand break repair. Black lines: duplex DNA with a DSB. Blue lines: 
intact duplex DNA. Dashed lines: newly synthesised DNA. Red circles: the NHEJ proteins. Black box: 
regions of homology. See text for details.
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1.6 Homologous recombination
There are several processes of DSB repair that occur by homologous recombination and 
are conserved from bacteria to humans (Cromie et al.^  2001; Fig. 1.6). The underlying 
principles appear to be similar, however, in that each utilises broadly the same proteins, 
and follows essentially the same catalytic steps (see Krogh and Symington, 2004; 
Paques and Haber, 1999; Symington, 2002) for a comprehensive review). The 
mechanism of homologous recombination can broadly be split into three distinct 
catalytic steps: presynapsis, synapsis and postsynapsis (Hamatake et al., 1989; Fig. 1.7). 
The first stage, presynapsis, involves the processing of the ends of the DSB to provide a 
substrate for homologous recombination. This is carried out by resection of the 5' end of 
the DSB to leave a 3' single strand overhang (Cao et al., 1990). In synapsis, the 3' 
overhang invades homologous DNA and creates recombination intermediates; this step 
is often known as strand exchange. Termination of homologous recombination, or 
postsynapsis, can be mediated through a number of different pathways (discussed 
below), initially depending on whether or not both ends of the DSB have invaded 
duplex DNA. Invasion of both ends of a DSB can result in the formation of four- 
stranded branched DNA structures known as Holliday junctions (Holliday, 1964), 
which must be resolved by specific enzymes. The concept of formation and resolution 
of Holliday junctions was developed in a model termed the DSB repair model (Szostak 
et al., 1983). In an alternative model, the invading DNA strand can be expelled from the 
duplex DNA and re-anneal with the broken end DNA in a process termed synthesis- 
dependant stand-annealing (SDSA) (Nassif et al., 1994). In both these models, gene 
conversion reactions occur, where there is nonreciprocal transfer of DNA sequence 
from the unbroken DNA to the molecule with the DSB.
Different forms of post-synaptic resolution can occur if the synaptic step proceeds in a 
different manner. Invasion of only one of the ends of the DSB can occur in a process 
known as break-induced replication (reviewed in Kraus et al., 2001; Paques and Haber, 
1999). In this case, a replication fork can be established that could potentially replicate 
the intact duplex DNA to the end of the chromosome. In another reaction, termed single 
stand annealing (reviewed in Paques and Haber, 1999; Symington, 2002), the broken 
ends do not invade intact DNA duplex, but rather homology is found around the DSB 
on the same molecule. Annealing then occurs and trimming, DNA synthesis and 
ligation complete the reaction.
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Figure 1.7: The double strand break repair model (Szostak et al., 1983). A double strand break is 
present in a strand of duplex DNA (Black lines). During presynapsis the ends of the DSB are processed to 
provide 3’ single strand overhangs. These subsequently invade intact duplex DNA (Blue lines) where 
they search for homology and create recombination intermediates in a process known as synapsis. During 
postsynapsis, DNA synthesis (Dashed lines) repairs any loss of sequence and the formation of Holliday 
junctions allows resolution of strand exchange intermediates. Resolution can either lead to a crossing over 
(both HJs being cut at points marked by different coloured arrowheads) or a non-cross over (both HJ 
being cut at points marked by the same coloured arrowheads).
1.6.1 Mechanisms of homologous recombination
Homologous recombination in eukaryotes utilises a large family of proteins initially 
identified in yeast and are known as the Rad52 epistasis group (reviewed in Symington,
2002). The members of this group are RadSO, RadSl, Rad52, Rad54, Rad55, Rad57, 
Rad59, Rdh54/Tidl, Mrell and Xrs2, and these proteins are central to the different 
stages of recombination reactions discussed above. Some, but not all, of these yeast 
proteins are conserved from bacteria to mammals, and the discussion below will 
describe the function of these proteins and highlight similarities and differences in other 
eukaryotes and in bacteria.
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1.6.2 Presynapsis
Presynapsis processes the ends of the DSB to provide a substrate for homologous 
recombination. This process is carried out in yeast by the Mrell/Rad50/Xrs2 (MRX) 
complex, which resects the 5' ends of the DSB to leave 3' single stranded DNA 
overhangs (Fig. 1.8). The primary evidence for this is suggested by the observation that 
5' to 3' resection is attenuated in mutants of these genes (Ivanov et aL, 1994). The role 
of Xrs2 has been defined as an aid to the targeting of the MRX complex, providing a 
preference for single strand-double strand DNA junctions compared to single or double 
stranded DNA, and as a regulator of the exonuclease activity of M rell and RadSO 
(Trujillo et al, 2003). Mrell and RadSO form a sub-complex that exhibits a double 
stranded DNA 3’ - 5' exonuclease activity (Trujillo and Sung, 2001). Since this activity 
is the opposite of that needed to create 3' single strand DNA ends, the authors suggest 
that a helicase activity is required. Unwinding of the double stranded DNA at a DSB 
would result in the formation of 5' and 3' single strand DNA ends, and endonuclease 
cleavage of the S' strand by the MRX complex would leave the required overhang. 
Mrell and RadSO are conserved in all kingdoms of life, but the bacterial equivalents, 
SbcC and SbcD, do not have the same central functions in end-processing during 
homologous recombination (Connelly et al., 1999). Xrs2 appears to be only present in 
eukaryotes, and is named Nbsl in mammals (Symington, 2002), Analysis of the MR- 
Nbsl complex in humans has suggested that resection of the DSB is carried out in a 
similar manner to yeast (Pauli and Gellert, 1998). Mutants of Mrel 1, RadSO and Xrs2 in 
yeast are all viable, whereas, M rell, RadSO and Nbsl are all essential for viability in 
vertebrate cells (Symington, 2002). The MRX complex has many cellular functions 
besides end-processing (reviewed in Symington, 2002): it has also been shown to have 
roles in the maintenance of telomeres (Le et al., 1999), in the creation and processing of 
DSBs during meiosis (Johzuka and Ogawa, 199S; Keeney, 2001) in signalling DNA 
damage (D'Amours and Jackson, 2002; Lisby et al., 2004) and in NHEJ (van Gent et 
al., 2001). DSB end processing is catalysed in bacteria by the RecBCD complex, which 
possesses 3' - 5' and 5' - 3' exonuclease activities (although the latter is much weaker), 
resulting in the preferential degradation of the 3' end of a DSB. In addition, after the 
recognition of a chi site, the 3' - 5' nuclease activity of RecBCD is attenuated, resulting 
in the production of a 3' single stranded DNA overhang to which RecA can bind 
(Anderson and Kowalczykowski, 1997; Kowalczykowski, 2000).
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Figure 1.8: Some proteins involved in yeast homologous recombination. The black lines represent the 
duplex DNA that has suffered a DSB and the blue lines represent the intact duplex used as a ten^late for 
the repair of the damaged strand. The dashed lines represent newly synthesised DNA and the coloured 
arrowheads mark the cut sites for the resolution on of the Holliday junctions. See text for further details of 
the proteins involved. MMR: Mismatch repair.
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Before the process of synapsis can take place, a nucleoprotein filament must be formed 
on the single strand DNA to allow it to invade the homologous DNA. In eukaryotes the 
protein that this involves is RadSl (Shinohara et al., 1992), which is a structural and 
functional homologue of RecA in bacteria and Rad A in archae (Brendel et al., 1997). 
RadSl is able to bind to both single strand DNA and double stranded DNA (Shinohara 
et al., 1992), but RadSl prefers tailed duplex DNA as a substrate for homologous 
recombination (Mazin et al., 2000). The formation of a RadSl nucleoprotein filaments 
results in a slight unwinding of the DNA, and 3 base pairs are bound to every RadSl 
molecule (Sung and Robberson, 199S). The crystal structures of S', cerevisiae RadSl 
and E. coli RecA nucleoprotein filaments have been solved (Conway et al., 2004; Story 
et al., 1992). Analysis of the pitch of RadSl filaments shows then to have a pitch of 130 
Â compared to 83 Â for the RecA nucleoprotein filament (Conway et al., 2004). RadSl 
is homologous to bacterial RecA, sharing 30% sequence similarity in the central 
conserved region (Shinohara et al., 1992). Despite the low sequence conservation the 
nucleoprotein filaments formed by RecA (reviewed in Kowalczykowski, 2000) appear 
similar to RadSl nucleoprotein filaments, although, they form with the opposite polarity 
(Shinohara et al., 1993).
The loading of RecA onto single strand DNA requires DSB processing by the RecBCD 
complex, but no accessory factors appear to be needed. Why this is the case is as yet 
unknown. In contrast, and despite the fact that RadSl can bind DNA on its own, the 
formation of a RadSl nucleoprotein filament appears to be stimulated, or aided, in yeast 
by RadS2, RadSS, RadS7 (Fig. 1.8), and replication protein A (RPA). RPA is a 
heterotrimeric complex of RFAl, RFA2 and RFA3 and is thought to aid the loading of 
RadSl onto single strand DNA by the removal of secondary structure (Sugiyama et al., 
1997; Sung and Robberson, 199S). The role of RadS2 appears to be to act as a mediator 
between RadSl and RPA, aiding RadSl to overcome the competition for single strand 
DNA posed by RPA (Sung, 1997a). It was originally though that RadS2 and Ku 
competed for DNA ends at a DSB, hence determining which pathway of DSB repair 
was taken (Van Dyck et al., 1999). However, RadS2 interacts preferentially with single 
strand DNA, whereas Ku interacts preferentially with double stranded DNA ends, 
suggesting that this is not the case (Ristic et al, 2003). Mutation of RadS2 results in the 
most severe recombination defects and DNA damage sensitivity of the entire RadS2 
epistasis group (Paques and Haber, 1999). This is probably because RadS2 contributes 
to all forms of homologous recombination, including RadSl-dependent DSB repair, 
break-induced replication (see below) and single strand annealing (see below;
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(Symington, 2002). Rad55 and Rad57 form a heterodimer which also acts to aid RadSl 
nucleoprotein filament formation, in a manner similar to RadS2 function, since single 
mutants of all three genes fail to form RadS 1 nucleoprotein filaments during meiosis 
(Gasior et al,, 1998), Mutation of RadSS or RadS7 results in a radiation sensitivity and 
recombination defects which can be suppressed by the over-expression of RadS 1 or 
RadS2 (Hays et al,, 199S; Johnson and Symington, 199S). In addition, the effects 
resulting from the loss of RadSS and RadS7 can be partially suppressed by mutations in 
RadSl, meaning that RadSl can act independently of these enzymes in some 
circumstances (Fortin and Symington, 2002).
In vertebrate cells, the number of proteins that contribute to RadSl function is 
significantly more than in yeast. Five RadSl-related proteins have been identified 
(RadS IB, RadS 1C, RadS ID, Xrcc2 and Xrcc3) which have been shown to form two, or 
perhaps three, discrete complexes (Liu et al,, 2002; Masson et al., 2001b; Fig. 1.9). One 
complex is composed of RadS 1C and Xrcc3 (the C3 complex), and the other (BCD2) 
contains RadS IB, RadS 1C, RadS ID and Xrcc2 (Masson et a l, 2001b). It is proposed 
that the BCD2 complex results from the joining of two sub-complexes: RadS IB and 
RadS 1C (BC) and RadS ID and Xrcc2 (D2) (Liu et al., 2002). The same authors also 
propose that the formation of the C3 complex might arise from the interaction of Xrcc3 
with RadS 1C within the BCD3 complex. Clearly defined roles for the RadSl-related 
proteins and complexes are still emerging. However, mutants of any of these five genes, 
generated in chicken DT40 cells, were viable but exhibited chromosomal instability and 
recombinational repair defects, suggesting that they all have roles in repair and 
recombination (Takata et al., 2001). On the other hand, mutants of RadS IB, RadS ID 
and Xrcc2 resulted in embryonic lethality in mice (Symington, 2002).
In humans, the formation of RadS 1 nucleoprotein filaments, as in yeast, requires RPA 
(Baumann and West, 1998) and RadS2 (Benson et al., 1998). It is proposed that this 
process is also aided by the RadSlB-RadSlC complex, in a process not dissimilar to 
that of the RadS S/57 heterodimer (Sigurdsson et al., 2001). The RadS 1C and Xrcc3 
complex has been shown to bind RadS 1 (Liu et al,, 2002). As yet no precise role has 
been suggested for RadS IB, RadS ID or Xrcc2 in DSB repair, although RadS ID has 
been shown to be involved in telomere maintenance (Tarsounas et al,, 2004b). Liu et al 
(2002) have proposed a model in which the 3' single strand DNA tail is bound by the 
RadSlC-Xrcc3 sub-complex, either on its own or as part of the BCD2 complex. 
Subsequent binding of Xrcc3 to RadS 1C, present as part of the BCD2 complex, would 
release RadS IB and the RadSlD-Xrcc2 sub-complex, leaving the RadSlC-Xrcc3
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complex to recruit RadSl to the DSB (Fig. 1.9). Indeed, it has been observed that 
Xrcc3 is recruited to the DSBs before, and independently of, RadSl (Forget et al., 
2004). However, the RadSlB-RadSlC sub-complex has also been shown to possess 
RadS 1 binding activity, although this appears to be weak (Lio et al., 2003). It is possible 
that RadS IB binding to RadS 1C partially obscures the RadSl binding domain, and the 
release of RadS IB caused by Xrcc3 binding could then free the RadSl binding site to 
allow RadS 1C to interact with RadSl with higher affinity. It seems likely that further 
work will add new dimensions to the roles of these RadSl-like proteins. Nevertheless, it 
seems unlikely that they are simply functional analogues of yeast RadS S/S 7, as other 
activities have been described at other stages of homologous recombination (see below).
Figure 1.9: A model of the complexes of RadSl and the 
RadSl-like proteins in humans. The diagram, which is a 
speculative model, takes into account all of the observed 
complexes discussed in the text. The proposers of this model 
suggest that a conformational change in RadS 1C could account 
for the specificity of interactions. 51: RadSl. B: RadS IB. C: 
RadS 1C. D RadS ID. 2: Xrcc2. 3: Xrcc3. See text for further 
details. Figure taken from Liu et al (2002).
Mammals also possess RadS2, which has been shown in humans to stimulate RadSl- 
dependant strand exchange (Benson et al., 1998). However, in contrast to yeast, it is not 
so critical for repair and recombination in mammals (Yamaguchi-Iwai et al., 1998). 
Another protein that is involved in the regulation of RadS 1 function in mammals is 
Brca2 (Pellegrini and Venkitaraman, 2004). As yet no homologue of Brca2 has been 
identified in yeast, although, one was recently identified in Ustilago maydis (Kojic et 
al., 2002) and many other eukaryotes (Lo et al., 2003). Brca2 contains a number of 30 -
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40 amino acid repeat sequences, known as the BRC repeats, which have been shown to 
bind RadSl and be essential for resistance to DNA damage (Chen et al., 1998). Brca2 
has also been shown to be involved in the sequestering of RadS 1 and the regulation of 
its DNA binding activity (Davies et al., 2001). This has led to suggestions that Brca2 
regulates the transfer of RadSl on to single stranded DNA (Pellegrini and 
Venkitaraman, 2004), and that it may also be involved in the removal of RadSl later on 
in DSB repair (Shivji and Venkitaraman, 2004).
1.6.3 Synapsis
Our understanding of how the RadS 1 nucleoprotein filament acts to find homologous 
sequence, and transfer base pairing between DNA molecules is not clear. However, it is 
thought that the alignment of the RadSl-single strand DNA filament with homologous 
sequence, often within intact duplex DNA, occurs not by the invading strand sliding 
along the duplex, but through random collisions (Adzuma, 1998), The recognition of 
homology during this process has been proposed to occur by one of two mechanisms. 
The invading DNA could recognise homology in a locally unwound region. 
Alternatively, the DNA could form a triple helix structure in which the invading single 
strand interacts with one or both strands of the duplex DNA (reviewed in Rao et al,
199S). Once a region of DNA sequence homology has been found, the intermediate 
structure is stabilised by the formation of base pairing between the single strand DNA 
and one of the stands of the duplex DNA. Elongation of the joint molecule can then take 
place by DNA synthesis and/or migration. In yeast and humans this can occur in either a 
5' to 3', or a 3' to 5', direction with respect to the single strand DNA (Namsaraev and 
Berg, 1998; Namsaraev and Berg, 2000; Sung and Robberson, 1995). This migration, 
however, has been shown to be impeded by non-homologous sequence (Namsaraev and 
Berg, 1998; Namsaraev and Berg, 2000; Sung and Robberson, 1995).
The ability of Rad51 to form D-loops (the bubble of unwound DNA on the intact strand 
generated by the invasion of the Rad51 nucleoprotein filament; Fig. 1.6), and to search 
for homology, on its own is poor. The discovery of the in vivo and in vitro interactions 
between Rad51 and Rad54 may explain, in yeast and mammals at least, how this is 
overcome (Jiang et al., 1996). Rad54 was shown to stimulate the rate of Rad51- 
dependant pairing between homologous single-strand and double-stranded DNA 
molecules (Petukhova et al,, 1998). Rad54 appears to result in an alteration in the DNA
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conformation, possibly through strand separation or unwinding (Petukhova et al., 
1999b), thus aiding Rad51 to overcome structural impediments that would otherwise 
limit homologous DNA pairing (Fig. 1.8). The ability of Rad54 to promote this reaction 
appears dependent on its interaction with the RadSl nucleoprotein filament (Van 
Komen et a l, 2000). RPA appears to be required at this step also, maximising the 
efficiency of the reaction, because binding of RPA to free single strand DNA prevents it 
fi-om interfering with, and inhibiting, homologous pairing (Van Komen et al., 2002). In 
humans, Rad54 appears to operate in a similar manner as it does in yeast (Sigurdsson et 
al., 2002). The ability of RadSl and RadS4 to promote strand exchange in humans has 
also been shown to be enhanced by the presence of chromatin (Alexiadis et al., 2004) 
when compared to previous findings using naked DNA as a substrate, suggesting that it 
may act to aid RadSl to overcome chromatin.
Recent analysis has suggested that mammalian RadS 1C might also be involved in the 
strand transfer step of homologous recombination, utilising a strand melting and 
separation activity (Lio et al., 2003). If correct, this suggests that RadS 1C operates at 
two stages: an early stage where it aids RadS 1 nucleoprotein filament formation and a 
later step in DNA pairing. This process would most likely be inefficient; however, the 
presence of RadSl bound to single strand DNA would promote the ability of RadS4 to 
unwind the duplex DNA, therefore promoting the reaction.
As in eukaryotes, little is known regarding strand invasion and homology searching 
during DSB repair in bacteria. However, it appears that RecA is capable of carrying out 
these processes on its own, but is dependent on RecBCD loading it onto single strand 
DNA in a chi dependent manner (Anderson and Kowalczykowski, 1997; 
Kowalczykowski, 2000)
1.6.4 Postsynapsis
Postsynapsis is the least defined of the three steps of homologous recombination. This 
process must begin with the initiation of DNA synthesis from the 3' OH of the invading 
DNA strand. It has been suggested that this is carried out by a replication fork similar to 
that used during replication initiated fi*om replication origins, since gene conversion 
events at the mating type locus in S. cerevisiae were observed to require both leading 
and lagging strand DNA synthesis (Holmes and Haber, 1999).
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In bacteria, the resolution of the Holliday junction molecules is well understood. RuvA, 
RuvB and RuvC are required for Holliday junction processing (reviewed in West, 
1997). The RuvAB complex is responsible for branch migration after formation of the 
Holliday junction (West, 1996). The Holliday junction is targeted by RuvA, which then 
enables RuvB to form around the two opposite arms of the Holliday junction. The RuvC 
protein is the endonuclease that cleaves the Holliday junction (Connolly et al,, 1991), in 
a process that acts in conjunction with the RuvAB complex (West, 1996). The 
resolution of the Holliday junction involves the introduction of two nicks into the DNA 
of like polarity at preferred cleavage sites (Figs. 1.6d, 1.7 & 1.8).
In eukaryotes, Holliday junction resolution is much less clear. In yeast, it was originally 
thought that Mus81, which forms a complex with Emel, acts in a similar manner to 
bacterial RuvC (Boddy et al., 2001). However, more recent evidence suggests that this 
is not the case, proposing a role for Mus81-Emel in meiotic crossing over, but not gene 
conversion (Smith et al., 2003). In humans, two putative Holliday junction resolution 
complexes with different specificities have been described. One of these contains 
Mus81 and may not truly be a Holliday junction resolvase (Constantinou et al., 2002). 
More recently, RadSlB was shown to have Holliday junction binding activity, 
suggesting that it might have a role in junction resolution or branch migration 
(Yokoyama et al., 2003). More recently still, it has been shown that Holliday junction 
resolution activity is reduced in CHO cell extracts carrying mutations of RadS 1C or 
Xrcc3, suggesting that they also might have a role(s) in this process (Liu et al., 2004). 
In the same study it was also suggested that RadS 1C is involved in branch migration as 
cell extracts depleted of RadS 1C showed reduced branch migration, a defect that was 
recovered when the extract was supplemented with any of the RadS 1C containing 
complexes (Liu et al., 2004).
1.6.4.1 Synthesis Dependent Strand Annealing
Synthesis Dependent Strand Annealing (SDSA) is an alternative strategy for post- 
synaptic resolution of RadSl-catalysed recombination intermediates (Nassif et al., 1994; 
Fig. 1.6e). This model was developed to explain the lack of crossing over events 
observed during mitotic gene conversion reactions, and is similar to the DSB repair 
model with two notable differences. One difference is that conservative DNA 
replication occurs, with all newly synthesised DNA ending up in the recipient molecule.
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The second is that the mechanism does not require the use of Holliday junctions. In this 
form of gene conversion, both 3' single strand DNA ends invade the duplex DNA and 
initiate DNA synthesis. The newly synthesised strands are then expelled from the
duplex and annealing of the strands then rejoins the broken DNA molecule (Nassif et
%al., 1994). One mechanism of SDSA that does allow crossing over was proposed by 
Ferguson and Holloman (1996). In their mechanism, they proposed that the migration of 
a single D-loop, and its subsequent annealing to the other end of the DSB, would result 
in the formation of a single Holliday junction that could either be resolved with or 
without a crossover event (Ferguson and Holloman, 1996).
1.6.4.2 Break Induced Replication
Break-induced replication (BIR), in contrast to gene conversion, requires invasion of 
only one end of the DSB (Fig. 1.6c). However, the initial steps of BIR and gene 
conversion are essentially the same. The 5' end of the DSB needs to be resected to 
provide a 3' single strand DNA overhang which then invades duplex and initiates 
replication. BIR, unusually, can still occur in the absence of RadSl, RadS4, RadSS or 
RadS7, proteins that act in gene conversion. Mutation of these genes has been shown to 
almost abolish gene conversion, but BIR can still take place (Maikova et al., 1996; 
Signon et al, 2001). In contrast, mutation of radSO, radS9 and rdhS4/tidl (radS4B; a 
homologue of RadS4 that appears to act in the same manner, but in meiotic 
recombination) was shown not to adversely affect gene conversion except when coupled 
with a mutation of radSl or radS4, which resulted in severe reductions of both gene 
conversion and BIR reactions (Signon et al, 2001). These results suggest that RadSl- 
independent BIR requires Rad50 (presumably with the other components of the MRX 
complex: Mrell and Xrs2), Rad59 and Rdh54/Tidl. How exactly BIR operates in the 
absence of RadSl and its cofactors has yet to be determined. However, the requirement 
for RadSO suggests that BIR may utilise the MRX complex to process the DSB to 
provide recombinogenic ends as it does in gene conversions. The only other 
requirement published to date is that of a 200 bp sequence located ~34kb from the DSB 
(Maikova et al, 2001). How exactly this sequence aids BIR remains to be defined.
More recently, the process of RadSl-dependent BIR has been described. This reaction 
requires the same genes as gene conversion reactions (RadS2, RadS4, RadSS and 
RadS 7), and therefore has been suggested to have a common strand invasion
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intermediate (Davis and Symington, 2004). This process has also been shown to be 
more efficient than the RadSl-independent BIR pathway and also to have no 
requirement for special facilitator sequences (Maikova et aL, 2005).
1.6.4.3 Single Strand Annealing
If a DSB occurs in between two repetitive sequences, repair of the break can result in a 
loss of DNA sequence in a process termed Single Strand Annealing (SSA) (reviewed in 
Paques and Haber, 1999). This mechanism arises due to the resection of both 5' ends of 
the DSB, revealing homologous 3' single strand DNA overhangs beyond the repetitive 
sequences. The exposure of two homologous regions allows them to be annealed to 
repair the break, but in the process lose one of the repetitive sequences and the sequence 
between them (Fig. 1.6b). Rad59 has been shown to be important for SSA between 
direct repeats, with the requirement for Rad59 increasing as the repeat length decreases 
(Symington, 2002). Rad59 has also been shown to bind DNA, preferentially single 
strand DNA, and be capable of annealing complementary single strand DNA 
(Petukhova et al., 1999a). After the annealing of the repeats, excision of the non- 
homologous 3' ends, DNA synthesis and ligation complete the reaction.
1.6.5 Meiotic recombination
Meiosis is a specialised form of cell division in some diploid organisms which involves 
a single round of DNA replication, followed by two subsequent cell divisions resulting 
in the generation of haploid cells (Page and Hawley, 2003). Meiotic recombination is an 
essential process of meiosis that stabilises the interactions between segregating 
chromosomes, generates diversity and promotes evolution. The mechanism of meiotic 
recombination is very similar to mitotic DSB repair, and appears to occur either by DSB 
repair or SDSA mechanisms (Smith and Nicolas, 1998). However, specific adaptations 
to this repair reaction are characteristic of meiosis (Fig. 1.10). During meiosis, DSBs are 
generated by the interactions of a number of proteins, with the topoisomerase-like 
Spoil transesterase catalysing DSB formation (Keeney et al., 1997). It is proposed that 
a pair of Spoil monomers cleave DNA by a reversible transesterase reaction in which a 
tyrosine side chain on the protein attacks the phosphodiester backbone (Keeney et al.,
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1997). Mutation of Spoil in yeast has been shown to result in the absence of DSBs, a 
lack of RadSl-Dmcl complex (see below), a lack of recombination and severe 
synaptonemal complex defects (Lichten, 2001). The generation of DSBs in addition to 
Spoil, requires a number of other proteins (Roeder, 1997). Whether or not the DSB 
generating complex assembles on the DNA as it is replicated is as yet still unknown. It 
is thought that the DSB is then resected, as it is in the DSB repair model, by the MRX 
complex (Keeney, 2001). In mice, humans, drosophila and plants homologues of yeast 
Spol 1 have been identified (Hartung and Puchta, 2000; McKim and Hayashi-Hagihara, 
1998; Romanienko and Camerini-Otero, 2000), and in mice Spoil has also been shown 
to generate DSBs (Keeney et aL, 1999). This suggests that the process of generating 
DSBs to initiate meiosis is conserved from yeast to mammals.
Meiotic recombination also requires a meiosis-specific homologue of RadSl, named 
Dmcl (Bishop et a l, 1992). RadSl and Dmcl proteins have high levels of sequence 
homology and both have distinct and overlapping roles in recombination (reviewed in 
(Masson and West, 2001). Dmcl has been shown to form multiple nuclear complexes 
(known as foci) prior to meiotic chromosome synapsis (Bishop et al., 1992), suggesting 
that it operates in a similar manner as RadSl in DSB repair. The presence of Dmcl has 
also been described in mammals, suggesting that the repair of the DSB is also 
conserved. Human Dmcl has been shown to bind DNA in an octomeric ring (Passy et 
al., 1999), interact with RadSl (Masson et al., 1999), and to be meiosis-specific (Gupta 
et al., 2001). In contrast to the filaments formed by RecA and RadSl on single stranded 
DNA, human Dmcl binds single stranded DNA like beads on a string (Masson et al, 
1999).
Mutation of Dmcl in yeast has been shown to result in defective reciprocal 
recombination, an accumulation of DSBs and the failure to form normal synaptonemal 
complexes (SC), all of which caused the mutants to arrest late in meiotic prophase 
(Bishop, 1994). Recombination in meiosis is very distinct from mitosis in that it occurs 
preferentially between homologous chromosomes rather than sister chromatids. The 
mutation of another gene, redl, which is also required for SC formation, was shown to 
almost eliminate the production of inter-homologue recombination intermediates 
(Schwacha and Kleckner, 1997). In the same study, redl dmcl double mutants were 
shown to have nearly abolished inter-homologue joint molecule formation, with RadSl 
promoting joint molecules between sister chromatids. Together, these results suggest 
that the role of Dmcl is to promote recombination between homologous chromosomes.
rather than sister chromatids, and that Redl functions to block joint molecule formation 
in the absence of Dmcl.
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Figure 1.10: The proteins of mitotic and meiotic recombination. A schematic representation of DSB 
repair including a list of the proteins involved in mitotic and meiotic recombination, highlighting those 
that are meiosis-specific. The figure does not include all of the proteins involved in these processes, 
merely a subset of them that have been discussed during this introduction. Figure adapted from Smith and 
Nicolas (1998).
RadSl and Dmcl have been shown to co-localise during meiotic recombination 
(Bishop, 1994), and, in yeast, this appears to be promoted by a RadS4 homologue, 
Rdh54/Tidl (Shinohara et al., 2000). Although RdhS4/Tidl has also been shown to 
operate in mitotic cells (Klein, 1997), it appears limited to aiding the process of 
recombination between homologous chromosomes, whereas Rad54 aids sister 
chromatid recombination (Arbel et al., 1999). A homologue of yeast Rdh54 has also
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been identified in mammals, named Rad54B, which has been shown to be involved in 
homologous recombination, although no direct interaction with RadSl or Dmcl was 
observed (Tanaka et aL, 2002). As yet, it has not been determined if mammalian 
RadS4B has a role in meiotic recombination.
The mismatch repair proteins, Mlhl, Mlh3, Msh4 and MshS, have been shown to 
function during meiotic recombination (Roeder, 1997). Mutations in msh4 and msh5 
result in a reduction of crossing over despite normal levels of gene conversion 
(Hollingsworth et ai, 1995; Novak et al., 2001). Different roles for the Mlh and Msh 
proteins have been suggested by the observation that reduction in the levels of crossing 
over in mlhl and mlhS mutants is much less pronounced (Kleckner, 1996; Roeder, 
1997). However, it appears that they may operate in the same pathway as the defects 
observed in an mlhl msh4 double mutant are no more severe than those of a msh4 single 
mutant (Hunter and Borts, 1997). Although the exact roles of these proteins have not yet 
been defined, recent findings have begun to do so. Msh4 and MshS have been shown to 
recognise Holliday junctions and to form a sliding clamp that embraces adjacent 
homologous duplex DNA (Snowden et al., 2004). Msh4 has also been shown to co- 
localise with RadSl and Dmcl (Neyton et al., 2004). These results have led to a 
proposed function of Msh4 and MshS in the stabilisation and preservation of a DSB 
repair intermediate.
1.6.6 The role of Mismatch repair
During replication or mutagenesis by some chemicals, base pair mismatches can arise 
which could lead to phenotypic changes if left unrepaired. The mismatch repair (MMR) 
machinery, which is responsible for recognising such mismatches, has a vital role in the 
maintenance genomic integrity (reviewed in Schofield and Hsieh, 2003). In addition, it 
plays a role in homologous recombination (reviewed in Evans and Alani, 2000), since 
mismatches can arise during recombination between non-identical DNA sequences. In 
eukaryotes, the initial steps of MMR involve the binding of bacterial MutS homologues 
(Msh) to a mismatch and, in a reaction that requires ATP, recruitment of MutL 
homologues (Mlh, or Pmsl or 2). Together, these complexes co-ordinate the removal of 
the mispaired bases and DNA re-synthesis. Msh2 forms heterodimers with the other 
MutS homologues, with the resulting complexes functioning in different types of MMR. 
Msh2-Msh6 recognises single-base mismatches, whereas Msh2-Msh3 recognises l-8bp
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insertion/deletion loops. 4 Mlh proteins have heen described, which form three different 
heterodimers: all these contain Mlhl, and one of either Mlh2, Mlh3 or Pmsl (Wang et 
aL, 1999). The distinctions between these heterodimers in the MMR reaction are yet to 
be elucidated
MMR also affects homologous recombination, inhibiting recombination between 
diverged sequences (Datta et al., 1996; Elliott and Jasin, 2001). Exactly how MMR 
inhibits recombination is not fully understood, but it has been suggested that the 
inhibition could take place during the processes of strand assimilation and/or branch 
migration, with MMR preventing strand exchange or branch migration in diverged 
sequences (Datta et al., 1996). Alternatively, MMR could result in the reversal of strand 
exchange intermediates, or destruction of intermediates with mismatches (Rayssiguier 
etal., 1989).
1.7 DNA repair, recombination and antigenic variation in T, brucei
In an attempt to define the pathways of DNA repair and recombination in T. brucei, 
functional analysis has been carried out on a number of homologues of some of the 
repair and recombination proteins mentioned in previous sections. The following 
section summarises the findings to date, and discusses the implied influences of these 
proteins on the mechanism of antigenic variation in T. brucei.
The first gene that was shown to have a role in DNA repair and recombination in T. 
brucei was RAD51, a homologue of eukaryotic RadSl, bacterial RecA and archeal 
RadA (McCulloch and Barry, 1999). Disruption of the RAD51 open reading frame, in 
both bloodstream form and procyclic stage cells, resulted in increased DNA damage 
sensitivity and a reduction in the efficiency of recombination, as measured by the rate of 
integration of transformed constructs. The same experiments also revealed unusual 
pathways of DNA recombination in RAD51 mutants. These results, as expected, 
confirm that RADSl indeed has a role in T. brucei repair and recombination. However, 
both processes were not abolished, suggesting that backup pathways must exist. Further 
analysis of the aberrant integrations taking place in the absence of RAD51 suggested 
that at least one backup pathway of recombination utilises small regions of homology 
during recombination. These small regions of homology were generally 7 - 13 bp in 
length, and in most cases contained base mismatches or insertions/deletions (Conway et 
al., 2002b). RAD51 has also been shown to be present in two other protozoan parasites;
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L. major (McKean et aL, 2001) and P. falciparum (Bhattacharyya and Kumar, 2003). In 
both organisms, increased expression of RAD51 was observed in response to DNA 
damage, suggesting that as in trypanosomes, RAD51 is involved in DNA damage 
repair.
T. brucei also contains homologues of eukaryotic Ku70 and Ku80. Disruption of either 
gene in T. brucei had no effect on DNA damage sensitivity, with either methyl 
methanesulphonate or phleomycin as damaging agents (Conway et al., 2002a). This 
suggests that either NHEJ is not present in T. brucei, or that homologous recombination 
dominates repair to such an extent that the NHEJ defect goes undetected. Determination 
of which of these possibilities is correct will require the generation of RAD51 and KU 
double mutants. T. brucei KU70 and KU80, however, were found to be important in the 
maintenance of transcriptionally active telomeres, since telomere shortening was 
observed in either mutant. Surprisingly, transcriptionally inactive telomeres were less 
prone to length changes (Conway et al, 2002a). This result suggested that the KU 
proteins are involved in a telomere maintenance pathway, a result confirmed by further 
analysis of KU80 in T. brucei (Janzen et al, 2004). Despite the observed telomere 
maintenance role of the KU proteins, no KU mutant clone was shown to have lost all 
telomere sequence. In fact, a telomere length equilibrium was reached in KU mutants 
grown in culture for extended periods of time, suggesting that at least one alternative, 
and uncharacterised, pathway exists for the maintenance of telomeres in T. brucei 
(Conway et a l, 2002a).
Another protein shown to have important roles in DNA repair and recombination in T. 
brucei is M rell. During the analysis of MREll function in T. brucei, mutants were 
observed to show DNA damage sensitivity to phleomycin, but not MMS, and also 
altered efficiencies and integration patterns during recombination with transformed 
DNA constructs (Robinson et al, 2002; Tan et a l, 2002). Although MREl 1 in T. brucei 
appears to be involved in repair and recombination, further results point to a role that 
may be quite different from that defined in other organisms. Mutation of MREll in T. 
brucei was shown to result in gross chromosomal rearrangements (OCRs) (Robinson et 
al, 2002). These OCRs appeared to occur only through the deletion of chromosome- 
internal sequence as only a shortening of chromosome length was observed and the 
terminal fragments remained largely intact. This appears different from MREl 1 mutant 
GCRs seen in yeast, where translocations, telomere deletions and chromosomal-internal 
deletions occurred (Chen and Kolodner, 1999). Despite all of the megabase 
chromosomes appearing to be affected by GCRs in T. brucei, the smaller intermediate
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chromosomes and the mini-chromosomes remained largely intact (Robinson et aL,
2002).
Five genes have been identified that, by sequence comparisons, are proposed to be 
involved in the MMR pathways of T. brucei (Bell et aL, 2004). Disruption of two of 
these genes, MSH2 and MLHl, has shown that they are indeed involved in MMR, with %loss of the genes resulting in increased rates of microsatellite variation and increased
-t:tolerance to A-methyl-A-nitro-A-nitrosoguanidine (Bell et al., 2004). Loss of MSH2, 
central to the ‘recognition’ MSH heterodimers of yeast, also resulted in an increased 
frequency of recombination between both homologous and diverged sequences (Bell 
and McCulloch, 2003). Therefore, as in yeast, the MMR pathways of T. brucei appear 
to act to prevent recombination between diverged sequences. However, a significant 
drop in the recombination efficiency of sequences showing just 1% divergence suggests 
that MMR does not account for all of this recombination inhibition.
The analysis of the mechanisms of recombination in other organisms allows us to 
predict how the process of recombinational switching might occur in trypanosomes. In 
theory the activation of array VSG genes requires a gene conversion reaction. It is most 
likely that this process would be carried out by SDSA (Barry, 1997; Borst et al., 1996), 
a conservative replication method, as opposed to DSB repair which could result in 
translocations. Recombination of telomeric VSG into the active BBS could proceed by 
gene conversion or BIR, as either would not lead to critical sequence loss since only 
telomeric sequences would be exchanged. Analysis of homologues of the proteins 
involved in these pathways in other organism could help start to define the mechanisms 
of recombinational switching in T. brucei.
To this end, disruption of RAD51 was shown to result in a reduction in the rate of VSG 
switching (McCulloch and Barry, 1999), showing that recombinational switching is 
likely to involve one of the mechanisms described above. What was unexpected was 
that both in situ and recombinational mechanisms were affected. Why this is the case is 
not yet known as, in situ switches are thought not to involve recombination.
Unexpectedly, the disruption of MREll resulted in no detectable defect in VSG 
switching (Robinson et al., 2002). This is particularly surprising when it is considered 
that loss of MREl 1 leads to a reduction in the ability to repair DSBs, the mechanism 
proposed to initiate VSG switching. This result could be explained by the initiation of 
DSB repair during VSG switching heing carried out by a specialised endonuclease.
Perhaps the form of DSB that is generated excludes any processing by MREll. 
Alternatively, VSG switching could be initiated from a stalled replication fork in a
40
pathway that does not require MREll. This is suggested by the observation that 
MREll mutants do not show increased sensitivity to MMS damage (Robinson et al.,
2002), which generates adducts on DNA that might be expected to induce replication 
fork stalling (Sedgwick, 2004), as opposed to phleomycin which directly creates DSBs 
(Giloni et al., 1981). For either explanation to be correct, the proposed role that MREl 1 
has in signalling DNA repair must be absent in T. brucei.
Mutation of KU was also shown not to effect VSG switching (Conway et al., 2002a), 
although this is perhaps not unexpected as NHEJ, a process that generates small levels 
of sequence alterations, is unlikely to be utilised in the life saving process of VSG 
switching. This reasoning would appear to rule out a transposition-based mode of VSG 
switching (Dujon, 1989), in keeping with the suggestion that RAD51 and homologous 
recombination drives VSG switching.
Despite influencing homologous recombination, MSH2 appears also not to influence 
VSG switching (Bell and McCulloch, 2003). There could be several explanations for 
this observation. The simplest explanation for this is that antigenic variation is driven 
largely by homologous recombination on perfectly matched sequences. If this is the 
case, the switching assay may not be sensitive enough to detect the slight increase in 
recombination efficiency observed in MMR-deficient T. brucei (Bell and McCulloch,
2003). However, we know that VSG gene conversion often utilises degenerate 70-bp 
repeats as part of the integration cassette. Alternatively, VSG switching may utilise a 
homologous recombination pathway exempt from regulation by MMR. This may be 
achieved by the exploitation of a novel homologous recombination pathway to carry out 
VSG switching. We already know that T. brucei utilises at least two pathways of 
homologous recombination, RAD51-dependent and RAD51-independent (Conway et 
al, 2002b).
The analysis of VSG switching in the mutants described above have all been carried out 
in a derivative of Lister 427 bloodstream cells (McCulloch et a l, 1997; Rudenko et a l,
1996), a monomorphic T. brucei cell line that switches at only background levels. It is 
therefore difficult to say what effect, if any, these genes would have in pleomorphic 
strains with substantially higher VSG switching frequencies. Indeed, recent work 
analysing RAD51 in ILTat 1.2, a pleomorphic cell line, has suggested that in high 
switching strains its role in VSG switching may not be as central as it is in 
monomorphic cell lines (P. Burton, PhD thesis).
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1.8 The aims of the project
Given that only one gene so far, RAD51, has been identified to have a role in antigenic 
variation, our picture of the genetic influences of this reaction is far from complete. In 
addition, RAD51 mutant T, brucei display a DNA damage sensitivity, a recombination 
defect and a reduced rate of VSG switching, but since these processes do still occur, 
backup pathways of repair, recombination and VSG switching must exist. The broad 
aim of this thesis is the identification and analysis of other genes that may contribute to 
these processes.
During this introduction I have discussed the recombination mechanisms in mammals 
and yeast, and discussed the fact that the central enzyme, Rad51, is aided by a number 
of cofactors.
In light of this knowledge, the three specific aims of this project are as follows:
i. To identify RADSl-liks genes present in T. brucei.
ii. To determine if any of the iMDJi-like genes have roles in DNA repair and
homologous recombination.
iii. To determine if any of the RAD51-\\kQ genes have roles in antigenic variation.
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2.1 Reagent abbreviations
BSA bovine serum albumin
CBSS Carter’s balanced salt solution
Ix: 0.023 M HEPES, 0.12 M NaCl, 5.41mM KCl, 0.55 mM CaCb, 0.4 
mM MgS0 4 , 5.6 mM Na2HP0 4 , 0.035 M glucose, 0.04 mM phenol red, 
pH to 7.4
CIP calf intestinal phosphatase
DAPI 4 ,6-diamidino-2-phenylindole
DEPC diethyl pyrocarbonate
Used at 0.1% w/v to remove RNAase
DMSO dimethyl sulphoxide
dNTP deoxynucleoside triphosphate
FITC fluorescein isothiocyanate
MMS methylmethane sulphonate
MNE MOP S/Sodium acetate/EDT A buffer
Ix: 0.024 M MOPS, 5 mM NaOAc, 1 mM EDTA. PH adjusted to 7 with 
NaOH and stored in the dark at 4°C
NDS solution for the manufacture of genomic plugs
Ix: 0.5 M EDTA, 0.5M TRIS base, 0.5 M NaOH, 17 mM lauroyl 
sarcosine. pH adjusted to 8 or 9 with NaOH
PBS phosphate buffered saline
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PS phosphate/sodium chloride buffer
Ix: 0.06 M Na2HP0 4 , 46 mM NaCl.
PSG phosphate/ sodium chloride/ glucose buffer
Ix: 0.06 M Na2HP04, 3,6 mM NaH2P0 4 , 46 mM NaCl, 55mM glucose, 
pH 8
RT reverse transcriptase/transcription
SDS sodium dodecyl sulphate
SOB bacterial media (per Litre): 20 g bacto-tryptone, 5 g bacto-yeast extract,
0.5 g NaCl
SOC SOB + 20 mM glucose
SSC sodium chloride/ sodium citrate solution
Ix: 0.15 M NaCl, 0.015 M NaaCeHsOy
TAB TRIS/ acetate/ EDTA buffer
Ix: 0.04 M TRIS base, 0.04 M glacial acetic acid, 1 mM EDTA
TBE TRIS/ borate/ EDTA buffer
Ix: 0.089 M TRIS base, 0.089 M ortho-boric acid, 2 mM EDTA
TBl/lOE TRIS/ borate/1/10 EDTA buffer
Ix: 0.089 M TRIS base, 0.089 M glacial acetic acid, 0.2 mM EDTA
TE 10 mM Tris.HCl, 1 mM EDTA pH8.0
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2.2 Trypanosome strains and their growth
The Trypanasoma brucei strain used in this study is 3174.2 (McCulloch et a l, 1997; 
Rudenko et al., 1996), a transgenic derivative of the Lister 427 strain. T. brucei 
bloodstream form cells of strain Lister 427, expressing MITatl.2a (VSG 221), was 
derived from an unknown number of syringe passages through rodent hosts over many 
decades (Melville et al., 2000). This strain switches the VSG being expressed at about 1 
X 10"^  -  1 X 10'  ^ switches/cell/generation (see section 1.3), and is monomorphic, 
displaying only the long slender bloodstream form stage routinely. The transgenic 427 
strain, 3174.2, contains hygromycin and G418 resistance genes in the ES containing 
VSG 221 to allow VSG switching analysis (see section 4.8). In vitro growth used HMI-9 
medium (Hirumi and Hirumi, 1989), whereas in vivo growth was carried out using adult 
female ICR mice (approx. 25 g) infected via interperitoneal injections.
2.3 Trypanosome isolation and stabilate preparation
Analysis of VSG switching and in vivo growth measurements required the recovery of 
trypanosomes from mouse blood after growth in the rodent host. For VSG switching 
(Section 2.4.1), the mice were exsanguinated by cardiac puncture, and the blood 
withdrawn into 5% sodium citrate anticoagulant in Carter’s Balanced Salt Solution 
(CBSS) (0.15 ml CBSS/5% sodium citrate per 0.85 ml blood). To isolate clonal 
switched variants, 2 x 0.4 ml of exsanguinated mouse blood was subsequently 
centrifuged at 5000 rpm in a micro-centrifuge for 5 min. The centrifugation separates 
the blood into red blood cells as a bottom layer and plasma as a top layer, with T. brucei 
and white blood cells found in the interphase. The top and middle layers were removed :
with a needle (19 G) and syringe, added to 40 mis of HMI-9 and plated out over 2 x 96 
well plates. For growth counts carried out during in vivo growth see Section 4.3.2.
Trypanosome stabilates were prepared by adding lOOpl of 100% glycerol to 900pl of T. 
brucei cultures at a density of 1-2 x 10^  cells.ml'% and 1 ml aliquots placed in cryotubes 
(Nunc). The stabilates were placed at -80°C overnight before being moved to liquid 
nitrogen for storage.
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2.4 Transformation of the 3174.2 strain
T. brucei cultures, grown to a maximum density of 1-2 x 10^  cells.ml"% were 
centrifuged at room temperature for 10 minutes at 1620 x g. The cells were then 
resuspended in Zimmerman Post-Fusion medium (132 mM NaCl, 8 mM Na2HP0 4 , 1.5 
mM KH2PO4, 0.5 mM Mg acetate, 0.09 mM Ca acetate, pH7.0) supplemented with 1% 
glucose (ZMG) at a concentration of 1 x 10^  cells.ml'\ 5 x 10^  trypanosomes were 
electroporated in 0.5 ml of ZMG at 1.5 kV and 25 pF capacitance using a Biorad Gene 
Puiser II. Approximately 5pg of DNA, that had been restriction digested, 
phenol/chloroform extracted and ethanol precipitated, was routinely used for all 
transformations. After electroporation cells were placed in 10 mis of HMI-9 for 24 
hours before being placed on antibiotic selection. The recovered cells were centrifuged 
at 1620 X g for 10 minutes at room temperature and resuspended in HMI-9 (containing 
the appropriate drug) at a concentration of 10^  cells per 18 mis. 1-2 x 10^  cells (unless 
otherwise stated) were subsequently plated out in 24 well plates, with 10^  cells plated 
out over 12 wells. Drugs used for selection were Hygromycin, G418, Blasticidin, 
Phleomycin and Puromycin at concentrations described in the text. Analysis of 
recombination efficiency used essentially the same procedure but different recovery 
periods and antibiotic selection concentrations (see Section 4.6 for details).
2.5 Analysis of VSG switching
The method used to analyse the frequency and mechanism of VSG switching is based 
upon that used by McCulloch et al (1997) and McCulloch and Barry (1999). Further 
details regarding this protocol can also be found in Chapter 4 (the analysis of switching 
frequency, Section 4.8.1, and the analysis of switching mechanism, Section 4.8.2).
2.5.1 Analysis of VSG switching frequency
To generate mice with acquired immunity against VSG221, mice were first injected 
with 2 X 10^  3174.2 wild type cells that had previously been grown on hygromycin (5 
pg.mf^) and G418 (2.5 pg.mf^) for a period of 5 days. These mice were then cured by 
injection of cymelarsan (Rhone Merieux; 5 mg.kg"*) 3-4 days later. To generate
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switched variants and calculate VSG switching frequency, the VSG221 innnunised 
mice were then injected with 4-8 x 10^  cells of the cell lines to be tested. These cell &
lines, that had previously been grown on hygromycin (5 pg.mf*) and G418 (2.5 
pg.ml'^) for a period of 5 days, were removed from antibiotic selection for 9 
generations, thereby allowing VSG switch variants to arise. Approximately 24 hours 
after injection into the mice, the surviving T. brucei were recovered from the mouse :
blood by the huffy coat method and plated out as described in Section 2.2. The 
estimated switching frequency for each cell line was calculated from the number of 
wells displaying viable T. brucei populations as described in Section 4.8.1.
2.5.2 Analysis of VSG switching mechanism
The mechanisms of VSG switching that had been used in switched variants were 
determined using a combination of antibiotic selection and PCR (for further details see 
Section 4.8.2). 10 pi of cells from wells showing growth after recovery from VSG221 
immunised mice were passaged into 1.5 mis of HMI-9 containing either hygromycin (5 
pg.ml'^), G418 (2.5 pg.ml'^) or no drug. Up to 10 days later, the cells were scored for 
drug resistance and genomic DNA prepared (as described in section 2.6) from the cells 
grown on no drug. PCR analysis was then carried out on the genomic DNA to 
determine the presence or absence of the hygromycin and G418 resistance genes, and 
the VSG221 gene as described in section 4.8.2.
2,6 Isolation of genomic DNA
Trypanosomes were harvested from culture by centrifugation at 1620 x g for 10 min at 
room temperature and resuspended in digestion buffer (50mM Tris.Cl (pH 8.0), ImM 
EDTA, lOOmM NaCl). 50 pi 10% SDS and 2.5 pi of proteinase K (at 20 mg.ml"^) were 
then added, and the preparations were incubated at 37°C overnight to lyse the 
trypanosomes and digest proteins. The DNA was recovered from the lysis reaction by 
phenol/chloroform extraction and ethanol precipitation (see Section 2.6.1).
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2.8 Polymerase chain reaction (PCR)
PCRs were set up in either 25 or 50 pi volumes. Routinely, diagnostic PCRs were set up 
in a 25 pi volume, whereas, PCRs to amplify DNA fragments for cloning were set up as 
50 pi reactions. 50 pi reactions were prepared as an exact double of the 25 pi reactions, 
and therefore only the setting up of the 25 pi reactions is described. For each reaction 
0.25 pi (1.25 units per reaction) of either Taq (ABgene -  5 U.pf*), or Herculase 
(Stratagene -  5 U.pf^), DNA polymerase was commonly used to amplify DNA. For 
each polymerase, 2.5 pi of supplied 10 x buffers and the manufacturer’s recommended 
MgClz was added, along with 1 pi of 10 mM dNTPs and 1 pi of each primer at 5 mM. 
The reaction conditions used were 95°C for 5 mins, followed by 30 cycles of 95°C for 1
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2.6.1 Phenol/chloroform extraction and ethanol precipitation
To extract genomic DNA from the T. brucei lysis reactions, or from other reaction 
mixtures, such as restriction digestions, an equal volume of phenol/chloroform (at a 1:1 
mixture) (Sigma) was added and the solution mixed thoroughly by gentle inversion (for 
genomic DNA) or vortexing (for other DNA forms). The two phases were separated by 
centrifugation at maximum speed in a microcentrifuge for 3 min at room temperature, 
after which the aqueous layer was removed and transferred to a fresh eppendorf tube. 2 
volumes of 100% ethanol and Ao the volume of 3 M sodium acetate (pH 5.2) were then 
added and the tube contents were mixed thoroughly. The tube was then incubated at |
3:-20°C for a minimum of 20 min, after which the DNA was harvested by spooling (for 
genomic DNA) or pelleted by centrifugation at maximum speed in a microcentrifuge for 
30 min at 4“C. The pellet was then washed in 1 ml 70% ethanol, air-dried, and 
resuspended in an appropriate volume of buffer (usually TE) or water.
2.7 Isolation of total RNA
Trypanosomes were harvested from culture medium by centrifugation at 1620 x g for 10 
min at room temperature. Total RNA was then isolated using the Qiagen RNeasy mini 
kit, following the manufacturer’s protocol and using a 25 G needle and a syringe to lyse 
the cells.
min, 50-60°C for 1 min and 72°C for 1 min per kb, and finally 72°C for 10 mins. PCR 
machines used were for the amplification of DNA were a Robocycler® (Stratagene) and 
a PCRsprint (Hybaid). PCRs were routinely purified using the Stratagene PCR 
purification kit, following the manufacturer’s protocol. Appendix 1 contains a list of the 
oligonucleotides used for PCRs.
2.8.1 Reverse transcription polymerase chain reaction (RT-PCR)
Before cDNA preparation, Z brucei RNA was treated with DNAase to remove any 
contaminating genomic DNA. 2 pg of RNA was incubated, for 15 min at room 
temperature, with 1 unit of DNAase (Invitrogen) and 1 pi of 10 x DNAase buffer, in a 
total volume of 10 pi made up with water. The reaction was terminated by the addition 
of 1 pi of 0.25 mM EDTA and heating to 65°C for 20 min.
cDNA was then prepared from the DNAase treated RNA using the SuperscriptTM 
First-Strand Synthesis System for RT-PCR kit (Invitrogen). 50 ng of random hexamers 
were added to 8 pi of the DNase treated RNA, with 1 pi of 10 mM dNTPs, and heated 
to 65°C for 5 min and then incubated on ice for 1 min. 4 pi 25mM MgClz, 2 pi 0.1 M 
DTT, 2 pi of 10 X RT buffer and 1 pi of RNaseOUT recombinant libonuclease inhibitor 
were added to the RNA solution and incubated for 2 min at 25®C. 1 pi of Superscript II 
reverse transcriptase (200 U.ml'^) was then added, and the reaction was incubated at 
25°C for 10 mins before being incubated at 42°C for 50 mins. For each cDNA 
preparation an identical reaction was also set up with the same DNAase treated RNA, 
but with water added instead of reverse transcriptase. This acted as a negative eontrol 
for the presence of DNA contamination in subsequent PCRs. Following cDNA 
generation, reverse transcriptase was heat-inactivated at 70°C for 15 min and the tube 
was subsequently chilled on ice. To remove any remaining single-stranded RNA, 1 pi of 
RNAase H (3.8 U.ml'^) was added and the reaction was incubated at 37°C for 20 min. 
This cDNA was then suitable as a template for PCR, with 1 pi commonly used in 25 pi 
PCRs.
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2.8.2 3 ' rapid amplification of cDNA ends (RACE)
To obtain the 3 ' sequences of partially sequenced genes, 3 ' RACE was carried out on 
cDNA generated from total RNA using the 3 ' RACE System for Rapid Amplification of ■fcDNA Ends kit (Life Technologies). The manufacturers protocol was followed with the 
exception of the steps relating to the generation of cDNA that were missed out as 
cDNA, generated using random oligonucleotides, and not RNA, was used as a starting 
template (further details regarding this protocol can be found in section 3.3).
2,9 DNA digestion, electrophoresis and Southern blotting
2.9.1 Restriction enzyme digestion of DNA
Restriction enzyme digestion of DNA was performed at the specified temperature using 
commercial restriction enzymes. Routinely 1 to 2 pg of DNA was digested in a reaction 
volume of 20 pi with 1 to 2 U of restriction enzyme (NEB) and 2 pi of the 
recommended buffer (lOx Buffer, NEB). If a larger quantity of digested DNA was 
required, the reactions were scaled up, to a maximum volume of 100 pi, and were 
subsequently phenolxhloroform extracted (Section 2.6.1). Plasmid DNA was routinely 
digested for 2 hours, whereas, genomic DNA was digested for a period ranging from 6 
hours to overnight.
2.9.2 Gel electrophoresis
Standard DNA separations were performed on 1.0% agarose gels (Seakem LE, BMA) 
run at lOOV in 1 x TAB buffer using a commercial 1 kb ladder as a size marker 
(Invitrogen). Digests of genomic DNA for Southern blots were electrophoresed on 0.8% 
agarose gels (Seakem LE, BMA) run at 30 V for 16-24 hours in 1 x TBE buffer. In both 
cases, gels routinely contained 0.2 pg.ml'^ ethidium bromide (EtBr) to facilitate 
visualisation of the DNA under UV light.
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2.9.3 Southern blotting
Agarose gels to be Southern blotted were Initially photographed on a UV 
transilluminator with a ruler parallel to the gel so that the sizes of bands detected by the 
hybridisation of radio actively labelled DNA (see section 2.10) could be measured. To 
nick the DNA, the gel was placed in 0.25 M HCl for 15 min and then rinsed with 
distilled water. Following this, the DNA was denatured by placing the gel in 
dénaturation solution (0.5 M NaOH, 1.5 M NaCl) for 30 min. After rinsing with 
distilled water, the gel was placed in neutralising solution (1 M Tris-HCl pH 8.0, 1.5 M 
NaCl) for a further 30 min. The DNA was transferred to a nylon membrane (Hybond- 
XL) by capillary blotting using 20 x SSC as the transfer buffer (Sambrook et al., 1989). 
Blotting was routinely performed for 24 h and then the DNA was crosslinked to the 
membrane using the auto crosslink setting on a UV stratalinker® (Stratagene).
2.10 Pulse Field Gel Electrophoresis (PFGE)
Chromosome sized DNA was separated by PFGE using the CHEF-DR III system (BIO­
RAD).
2.10.1 The preparation of genomic plugs
Each genomic agarose plug contained 5 x 10^  trypanosomes. The trypanosomes, 
growing in HMI-9, were centrifuged at 1620 x g for 10 min at room temperature and 
washed twice in the same volume of PSG. For a single agarose plug, 5 x 10^  T. brucei 
cells were then centrifuged at 1620 x g for 10 min at room temperature, the pellet 
resuspended in 50 pi of PSG and warmed to 37°C for 1 min. This was then mixed with 
50 pi of 2% low-melting point agarose (InCert agarose, FMC Bioproducts) solution 
(which had been prepared in 1 x TBViqE and held at 37‘^ C), and dispensed into a plug 
mould (BIO-RAD) and left to set at 4°C.
When solid, plugs were dispensed into tubes to which a minimal volume of NDS pH9 
containing 1 mg.mf^ proteinase K was added, and the tubes incubated at 50°C for 24 
hours. The buffer was then changed to NDS pH8 containing 1 mg.ml'^ proteinase K and
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2.11 RNA electrophoresis and Northern blotting
2.11.1 RNA electrophoresis
RNA separations were performed on 1.0% agarose gels (Seakem LE, BMA) containing 
2.2M formaldehyde, and run at 30 V for 16-24 hours in 1 x MNE buffer using a 
commercial 0.2-10 kb ladder as a size marker (Sigma). The RNA samples were added to 
20 pi of RNA loading buffer (60 pi formaldehyde, 20 pi formamide, 24 pi 5 x MNE 
buffer and 16 pi of H2O) and Ipl of EtBr (0.2 pg.mf^) and incubated at 65°C for 5 mins 
before separation.
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incubated at 50°C for another 24 hours. After this, the plugs were transferred to NDS 
pH8 for storage at 4°C.
2.10.2 Pulse Field Gel Electrophoresis
3 litres of 1 x TBViqE was placed in the PFGE tank and allowed to circulate at the 
running temperature of 12°C. After 30 mins this buffer was used to equilibrate the 
genomic plugs for 1 hour at room temperature and then stored at 4°C overnight. The 
following day, 110 mis of 1 x TBl/lOE was removed from the PEG tank and used to 
make a 1% agarose gel (Seakem Gold agarose, FMC Bioproducts). 100 mis of this was 
poured into a gel tray and the remainder kept at 37°C. When solid, the comb was 
removed, the agarose genomic pugs placed into the wells and the wells sealed using the 
remaining agarose. The gel was then electrophoresed at 4.6 V.cm"  ^ for 42 hours with the 
electrode switching time linearly ramped from 8 - 1 5  seconds. The gel was then stained 
by soaking in 200 mis of the running buffer containing 4pl of EtBr (10 mg.ml* )^, and 
then rinsed with distilled water before visualisation under UV light. PFGE gels were 
then Southern blotted as described in Section 2.8.3.
2.11.2 Northern blotting
Agarose gels to be Northern blotted were initially photographed on a UV
transilluminator with a ruler parallel to the gel so that the sizes of bands detected by the j:hybridisation of radioactively labelled DNA (see section 2.10) could be measured. Gels twere then soaked in sodium phosphate (pH 6.5) for 15 mins to remove the 
formaldehyde. The RNA was transferred to a nylon membrane (Hybond-XL) by 
capillary blotting using sodium phosphate (pH 6.5) as the transfer buffer. Blotting was 
routinely performed for 24 h and then the RNA was crosslinked to the membrane using 
the auto crosslink setting on a UV stratalinker® (Stratagene).
2.12 Radiolabelling and hybridisation of DNA probes
2.12.1 Probe manufacture by random hexamer radiolabelling of DNA
The DNA fragments used for probes in this study were PCR products that were gel 
extracted using the Qiagen gel extraction kit following the manufacturers protocol. 
Radiolabelling of these DNA fragments was performed using a commercial kit (Prime- 
It II kit, Stratagene). 25 ng of the DNA template was mixed with 10 pi of random- 
sequence oligonucleotides and sterile, distilled water, in a total reaction volume of 36 
pi. The mixture was then heated to 95°C for 5 min to denature the DNA and cooled to 
allow the random oligomers to anneal. 10 pi 5 x primer buffer, 3 pi of ^^ P labelled 
dCTP (30 pCi) and 1 pi Klenow (5U. pl"^ ) was then added, mixed, and incubated at 
37°C for 10 min. The resultant probes were then purified from the unincorporated 
nucleotides by passage through Microspin columns (Amersham) by centrifuging at 
3000 rpm in a microcentrifuge for 2 mins at room temp. After purification, the probes 
were denatured at 95°C for 5 min before hybridisation.
2.12.2 Hybridisation of radiolabelled DNA probes
Nylon filters of blotted DNA or RNA (Sections 2.8.3 and 2.10.2) were placed in glass 
hybridisation tubes (Hybaid) and approximately 50 mis of pre-warmed Church-Gilbert 
solution (0.342 M Na2HP0 4 , 0.158 M NaH2P0 4 .2H2 0 , 0.257 M SDS and 1 mM EDTA
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2.12.3 Stripping of hybridised nylon-membranes
Nylon membranes of blotted DNA or RNA were stripped of hybridised probe fragments 
by pouring boiling 0.1% SDS onto them whilst present in a heat resistant container and 
then allowing the SDS to cool to room temperature. The procedure was repeated again, 
and the membrane rinsed in 0.1 x SSC. Following stripping, the filters were checked for 
successful stripping using a phosphoimage screen (Fuji) at room temperature for 24 h. 
Following this, the membranes were then ready for re-hybridisation.
2.13 Cloning of DNA fragments
2.13.1 Cloning using T4 DNA ligase
DNA fragments for cloning were PCR amplified and PCR purified (Section 2.7) and 
restriction digested (Section 2.8.1). On occasion, DNA fragments for cloning required 
an overhang to be filled in prior to ligation. This was achieved for 5' overhangs by 
using the Klenow fragment of E. coli polymerase I (NEB), after heat-inactivation of the 
restriction enzyme(s) used to cleave the DNA. 1 pi of klenow, 1 pi of 10 mM dNTPs, 
0.5 pi of the same restriction enzyme buffer (NEB), and 2.5 pi of HgO were added to 
the heat-inactivated digestion reaction, and incubated at 37®C for 30 min. Filling in of 3' 
overhangs was not carried out during this project.
Self-ligation of the restriction digested vectors was prevented by treatment with Calf- 
intestinal phosphatase (CIP; Roche Diagnostics), which removed the 5' phosphate
55
per litre) added and the filters pre-hybridised for a minimum of 1 h at 65 °C in a rotating 
hybridisation oven. The denatured, radiolabelled probe (Section 2.11.1) was then added 
to the Church-Gilbert solution in the tube, and the hybridisation was left for 16-24 h at 
65°C. After hybridisation, the filters were washed at 65°C, in a rotating oven, with 2 x 
SSC, 0.1% SDS for 30 mins and then 0.2 x SSC, 0.1% SDS for another 30 mins. The 
filters were finally rinsed in 0.1 x SSC at room temperature and heat-sealed in plastic. 
The membrane was visualised using a phosphoimage screen (Fuji) at room temperature 
for 2 to 48 h and developed using a Typhoon 8600 (Amersham), again depending on the 
strength of the signal.
groups. 0.5 pi of CIP (10 U.pl'^) was added to the digestion reaction, which was 
incubated at 37®C for 10 min. After CIP treatment, the vector was purified either by 
phenolxhloroform extraction or gel extraction (using the Qiagen gel extraction kit) 
following electrophoresis.
Ligation of DNA fragments into a plasmid vector (e.g. pBluescript (Stratagene) 
derivatives thereof) were carried out in a 10 pi volume with 1 pi. of T4 DNA ligase 
(400 U.ml'\ NEB) and 1 pi of ligase buffer (NEB) which was incubated at room 
temperature for 6 hours. 6pl of this ligation reaction was subsequently used to transform 
80pl of E. coli XI-1 blue MRF' cells (see section 2.11.3).
2.13.2 Cloning into TOPO vector
PCR products generated by use of Taq DNA polymerase (AB gene) were suitable for 
cloning into this vector, as this enzyme produces a 3' single adenosine overhang. 0 .5 -4  
pi of PCR product was incubated with 1 pi of salt solution and 1 pi of TOPO TA vector 
(Invitrogen), in a total volume of 6 pi made up with water, for 5 min at room 
temperature. 2 pi of this reaction was subsequently used to transform 25 pi of TOP lOF' 
(Invitrogen) cells (see section 2.11.3).
2.13.3 Transformation ofE. coli and plasmid retrieval
The transformation of both MRF' and TOP lOF' E. coli cells was carried using heat 
shock. Ligations and cells were mixed gently and left on ice for 30 min. Following this, 
the cells were heat shocked at 42°C for 45 s, and then immediately transferred to ice for 
2 mins. Transformations of ampicillin resistance containing plasmids were then spread 
over L-agar plates containing ampicillin at a final concentration of 50 pg.ml'^ (Sigma). 
However, transformations of chloramphenicol resistance containing plasmids required 
expression of the drug resistance gene before plating on selective media. To do this, 1 
ml of SOC was added to the transformed cells, which were then incubated at 37°C for 1 
h. The cells were then centrifuged for 1 min at 10,000 rpm in a micro-centrifuge, the 
supernatant was poured off, and the pellet resuspended in 100 pi of SOC. This 
suspension of cells was then spread over L-agar plates containing chloramphenicol at a 
final concentration of 25 pg.ml'^ (Sigma), and incubated overnight at 37°C. Single
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colonies from these plates were then picked and used to inoculate L-broth (also 
containing the appropriate antibiotic at the same concentration as contained in the agar 
plates), and grown up overnight at 37° C. Plasmids were then prepared from 1.5-3 ml of 
the overnight culture using the Qiagen miniprep kit, or from 200 - 400 ml of culture 
using the Qiagen Maxiprep kit, following the manufacturers instructions.
2,14 T, brucei staining and hybridisation
T. brucei cells were visualised using an Axioskop 2 microscope (Zeiss) and Openlab 
software (hnprovw/ort).
2.14.1 DAPI staining
1 ml of T. brucei culture, at a density of 1-2 x 10^  cells.ml ^ was centrifuged, washed 
twice with PBS before being resuspended in 1 ml of PBS. 10 pi samples were then 
spotted onto multi-spot microscope slides (C.A.Hendley Ltd.) and allowed to air-dry. 
The trypanosomes were then fixed by soaking in methanol for 5 minutes at room 
temperature and again allowed to air dry before vectashield with DAPI (Vector 
Laboratories Inc.) was added, a coverslip positioned and the slide sealed with clear nail 
varnish.
2.14.2 in situ hybridisation
The in situ hybridisation protocol is described in Section 5.2.2. The RAD51 antibody 
used in this assay was a rabbit polyclonal antiserum (Diagnostics Scotland) generated in 
response to His tag purified, E. coli expressed recombinant T. brucei RAD51 (supplied 
by K. Norrby). FITC conjugated secondary antibody used was a goat-derived anti-rabbit 
IgG (whole molecule; Sigma).
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C h a p t e r s
R A D 51-U K S. GENES IN T. BRUCEI
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3.1 Introduction
Humans, yeast and bacteria are well known to have an array of proteins that act to repair 
DNA and maintain genomic integrity. This array of proteins revolves around a core 
strand exchange enzyme, Rad51 (RecA in bacteria), and a number of cofactors that aid 
RadSl in its role as a repair enzyme. So far only RAD51 has been shown to have a role 
in recombination during antigenic variation in T. brucei. However, in a RAD51 mutant 
repair, recombination and antigenic variation still occur, albeit at a reduced level. As a 
result it was concluded that back-up pathways must exist for these processes. To 
examine this question, this project has attempted to identify potential -like genes
in T. brucei, since these are well-characterised examples of factors that act in 
homologous recombination. To do this, the T. brucei genome was BLAST searched 
with the amino acid sequences of S. cerevisiae and 7, brucei RAD51, and with E. coli 
RecA (see Appendix 2 for accession numbers). As a result of this, five further RAD51- 
related genes were identified, one of which was incomplete at the outset of this work. 
This chapter describes the experiments carried out to obtain the missing 3' sequence of 
one of the RAD51-\\kQ genes, and sequence analysis to examine the potential for each of 
the RriDJi-related genes to encode a strand exchange enzyme. In addition, this chapter 
describes initial functional characterisation of three of the -like genes.
3.2 Identification of putative RziDJf -like genes in T. brucei
The T. brucei RAD51A5ke genes were identified through BLAST searches of the 
incomplete (at the outset of this work) 7. brucei database, carried out throughout the 
course of this project. TBLASTN searches of sequence reads and assembled contigs 
were carried out using S. cerevisiae and 7. brucei RAD51, and E. coli RecA, as query 
sequences, searching via omniblast at Gene DB (Sanger). At the start of the project, 
Oct/Nov 2001, RAD51 searches revealed the complete RAD51 sequence, a complete 
lowly related sequence (subsequently named RAD51-3) and a partial, highly related 
sequence (section 3.3; subsequently named DMCl). Searches with E. coli RecA 
revealed a complete, highly divergent open reading frame not initially recognised by the 
RAD51 searches (subsequently named RAD51-5). The same searches revealed multiple 
further small sections of homology that were monitored through out to see if they
became part of larger contigs containing other genes. Later in the project, approximately
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Dec 2002, this revealed two further lowly-related genes (subsequently named RAD51-4 
and RAD51-6).
3.3 3' rapid amplification of cDNA ends to obtain DMCl 3' sequence
Before the analysis of one of the RAD51-\\kQ genes, named DMCl (see below), could 
be conducted, the complete open reading frame needed to be established, as the 3' end 
was absent in the available T. brucei genome sequence. At the beginning of this project, 
the incomplete T brucei genome database contained only 780 bp of DMCL To obtain 
the remainder of the sequence, 3' rapid amplification of cDNA ends (3' RACE, Life 
Technologies) was carried out. This technique utilises the poly-A tail, added to the 3' 
end of every mRNA, to anneal an adapter primer in order to generate cDNA from 
mRNA sequences in total RNA extracts. Reverse Transcriptase-PCR (RT-PCR) is then 
carried out to amplify the gene of interest using a gene-specific primer and an ‘abridged 
universal amplification primer’, specific for the adapter primer (Fig 3.1).
m RNA 5 ’---------------------------------------------------  AAA AAA 3EZ13’
cDNA 3 '^ ^ ----------------------------------------------- TTT TTT M MZZZEZI 5"
<^3DSE]
Figure 3.1: The use of 3' RACE to amplify the 3' end of genes. The adapter primer (AP) is used to 
generate cDNA by reverse transcription from total RNA, after which the RNA is degraded. The 3' end of 
a gene of interest can then be amplified by RT-PCR using a gene specific primer, in this case DMCI-D3 
(D3) or DMC1-D2 (D2), and the abridged universal amplification primer (AUAP), specific for the 
adapter primer.
For the DMCl gene, RT-PCR was carried out on cDNA generated, as described above, 
from Lister 427 bloodstream form-derived total RNA (A. Lewis, gift) using Taq DNA 
polymerase and primers DMC1-D3, DMC1-D2 (Appendix 1) and the abridged universal 
amplification primer (AUAP). The primers DMC1-D3 and DMC1-D2 were designed 
using sequence 231 bp and 146 bp, respectively, from the 3' end of the available DMCl 
sequence. RT-PCR reactions were carried out using both combinations of primers, as
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well as individual primer controls, from both RT-treated and RT-untreated cDNA 
samples (Fig 3.2).
RT- Primers RT+
1 AUAP & DMCIA-Ui 6
2 AUAP 7
3 DMClA-m 8
4 AUAP & DMC1A-D2 9
5 DMC1A-D2 10
1 2 3 4 5 6  7 8 9 10
Figure 3.2: 3' RACE reactions
carried out to obtain DMCl 3' 
sequence. RT-PCR reactions were 
carried out as listed, of which 5 pi 
sanples were separated by agarose gel 
electrophoresis. Primer names are 
shown in Fig 3.1 and discussed in the 
text. RT+: reverse transcriptase treated 
cDNA. RT-: reverse transcriptase un­
treated cDNA.
A Strong product was generated in each of the two-primer reverse transcriptase plus 
reactions, with AUAP and DMC1-D3 (Fig 3.2, lane 6) resulting in a PCR product 
approximately 1150 bp in size, and AUAP and DMC1-D2 (Fig 3.2, lane 9) resulting in a 
PCR product approximately 1050 bp in size. The size difference between the two 
products, approximately 100 bp, suggested that the products are DMC7-specific, as the 
two gene-specific primers hybridise 85 bp apart. Furthermore, no products were 
generated in the reverse transcriptase untreated controls, and all single primer reactions 
gave diffuse products, even though both the DMC1-D3 and D2 primers (Fig 3.2, lanes 8 
and 10) produced fragments of similar size to their cognate two primer reactions (Fig 
3.2, lanes 6 and 9). The two specific products were Topo cloned (TOPO TA cloning 
kit. Life Technologies; section 2.12.2) and sequenced (MBSU sequencing service, 
Glasgow). The sequences obtained from each product and the existing DMCl sequence 
were then aligned using Contig Express (Vector NTI suite 9, Invitrogen life science 
software) resulting in the assembly of an uninterrupted open reading frame 1047 bp in 
length. Almost immediately after this derivation of the putative DMCl open reading 
frame, the T. brucei genome database was updated and included the complete DMCl 
sequence. Comparison of the DMCl sequence obtained by 3' RACE with that contained 
within the database was carried out using AlignX (Vector NTI suite 9, Invitrogen life
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science software), which showed the sequences to be near identical (data not shown). 
For the analysis of the RAD51-like genes during this project gene sequences from the T. 
brucei genome database were used.
' ■
i'
3.4 Sequence homologies and phylogenetics
Having identified 5 further iL4Z)5i-related genes by searching the T. brucei genome 
database, BLASTp searches were carried out against the NCBI database using the 
predicted amino acid sequences of each of the genes (Table 3.1). This provided a crude 
estimate of whether or not these proteins are identifiable as Rad51- or RecA-like 
proteins in other organisms, rather than other proteins. In all cases the most recognised 
proteins were indeed RadSl- or RecA-related proteins, although for two (RAD51-5 and 
RADS 1-6) the level of confidence in these hits was very low. The genes were given 
generic names based on their homology to RadSl (RecA) sequences, although this was 
not intended to infer a prediction of their function.
Gene Homologue BLASTp Hit
RAD51-3 Homo sapiens RadSl C 
Chlamydomonas reinhardtii Rad51C Musmusculus RadSl C
2.00E-27
3.00E-2S
4.00E-2S
RAD51-4 Schizosaccharomyces pombe DMC1 
Coprinopsis cinerea Lim15/DMC1 
Entamoeba histolytica DMC1
5.00E-12
1.00Ê-10
1.00E-10
RAD51-5 Acidocella facilis RecA 
Vibrio cindnnatiensis RecA 
Aeromonas salmonicida RecA
0.002
0.007
0.007
RAD51-6 Arabidopsis thaliana XRCC3p Methanococcoides burtonii RecA/RadA 
Zeamays RadSlA
2.00E-07
0.005
0.035
DMC1 Leishmaniama major DMC1 Oryzasativa DMC1B 
Oryza sath/a LimlSB
1.00E-145
1.00E-113
1.00E-113
Table 3.1: BLASTp search results for 
the T. brucei RADSl homologues.
Three of the top hits obtained when 
carrying out BLASTp searches using 
the amino acid sequences of the T. 
brucei -related genes are shown.
The predicted amino acid sequences for each of the 5 Ry4D57-related genes were next 
analysed to determine their potential to encode strand exchange enzymes. To do this, 
the sequences were compared to the conserved domains of strand exchange enzymes 
identified in the study by Brendel et al (1997). In this work, 15 RadSl/Dmcl/RadA 
proteins and 13 RecA proteins from a diverse range of organisms were compared to 
define conserved domains within this group of proteins. The authors identified 6 
domains common to each of the RadS 1/Dmc 1/RadA sequences analysed and within 
those domains, eight sub-domains conserved also within the RecA sequences (Fig 3.3).
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Figure 33: Alignment of the amino acid sequences of T. brucei RAD51 and the RAD51 homologues. 
Top: The alignment of the polypeptide sequences of the T. brucei RAD51-related genes based on the 
domains identified by Brendel et al (1997) with general domain functions indicated. A: possibly interacts 
with other factors and/or nucleic acids. B1 & B2; enconpasses the hydrophobic core of the RecA 
structure and contains the Walker A box that binds ATP. Cl: comprises a highly conserved monomer- 
monomer surface. C2: conserved between the Rad51/Dmc 1/RadA and RecA sequences. Dl: comprises a 
helix in the RecA structure and forms part of a monomer-monomer surface. El: contains the Walker B 
box that hydrolyses ATP. E2: forms part of 2 loops, a helix and a P-strand. F: involved in monomer- 
monomer interactions and DNA binding. RecA-specific: possibly binds LexA/UmuD. Lighter colours and 
dashed lines represent lower conservation. Bottom: T. brucei RAD51 polypeptide sequence (top) is 
compared to all of the RAD5l'\ik& genes found in T. brucei lined up using the conserved Walker A (A) 
and B (B) boxes. See appendix 2 for accession numbers. The conserved domains described by Brendel et 
al (1997) are shown (grey writing and dashed line) as are the putative BRC consensus motif (PM; 
Pellegrini et al., 2002), the helix-hairpin-helix motif (H-h-H; Grishin, 2000) and the conserved residues 
(•; Story et al (1993). The alignment was carried out using ClustalW (Cheima et al., 2003) and coloured 
using Boxshade 3.21 (http://www.ch.embnet.org/software/ BOX fbrm.html).
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In addition, Rad51/Dmc 1/RadA sequences were found to contain an N-terminal 
extension (domain A) absent from the bacterial RecA sequences, and the RecA 
sequences were found to contain a unique C-terminal extension. The 5 recently 
identified T. brucei RAD51-like polypeptides and the canonical T. brucei RAD51, were 
aligned with each other by ClustalW, via Vector NTI (Vector NTI suite 9, Invitrogen 
life science software) and manual adjustments made to the alignment based on the 
conserved residues identified by Brendel et al (1997). From the sequence comparisons 
most of the conserved domains described by Brendel et al could be identified in each of 
the proteins. All of the conserved domains could be unambiguously identified in T. 
brucei RAD51 and DMCl. T. brucei RAD51-3 appears somewhat more diverged, with 
putative insertions in sub domains C2 and E2 and sequence divergence in the N- 
terminal A domain. T. brucei RAD51-4, RAD51-5 and RAD51-6 are yet further 
diverged. Sub domains A, Cl, C2, Dl, E2 and F were difficult to identify in RAD51-4, 
Similarly, A, Cl, C2, Dl and F were diverged in RAD51-6. Finally, RAD51-5 was 
diverged in Cl, C2, Dl and E2 and appeared to be severely truncated in the 
Rad51/Dmc 1/RadA specific N-terminal A domain, assuming the predicted start codon 
is correct. Despite the above sequence divergences, putative Walker A and B boxes 
(Walker et al., 1982), responsible for ATP binding and hydrolysis, could be identified in 
all the T. brucei RAD51-iike sequences, with one possible exception. In RAD51-4, a 
conserved serine residue has been changed to aspartic acid within the putative Walker B 
box (D277). Assuming this is a genuine coding change and not a sequence error, it 
suggests that all the T. brucei RAD51-like proteins, except RAD51-4, are capable of 
ATP binding and hydrolysis.
Story et al (1993) identified 12 amino acid residues central to the catalytic activity and 
structural integrity of RadSl, Dmcl and RecA in many organisms. The sequence 
comparisons suggest that although these are universally conserved in T. brucei RAD51 
and DMCl, they are much less conserved in the four other proteins. This may indicate 
that these are not capable of strand exchange themselves, but contribute to RAD51 or 
DMCl catalysis. However, no 3-dimensional structure for any RADS 1-related protein, 
other than DMCl (Masson et al., 1999; Passy et al., 1999), has been determined, so this 
is a preliminary conclusion. Further sequence elements with RadSl proteins have been 
determined by recent structural studies (Pellegrini et al., 2002; Shao and Grishin, 2000). 
Pellegrini et al (2002) in an attempt to define the interactions between RadSl and Brca2 
analysed RadSl sequences looking for motifs similar to the BRC repeat motifs. They 
found a highly conserved BRC repeat motif conserved within RadSl polypeptides from
a range of organisms. This motif could only be found in T. brucei RAD51 and was 
absent from all the other RAD51-related proteins. T. brucei DMCl sequence contained 
a highly conserved glycine residue in this motif, but the conserved alanine has changed 
to a glycine (G99) and it was deemed that this would result in a non-frmctional motif. 
Shao and Grishin (2000) describe helix-hairpin-helix motifs, which are involved in non- 
sequence-specific DNA binding, present within a wide range of proteins. In this work 
they show two conserved helix-hairpin-helix motifs, linked by an a-helix, conserved in 
the N-terminal region of H. sapiens Rad51. Analysis of the polypeptide sequences of 
the T. brucei R/4D57-related genes was carried out to determine the presence or absence 
of helix-hairpin-helix motifs. From these results, RAD51 and DMCl appeared to 
contain one helix-hairpin-helix motif, whereas they appeared to be absent in all of the 
other RAD51-related proteins. All conserved helix-hairpin-helix residues found in H. 
sapiens RadSl were found to be conserved in T. brucei RAD51; however, in DMCl the 
central conserved residue has been changed to leucine (L76), although this reside was 
conserved in the helix-hairpin-helix motifs in other proteins.
The levels of sequence homology of the T. brucei RADS 1-like polypeptides, compared 
with T. brucei RADSl or DMCl, in the alignments appear to be somewhat low. This 
result was confirmed by determining the sequence identities of the T. brucei RAD51- 
like polypeptides to 7. brucei RAD51 in pairwise comparisons (Table 3.2). To examine 
this question further, phylogenetic analysis was carried out using the polypeptide 
sequences of a number of RecA and RadSl-like proteins from a wide range of 
organisms (Fig 3.4). To do this, only those RadSl or RadSl-related proteins that have 
been functionally examined were considered. These were 7. brucei RAD51 (McCulloch 
and Barry, 1999), Leishmania major RAD51 (McKean et al., 2001), Plasmodium 
falciparum RAD51 (Bhattacharyya and Kumar, 2003), Saccharomyces cerevisiae 
RAD51/55/57 and DMCl (Paques and Haber, 1999), Schizosaccharomyces pombe 
Rhp51/55/57 (Grishchuk and Kohli, 2003) and Dmcl (Fukushima et al., 2000), Homo 
sapiens RAD51/L1/C/L3, XRCC2/3 (Masson et al., 2001b) and DMCl (Masson et al., 
1999), Drosophila melanogaster Rad51/51C/51D and SpnB/D (Staeva-Vieira et al,
2003), Arabidopsis thaliana Rad51/51C, XRCC3 and Dmcl (Osakabe et al, 2002), 
Oryza sativa DMCIA/B (Kathiresan et al, 2002), Ustilago maydis Rad51 and Rec2 
(Ferguson et al, 1997), Escherichia coli RecA (Brendel et a l, 1997), Bacillus subtilis 
RecA (Brendel et a l, 1997), Streptomyces lividans RecA (Brendel et a l, 1997), 
Campylobacter jejuni RecA (Guerry et a l, 1994), Neisseria gonorrhoeae RecA 
(Koomey and Falkow, 1987) and Staphylococcus aureus RecA (Bayles et a l, 1994).
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Included in the phylogenetic comparisons were the T. brucei RAD51-\i\iQ genes, and 
Dmcl from L. major and P. falciparum, none of which have been functionally 
characterised. In this analysis, the RadSl, Dmcl and RecA proteins formed discrete 
groupings, whereas the RadSl-like proteins showed less similarity and did not group 
together. This suggests that the level of conservation, beyond the RadSl and Dmcl 
polypeptides, in eukaryotes is overall low, and it is not possible to infer functional 
relationships between the RADS 1 -like proteins. Whether or not this means that these 
genes arose independently in each organism, or have loosely defined functions that 
allow broad sequence diversification, is not clear (Bennett and Holloman, 2001; 
DiRuggiero et al., 1999; Thacker, 1999; Yang et al., 2001).
To illustrate this further, all RAD51-\\Vq genes from T. brucei and H. sapiens were 
compared (Table 3.3). This comparison shows that the levels of sequence conservation 
between the RADSl and DMC 1(A) sequences is high (4S-60% identity), but for the 
other RADS 1-like proteins only low levels of sequence identity can be found (8-24%). 
On this basis, no clear orthologues can be discerned.
H. sapiens
RAD51 
DMCl 
§ RAD51-4I RAD51-3
RAD51-6
RAD51-5
H.saplens
RAD51 100100 51.665.1 16.124.9 21.033.6 24.737.1 22.233.1 15.827.0
RAD51 DMCl XRCC2 XRCC3 RAD51B RAD51C RAD51D T B m aRAD51
60.1 44.8 14.3 20.3 20.2 19.5 16.2 100
70.8 57.6 21.7 32.0 33.6 33.3 25.5 100
52.7 57.0 14.6 20.7 23.8 19.7 14.8 49.2 1
67.3 70.1 24.8 33.0 38.2 34.1 26.6 62.6
15.5 15.1 10.9 17.4 15.8 15.7 16.4 15.6 I
29.4 27.2 18.9 28.9 28.1 25.9 27.5 29.1
17.7 18.1 12.4 16.3 17.0 22.8 10.8 17.0 :
27.6 26.0 19.4 27.8 26.4 33.5 20.3 25.9 :
16.8 15.7 8.0 17.0 14.9 15.6 11.7 15.9
23.7 25.7 15.9 26.4 25.1 27.0 20.1 26.3
11.3 9.5 13.5 11.8 12.1 12.2 13.5 10.8
22.8 22.2 23.0 21.1 23.7 24.3 22.7 2 5 2 .
Table 3.2: The sequence homology of the RAD51-like proteins of T. brucei and H. sapiens. The
sequence identities (large numbers) and similarities (small numbers) when comparing each of the T. 
brucei and H. sapiens RAD51-like proteins are shown. The identities and similarities were generated 
through pair wise comparison using AlignX (Vector NTI).
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D.m-RAD51D A.t-mtRECA
A.t-ctRECAS.P-RHP55 H.S-XRCC2S.C-RAD55 C.j-RECA
E.c-RECA
T.b-RAD51-5
N.g-RECA
S.I-RECA
D.m-RAD51C B.s-RECA
- —  S.a-RECA
T.b-RAD51-6
H.S-RAD51L3
D.m-SPNB
A.t-XRCC3a -  U.m-REC2
H.S-XRCC3 H.S-RAD51L1
P.f
S.P-RHP57 D.m
T.b
S.C-RAD57 Lm
A.t
A.t-RAD51Ca H.s
H.S-RAD51C
S.p‘ S.c P.fT.b-RAD51-3 O.s-b H.sO.s-a A.t 0.1L.m T.b
Figure 3.4: Phylogenetic tree of RecA and RadSl-like proteins. The polypeptide sequences of 9 
RadSl, 9 Dmcl, 8 RecA and 19 RadSl-like genes from T. brucei (T.b-), Leishmania major (L.m-), 
Plasmodium falciparum (P.f-), Saccharomyces cerevisiae (S.c-), Schizosaccharomyces pombe (S.p-), 
Homo sapiens (H.s-), Drosophila melanogaster (D.m-), Arabidopsis thaliana (A.t-), Oryza sativa (O.s-), 
Ustilago maydis (U.m-). Escherichia coli (E.c-), Campylobacter jejuni (C.j-), Neisseria gonorrhoeae 
(N.g-), Bacillus subtilis (B.s-), Streptomyces lividans (S.1-) and Staphylococcus aureus (S.a-) were 
conqiared by ClustalW (Chenna et al., 2003). The sequence comparison was then used to generate a 
phylogenetic tree and visualised using Tree view (Page, 1996). The RadSl sequences are shown in blue, 
the Dmcl sequences in red, the RecA sequences in green and the RadSl-like sequences in black.
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It is interesting that the number of RadSl-lïks genes that an organism possesses varies. 
It may be that the overall number of Rad51-\\kQ genes is related to the size of the 
genome (Table 3.3), since multi-cellular eukaryotes such as H. sapiens^ A. thaliana and 
D. melanogaster have 7, 6 and 6 Rad51-\ike genes, respectively, in total. In contrast, 
single-celled fungi such as 5". cerevisiae and S. pombe contain 4 (although S. pombe 
may in fact contain a fifth RadSl-like gene; Grishchuk and Kohli, 2003). T, brucei, with 
6 RAD5J-like genes, is either unusual or the relationship between genome size and 
Rad51-like gene number is incorrect. To examine this we looked for 7641)57-like genes 
in the genomes of the related Kinetoplastids, Trypanasoma cruzi and Leishmania major. 
To date, only the canonical RAD51 has been detailed in L. major (McKean et ah, 2001). 
BLASTp searching the predicted genes in each genome, initially using T. brucei 
RAD51 and the canonical RAD51 from the two other parasites, identified 6 RAD51- 
related genes in T. cruzi and 5 in L. major (Table 3.3). Sequence comparisons of the 
predicted polypeptides within each genome are shown in Figures 3.5 and 3.6.
«
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Table 3.3; jRad57-like gene 
numbers in eukaryotes. The
number of Rad51 genes found in 
a range of eukaryotes and their 
potential function are shown.
H. sapiens RAD51 DMCl 5 RADSMike
A. thaliana RAD51 DMCl 4 RAD51-llke
D. m elanogaster RAD51 4 RADSMike
S. cerevislae/pombe RAD51 DMCl 2 RADSl-like
L. major RAD51 DMCl 3 RADSMike
T. brucei/T. cruzi RAD51 DMCl 4 RADSl-like
strand exchange strand exchange strand exchange
m itosis/m eiosis meiosis co-factors?
The polypeptide sequences of the RAD51-Uke proteins found in T. cruzi and L. major 
are also equally divergent in comparison to each other as the RAD51-like proteins of T. 
brucei, suggesting that this divergence is not a specific, unusual trait for T. brucei. 
However, comparison of the polypeptide sequences of the RAD51-like proteins found 
in T. cruzi (Table 3.5) andL. major (Table 3.6) to those found in T. brucei suggests that 
each of the T. brucei RAD51-like proteins appears to contain an orthologue in T. cruzi 
and L. major. The exception to this is T. brucei RAD51-5, where an orthologue cannot 
be found in L. major. Whether this is because the L. major Rad51-5 is too diverged to 
be identified, has not been sequenced yet, or is truly absent is not known. This result
6 8
//A:
suggests that it is a trait of Kinetoplastids to contain an unusually large number of 
7647)57-related genes that show high levels of sequence divergence.
T. brucei
RAD51 DMC1 T. cruzi RAD51-3 RAD51-4 RAD51-5 RAD51-6RAD51 79.9 48.5 18.1 17.1 12.8 16.7DMC1 48.2 88.0 18.5 15.9 11.7 15.9RAD51-3 16.1 17.1 49.8 14.6 12.5 12.7RAD51-4 14.6 18.2 14.3 39.9 15.6 13.3RAD51-5 11.4 12.1 12.4 12.4 34.8 13.8RAD51-6 15.3 17.2 16.4 13.8 17.1 39.2
The sequence identities obtained when comparing the RAD51-like proteins fr<
brucei and T. cruzi. The sequence identities obtained using AlignX (Vector NTI) to con^are each of the 
T.cruzi RAD51-like proteins to those of T. brucei are shown. The highest sequence identity for each T. 
cruzi protein is highlighted in blue, and they have been named based on this.
T. brucei
RAD51 DMC1 L. major RAD51-3 RAD51-4 RAD51-5 RAD51RAD51 77.5 46.5 9.6 15.6 X 10.0DMC1 47.7 72.4 10.3 13.7 X 9.0RAD51-3 16.3 17.2 23.9 13.2 X 11.4RAD51-4 15.5 17.6 12.7 18.0 X 12.6RAD51-5 9.8 13.6 7.6 12.9 X 8.7RAD51-6 17.2 17.8 15.1 13.8 X 21.9
Table 3.5: The sequence identities obtained when comparing the RADSl-like proteins from T. 
brucei and L. major. The sequence identities obtained using AlignX (Vector NTI) to compare each of the 
L  major RAD5I-like proteins to those of T. brucei are shown. The highest sequence identity for each L  
major protein is highlighted in blue, and they have been named based on this.
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Figure 3.5: Alignment of the amino acid sequences of RAD51 and RAD51-like proteins of T. cruzi.
T. cruzi (T.C-) RAD51 polypeptide sequence (top) is con^ared to those of the RAD51-like proteins found 
in T. cruzi. See appendix 2 for accession numbers. ITie alignment was carried out using ClustalW 
(Chenna et al., 2003) and coloured using Boxshade 3.21 (http://www.ch.embnet.org/software/ 
BOX_form.html).
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Figure 3.6: Alignment of the amino acid sequences of RAD51 and RAD51-like proteins of L. major.
L  major (L.m-) RAD51 polypeptide sequence (top) is compared to those of the RAD51-like proteins 
found in L. major. See appendix 2 for accession numbers. The alignment was carried out using ClustalW 
(Chenna et al., 2003) and coloured using Boxshade 3.21 (http://www.ch.embnet.org/software/ 
BOX_form.html).
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3.5 Sequence comparisons of 71 brucei RAD51-3, RAD51-5 and DMCl
Functional characterisation of all of the T. brucei RADSlAikQ genes, by genetic 
manipulation, was deemed beyond the scope of this project, and three genes were 
therefore chosen for further analysis. These were RAD51-3, RAD51-5 and DMCL {Further sequence analysis of these proteins and an explanation of their selection is 4
provided below.
Sequence alignments of the predicted amino acid sequences of the T. brucei RAD51-3,
RAD51-5 and DMCl proteins were carried out to determine their homology to a 
number of putative orthologues, based on their best BLASTp hits. In these cases the 
ClustalW alignments were not manually manipulated to maximise homology. |
Alignment of the T. brucei RAD51 polypeptide sequence to RadSl sequences from 
other organisms, carried out for comparison, showed 51-79% sequence identity (Fig 
3.7). r. brucei RAD51-3 showed less homology to RadSl proteins (in the range 12.2 to 
17.7%) and was more homologous with RadS 7 sequences from yeast and RadS 1C from 
humans. Even here, the levels of sequence identity were low, however: between 13 and 
33% (Fig 3.8). T, brucei RADS 1-5, initially identified by searches with RecA, was first 
compared with bacterial RecA sequences. This showed low levels of homology, in the 
range of 9-29% sequence identity (Fig 3.9). However, comparison of T. brucei RAD51- 
5 with RadSl sequences, including T. brucei RAD51, resulted in even lower identifiable 
homology: 8-21% sequence identity (Fig 3.10). This indicates that 7. brucei RAD51-S 
is substantially diverged, a result that is not unusual for a strand exchange enzyme (as 
has already been discussed). Very divergent strand exchange enzymes have also been 
described in U. maydis, which has been shown to encode two stand exchange enzymes:
RadSl, which is highly homologous to other RadSl proteins, and Rec2, which is much 
more highly divergent (Bennett and Holloman, 2001). Bacterial RecA has also been 
shown to operate in a eukaryotic system, suggesting that a strand exchange enzyme 
most homologous to a bacterial enzyme does not necessarily mean that the enzyme that 
will not function. T, brucei DMCl, like RADSl, showed high levels of sequence 
homology, with 53-73% sequence identity seen in comparison with Dmcl sequences 
from other organisms (Fig 3.11). In comparison, it showed lower levels of sequence 
homology with RadSl sequences (44 to 52.7% alignments not shown), suggesting that 
T. brucei DMCl is most likely a counterpart of meiosis-specific RadSl orthologues, 
although it should be noted that, of the sequences aligned in Fig 3.11, only the yeast, 
human and rice Dmcl sequences have been shown to act during meiotic exchange.
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Figure 3.7: Alignment of the amino acid sequences of T. brucei RAD51 with other RadSl proteins.
The T. brucei (T.b-) RAD51 polypeptide sequence (top) is compared to the RadSl sequences of 
Leishmania major (L.m-), Plasmodium falciparum (P.f-), Saccharomyces cerevisiae (S.c-), 
Schizosaccharomyces pombe (S.p-), Homo sapiens (H.s ), Drosophila melanogaster (D.m-), Arabidopsis 
thaliana (A.t-) and Ustilago maydis (U.m-). See appendix 2 for accession numbers. The identity values, 
calculated using AlignX, are shown (in brackets) for each of the RadSl polypeptides compared to T. 
brucei RADSL The alignment was carried out using ClustalW (Chenna et al., 2003) and coloured using 
Boxshade 3.21 (http://www.ch.embnet.org/software/BOX_form.html).
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Figure 3.8: Alignment of the amino acid sequences of T, brucei RAD51-3 with Rad57 proteins. The
T. brucei (T.b-) RAD51-3 polypeptide sequence (top) is compared to the Rad57 sequences of 
Saccharomyces cerevisiae (S.c-), Schizosaccharomyces pombe (S.p-), Homo sapiens (H.s ), Drosophila 
melanogaster (D.m-) 2caA Arabidopsis thaliana (A.t-). See appendix 2 for accession numbers. The identity 
values, calculated using AlignX, are shown (in brackets) for each of the Rad57 polypeptides compared to 
T. brucei RAD51-3. The alignment was carried out using ClustalW (Chenna et al., 2003) and coloured 
using Boxshade 3.21 (http://www.ch.embnet.org/software/BOX_form.html).
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Figure 3.9: Alignment of the amino acid sequences of T. brucei RAD51-5 with RecA proteins. The T.
brucei (T.b-) RAD51-5 polypeptide sequence (top) is compared to the RecA sequences of Escherichia 
coli (E.C-), Campylobacter jejuni (C.j-), Neisseria gonorrhoeae (N.g-), Bacillus subtilis (B.s ), 
Streptomyces lividans (S.1-), Staphylococcus aureus (S.a-) and two Arabidopsis thaliana RecA sequences 
with chloroplast (A.t-ct) and mitochondrial (A.t-mt) localisation. See appendix 2 for accession numbers. 
The identity values, calculated using AlignX, are shown (in brackets) for each of the RecA polypeptides 
conpared to T. brucei RAD51-5. The alignment was carried out using ClustalW (Chenna et al., 2003) 
and coloured using Boxshade 3.21 (htq)://www.ch.embnet.org/software/BOX fbrm.html).
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Figure 3.10: Alignment of the amino acid sequences of T. brucei RAD51-5 with RadSl proteins. The
T. brucei (T.b-) RAD51-5 polypeptide sequence (top) is compared to the RadSl sequences as shown in 
figure 3.7. The identity values, calculated using AlignX, are shown (in brackets) for each of the RadSl 
polypeptides compared to T. brucei RADS 1-S. The alignment was carried out using ClustalW (Chenna et 
al., 2003) and coloured using Boxshade 3.21 (http://www.ch.embnet.org/software /BOX fbmihtml).
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Figure 3.11: Alignment of the amino acid sequences of T. brucei DMCl with other Dmcl proteins.
The T. brucei (T.b-) DMCl polypeptide sequence (top) is conqjared to the Dmcl sequences of 
Leishmania major (L.m-), Plasmodium falciparum (P.f-), Saccharomyces cerevisiae (S.c-), 
Schizosaccharomyces pombe (S.p-), Homo sapiens (H.s-), Arabidopsis thaliana (A.t-), Drosophila 
melanogaster (D.m-) and the two DMCl sequences from Oryza sativa (O.s ). See appendix 2 for 
accession num^rs. The identity values, calculated using AlignX, are shown (in brackets) for each of the 
Dmcl polypeptides compared to T. brucei DMCL The alignment was carried out using ClustalW 
(Chenna et a l, 2003) and coloured using Boxshade 3.21 (htq)://www.ch.embnet.org/software/ 
BOX fbrm.html).
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The remainder of this thesis considers the functions of T. brucei RAD51-3, RAD51-5 
and DMCl in bloodstream stage cells. These were chosen, in part, because they were 
the first 7647)57-like genes to emerge intact from the genome sequencing initiative. 
However, they are interesting choices for a number of reasons. As has been argued 
above, it is not possible to infer their likely roles through sequence comparisons, with 
the possible exception of DMCl, which groups closely with meiosis-related RAD51 
proteins and might therefore act in that process (Single et al., 2001; Gibson, 2001; 
Gibson and Stevens, 1999), Each has the capacity to independently catalyse DNA 
strand exchange, rather than act as cofactors, given the retention of Walker A and B 
boxes. It would be interesting if DMCl had adopted roles in mitotic recombination, 
whilst 7647)57-5 is, arguably, the best conserved of the 7647)57-like genes, beyond 
7647)57 itself and DMCL 7647)57-5 is the most diverged in sequence and may be absent 
in L. major (potentially indicating a function specific to T. brucei and T. cruzi).
3.6 Analysis of copy number of T, brucei 7647)57-5,7647)57-5 and DMCl
To determine the number of copies of 764D57-5, RAD51-5 and DMCl in the T. brucei 
genome. Southern analysis was carried out. Genomic DNA from 427 bloodstream form 
cells was restriction digested using BamYïl, EcoRl, EcoRY, Hindlll and Sacll, separated 
by gel electrophoresis on a 0.8% 1 x TBE gel and transferred to a nylon membrane by 
Southern blotting. The blots were then probed with the entire open reading frame of 
each gene, which were PCR-amplified using Taq DNA polymerase and primers ‘For’ 
and ‘Rev’ for each gene (Appendix 1). RAD5Î, which had been shown previously to be 
single copy (McCulloch and Barry, 1999) was examined also as a control. The 
individual digestions, probed with each open reading frame, in general resulted in the 
production of a single band. The exceptions to this were EcoRY for 7647)57, BamhLl for 
7647)57-5, EcoRY for RAD51-5 and Sacll for DMCL, in each case the restriction 
enzyme cuts within the open reading frame, resulting in the production of two bands |
(Fig 3.12). The BamlAl digestion for DMCl should also have produced two bands in 
this analysis, as it cuts in the open reading frame, but only a single band is visible. This 
is most readily explained by a base pair difference between the 927 strain sequenced for 
the T. brucei genome database and the 427 strain utilised during this assay. Despite this, 
the result suggests that the RAD51-3, RAD51-5 and DMCl are single copy.
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Figure 3.12: Southern analysis RAD51 RAD51-3 R A D Sl‘5  DMClof the copy number of the
RADSI-WVr genes. Genomic - 5 ^ 2 “
enzymes (indicated) and probed 
with the open reading frame of 
one of the /L4D5y~like genes.
Lanes marked with an asterisk 
(♦) are those where two bands are 
visible.
3.7 Analysis of life cycle stage expression of RAD51-3, RAD51-S and DMCL
During the life cycle of T. brucei the expression levels of many genes differ depending 
on what stage the cell is in. Examples of this include the VSG, which is expressed only 
in the bloodstream, and procyclin, which is expressed only in the procyclic stage (Pays 
et al., 1994). The stages at which the control of these expression changes have been 
shown to occur encompass transcription initiation, mRNA processing, mRNA stability 
and protein production (Campbell et al., 2003; D'Orso et al., 2003; Vanhamme et al., 
1995). To examine if any of the RAD51-\\kQ genes are expressed in a lifecycle stage- 
dependant manner, the levels of their mRNA was assayed. RAD51 was analysed also as 
a form of control, as it has already been shown to function in DNA repair and 
recombination in bloodstream and procyclic form cells (McCulloch and Barry, 1999). 
This question is particularly relevant for DMCl, as it has been shown to be most 
homologous to meiosis-specific RAD51 homologues, DMCl, in various organisms 
(Bishop et al., 1992; Doutriaux et al., 1998; Fukushima et al., 2000; Masson et al., 
1999; Staeva-Vieira et al., 2003). If DMCl is truly a meiosis-specific factor, it is 
possible that its expression could be limited to the T. brucei salivary gland stage, where 
meiosis is proposed to take place in T. brucei (Bingle et al., 2001). To perform this 
analysis, RT-PCR was carried out on cDNA (P. Blundell, gift) generated from total 
RNA from five life cycle stages: EATRO 795 pleomorphic bloodstream form cells, 
tsetse fly midgut-derived cells, salivary gland-derived cells, early bloodstream form 
cells (these are tsetse fly transmitted T. brucei that have been injected into mice and 
continue to express Metacyclic VSG; Barry and McCulloch, 2001) and Lister 427 
monomorphic bloodstream form cells. In each case cDNA samples prepared without 
reverse transcriptase were also used to control for genomic DNA contamination. The 
RT-PCR was carried out using oligonucleotide primers specific for each of the genes.
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For RAD51, the primers RAD51-}\ and RAD51-U3 (Appendix 1) were used, which 
should give a product of 401 bp (Fig 3.13). For 7647)57-5, the primers 7647)57-5-Dl and 
7647)57-5-Ul (Appendix 1) were used, which should give a product of 586 bp (Fig 
3.13). For 7647)57-5, the primers 7647)57-5- D2 and 7647)57-5-Ul (Appendix 1) were 
used, which should give a product of 178 bp (Fig 3.13). Finally, for DMCI, the primers 
DMC 1-Vox and DA7C7-U1 (Appendix 1) were used, which should give a product of 402 
bp (Fig 3.13). In each case, a specific product of the appropriate size was generated in 
each of the life cycle stages tested, with no genomic DNA contamination in the reverse 
transcriptase minus control.
RAD51
RAD51-3
RAD51-5
DMCl
Figure 3.13: The expression of the RADSl-\ike genes in different life cycle stages. RT-PCR was 
carried out on cDNA generated from total RNA from trypanosomes from five life cycle stages. Gene 
specific primers were used to assay expression of the genes in each of the life cycle stages using reverse 
transcriptase plus (RT+) and minus (RT-) cDNA sangles. Mono: monomorphic Lister 427 bloodstream 
form. BSP: EATRO 795 bloodstream form. MG: mid-gut derived T. brucei. M: metacyclic derived T. 
brucei. EBSF: early BSP EATRO 795 T. brucei.
This result suggests that each of the 764D57-like genes, including DMC I, are expressed, 
or at least transcribed, continually throughout the life cycle. Given the limited number 
of T. brucei cells recoverable during tsetse fly transmission, there was insufficient 
cDNA to allow more quantitative PCR approaches to be used which might have 
indicated changes in mRNA abundance of the different genes. As specific antibodies 
directed against the different proteins are not available, this could not be pursued further 
by Western analysis.
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3.8 Analysis of 164Z)5i“like mRNA level in response to DNA damage
s
Many organisms have been shown to increase expression of repair genes in response to 
DNA damage. One of the best characterised is the SOS response of E. coli, and other 
bacteria, involving the LexA repressor that, in the absence of DNA damage, prevents 
expression of the SOS genes (Kuzminov, 1999). In response to DNA damage bacterial 
RecA is activated when it forms a nucleoprotein filament on single strand DNA formed 
as a result of the cells attempt to replicate damaged DNA (Smith and Walker, 1998).
Active RecA then induces self-cleavage of the LexA repressor, leading to the induced 
expression of approximately 20 repair genes (Kuzminov, 1999), One of the genes that 
becomes up-regulated is RecA itself, the level of which can increase as much as 50-fold.
The same SOS response is not present in the archae or in eukaryotes, but here also 
RadA and Rad51 up-regulation is seen. For example, in S. cerevisiae and S. pombe 
Rad51 was shown to be induced (approximately 3 to 5-foId) in response to DNA 
damage, along with 25 other genes (Essers et ah, 2002; Lisby et ah, 2004; Mercier et 
al, 2001). In Tetrahymena thermophillia, Rad51 levels have been suggested to increase 
by up to 100-fold in response to DNA damage (Campbell and Romero, 1998). Similar 
observations have also been made in protozoa, as both L. major (McKean et al., 2001) 
and P. falciparum (Bhattacharyya and Kumar, 2003) were observed to increase RadSl 
expression in response to DNA damage. Exceptions to this general rule do exist, 
however. There is little evidence for increased Rad51 in mammalian cells exposed to 
DNA damage. Moreover, some archae induce RadA expression (Reich et al., 2001), 
whilst others do not (Komori et al., 2000) and some bacteria appear to lack an SOS 
response (Black et al., 1998).
In light of this knowledge, we wanted to test whether or not T. brucei operates in a 
similar manner and up-regulates the expression of RAD51, or any of the three RAD51- 
like genes, in response to DNA damage. The potential DNA damage induction of 
RADS 1-like genes has not been widely studied, but XRCC3 and Rad51C in Arabidopsis 
thaliana are modestly induced following y irradiation (Osakabe et al., 2002). For T. 
brucei we could analyse only the mRNA level, as antibodies for the RAD51-like 
proteins were not available. However, if it emerged that changes in mRNA levels, 
whether through altered transcription rates or changes in mRNA stability, were a 
general feature of the putative repair genes, it may provide a quick, simple assay to 
define any genes involved in DNA damage repair.
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3.8.1 Analysis of the mRNA level of R A D 51 and the 3 764Z>5/-like genes
From the previous RT-PCR, we already know that each of the genes is expressed, or at 
least transcribed, in bloodstream form cells (section 3.4). However, this analysis was 
conducted in a non-quantitative manner and suggests little about the relative expression 
level of each of the genes. Therefore, before the analysis of the expression of the 
RAD51-like genes following DNA damage could be performed, the quantity of RNA 
required to produce a suitable signal on a Northern blot had to be assessed. To do this, 
total RNA was extracted (RNeasy Mini Kit, Qiagen) from 100 mis of bloodstream form 
Lister 427 wild type cells, grown to a density of 2 x 10^  cells.ml'*, and quantified by 
spectrophotometer (Beckman DU650 spectrophotometer). Four repetitions of 5, 10 and 
20 pg samples were separated by electrophoresis on a denaturing formaldehyde gel 
(section 2.10.1) before being transferred to a nylon membrane by Northern blotting 
(section 2.10.2). The blots were then probed with the entire open reading frame of one 
of the 3 RAD51-\\kQ genes, or with RADSL In each case a single specific band was 
generated in each lane which we assumed to be mature mRNA (Fig 3.14). All four of 
the genes produced a detectable signal with 5 pg of total RNA, including DMCL This 
indicates that each gene produces a putative mRNA in bloodstream form cells, although 
it is not possible to assess if they are all translated to protein, nor the relative stability of 
the RNA species.
RAD51 RAD51-3 RAD51-5 DMCl
a .  o. a.
^ S R
1 —  
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Figure 3.14: Northern analysis of 
RAD51 and the three RADSl-\\\üt 
genes. The quantity of total RNA 
loaded in each lane is indicated and 
size markers are shown.
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3.8.2 Analysis of the eff^ ect of phleomycin
The DNA damaging agent chosen for use during the analysis of potential changes in 
mRNA levels was phleomycin. Two primary reasons dictated this choice. First, it is a 
compound known to directly cause double strand breaks (Giloni et al.y 1981), in 
contrast to other DNA damage agents often used, such as Methylmethane Sulphonate 
(MMS; Sedgwick, 2004). Second, it was the DNA damaging agent used during the 
analysis of RAD51 expression in the related parasite L. major (McKean et al.y 2001). 
Before examining the effect on T. brucei RAD51 expression, an attempt was made to 
examine the effect of phleomycin on T. brucei genomic DNA and on growth. To do 
this, bloodstream form Lister 427 wild type cells were grown to a density of 2 x 10^  
cells.mf’, then diluted to 1.5 x 10^  cells.ml'^ and phleomycin was added to 10 pg.ml ’. 
From this, cell counts were made for a period of 24 hours and 5x10^ cells were used to 
generate genomic plugs (section 2.9.1) at 0, 4, 8 and 24 hour time points. The growth 
following DNA damage is shown in Fig 3.15, from this it is apparent that over 24 hours 
the concentration of phleomycin causes a cessation of population doubling, but little 
decrease in cell number.
» Expt 1 
-*-Expt 2*■g 4 - -
240 8 12 16 204
Figure 3.15: Growth effect of 10 
pg.ml*' phleomycin on Lister 427 
wild type cells. The growth counts 
carried out during exposure to 10 
pg.ml* phleomycin for three 
experiments (EXPT 1,2 and 3) are 
shown. The result for a control 
experiment (WT), where cells were 
not exposed to phleomycin, is also 
shown.
Time (hours)
To examine the effect of phleomycin on the T. brucei genome, the genomic plugs were 
placed in the wells of a 1% agarose gel (Seakem LE) and the DNA was separated by 
pulsed field electrophoresis (section 2.10). The gel was then Southern blotted before 
being probed with p-tubulin (Fig 3.16). From this result, a faint smear was visible below 
the intact chromosomal band (>194 kbp), which appeared to increase in intensity as 
time increased. This smear is most likely the result of the phleomycin causing DNA 
breaks, resulting in fragmented chromosomes that are able to migrate further into the gel 
during electrophoresis. The increase in intensity of the smear is due to the increase in
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exposure to the DNA damaging agent. Although it is possible that damage may have 
occurred during the preparation of the genomic plugs rather than by phleomycin- 
treatment, or that the later time points have more DNA loaded, no convenient control is 
available, as all T. brucei genomic DNA is likely to be affected by phleomycin damage. 
The approximately equal intensity of the intact chromosomal bands suggests that the 
loading of the samples is approximately equal. However, when looking at the 
chromosomal band in the ethidium gel it may appear as if the 24 hour time point has 
had more DNA loaded compared to the other time points. This is probably the result of 
damage to the chromosomes resulting in a more disperse, overexposed band. Even if the 
24 hour time point were to have more DNA loaded it still appears that damage is being 
caused as after 8 hours a smear, which is under 49 kbp in size, is visible that is not 
present at 0 and 4 hour time points. Overall, the results of this assay suggest that 
phleomycin has caused DNA breaks in this assay.
Time (hours) Time (hours)
Figure 3.16: PFGE of Lister 427 wild type cells 
exposed to 10 pg.ml ' phleomycin. Lister 427 wild 
type cells were grown in the presence of 10 pg.ml * 
phleomycin for 0, 4, 8 and 24 hours. The DNA was 
then separated by PFGE and subsequently the gel 
was Southern blotted and probed with P-tubulin. Size 
markers (Lambda CHEF DNA ladder, BioRad) are 
indicated.
8 24 8 24
3.8.3 Analysis of the effect of phleomycin on RADSl^ RAD51~3, RADSl-S and 
DM Cl mRNA levels
The mRNA levels of RAD51 and the 3 /L4D5/-like genes were analysed at 0, 4, 8 and 
24 hour time points after exposure to 1, 2 or 10 pg.mf’ phleomycin. Three repetitions 
were carried out at 10 pg.ml*' and 2 repetitions at 1 and 2 pg.ml *. Bloodstream form 
Lister 427 wild type cells were grown to a density of 2 x 10^  cells.ml*’ before being 
diluted to 1.5 x 10^  cells.mf’ containing phleomycin. Total RNA was then extracted
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from 100 mis of cells at 0, 4, 8 and 24 hour time points and quantified by 
spectrophotometer (Beckman DU650 spectrophotometer). Four repetitions of 5 pg 
samples from each time point were separated by electrophoresis on a denaturing 
formaldehyde gel and subsequently transferred to a nylon membrane by Northern 
blotting. The blots were then probed with the open reading frame of one of the 3 
RAD51-\\ke genes, or RAD5L The bands present in each of the developed blots were 
quantified (Image Quant) before the blots were stripped (section 2.11.3), re-probed with 
GPI-8 (Lillico et al., 2003) and re-quantified (Fig 3.17).
RAD51 RAD51-3 RAD51-5 DMCl
Gene
GPI-8
Gene
GPI-8
Gene
GPI-8
0 4 8 24 0 4 8 24 0 4 8 24 0 4 8 24
Time (hours)
Figure 3.17: Northern analysis of the mRNA levels of RADSl and the 3 lL4/>5/-llke genes in 
response to phleomycin. Examples of the Northern blots of total RNA probed with the open reading 
frame of the gene of interest (Gene) which were stripped and re-probed with GPI-8 are shown. Cells were 
exposed to varying concentrations of phleomycin for 0,4, 8 or 24 hours.
GPI-8 was used as a single copy gene control as its expression level should not alter in 
response to DNA damage, since it is involved in surface molecule biosynthesis (Lillico 
et al., 2003). For both the /MDJ7-related genes and GPI-8 values determined at 0 hours 
were counted as 100% and the values for the 4, 8 and 24 hour time points calculated 
relative to 100%. By then comparing the RADSl and /L4D57-like gene values to the 
GPI-8 values, any changes in mRNA levels in response to DNA damage could be 
determined, whilst removing any error due to loading. The results of this analysis are 
shown in Tables 3.7 and 3.8 and graphed in figure 3.18. iT-
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Probe GENE GPI-8A Time(hours) Expt 1 Expt 2 Avge St dev Expt 1 Expt 2 Avge St dev
RAD51 0 100.0 100.0 100.0 0.0 100.0 100.0 100.0 0.04 112.8 93.2 103.0 13.9 1061 74.2 90.2 22.68 117.5 128.3 122.9 7.6 79.8 71.0 75.4 6.224 149.6 134.7 142.2 10.5 94.7 78.0 86.4 11.8
RAD51-3 0 100.0 100.0 100.0 0.0 100.0 looa 100.0 0.04 103.7 75.0 89.4 20.3 98.9 75.4 87.2 16.68 99.8 91.6 95.7 5.8 66.7 65.2 66.0 1.124 122.9 106.7 114.8 11.5 84.0 71.0 77.5 9.2
RAD51-5 0 100.0 100.0 100.0 0.0 100.0 100.0 100.0 0.04 92.6 87.0 89.8 4.0 109 76.9 93.0 22.78 90.0 108.6 99.3 13.2 77.1 64.0 70.6 9.324 103.3 103.6 103.5 0.2 94.1 79.4 86.8 10.4
DMC1 0 100.0 100.0 100.0 0.0 100.0 100.0 100.0 0.04 100.7 74.4 87.6 18.6 92.2 77.4 84.8 10.58 111.4 107.8 109.6 2.5 75.2 67.8 71.5 5.224 163.8 148.8 156.3 10.6 87.7 85.0 86.4 1.9
B Probe GENE GPI-8Time(hours) Expti Expt 2 Avge St dev Expt 1 Expt 2 Avge St dev
RAD51 0 100.0 100.0 100.0 0.0 100.0 100# 100.0 0.04 99.8 119.3 109.6 13.8 78.4 110.9 94.7 23.08 98.0 133,0 115.5 24.7 64.8 101.3 83.1 25.824 132.2 144.6 138.4 8.8 81.8 111.8^ 96.8 21.2
RAD51-3 0 1(k).0 100.0 100.0 0.0 iOè^ 100,0 100.0 0.04 99.5 110.0 104.8 7.4 88.8 108.2 98.5 13.78 79.2 116.5 97.9 26.4 70.0 114.3 92.2 31.324 112.2 126.3 119.3 10.0 99.1 127.3 113.2 19.9
RAD51-5 0 100.0 100.0 100.0 0.0 100.0 1(8.0 100.0 0.04 94.8 111.1 103.0 11.5 109.3 87.7 98.5 15.38 82.7 117.8 100.3 24.8 99.7 69.5 84.6 21.424 107.7 106.2 107.0 1.1 10t.2 101.6 101.4 0.3 1
DMC1 0 100.0 100.0 100.0 0.0 100.0 1004 100.0 0.0 14 109.7 125.5 117.6 11.2 93.1 107.8 100.4 10.48 127.0 167.7 147.4 28.8 79.1 102.8 91.0 16.824 171.4 193.6 182.5 15.7 108.7 115.7 112.2 4.9
Table 3.6: The mRNA levels of RAD5I and the 3 RAD51-\\Vit genes In response to 1 and 2 pg.ml ' 
phleomycin. The results for the two repetitions of the DNA damage experiments (Expt 1 and 2) carried 
out at 1 (A) and 2 (B) pg.ml-1 phleomycin are shown. The values represent the quantification of Northern 
blots probed with RADSl, RAD51-3, RAD51-5 or DMCl (GENE) and their subsequent quantification 
after re-probing with GPI-8 (GPI-8): the quantification value obtained for time 0 hours was regarded as 
100% and all other values scaled accordingly. Averages (Avge) and the standard deviations (St dev) 
generated from the data are also shown.
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Probe GENE GPI-8
Time
(hours)
B tp t1 Expt 2 Expt3 Avge St dev Expti Expt 2 Expt 3 Avge St dev
RAD51 0 ibo.o 100.0 100.0 100.0 0.0 100.6 100.6 160.0 100.0 0.0
4 158.4 93.4 91.3 114.4 38.1 131.3 93.2 87.8 104.1 23.7
8 133.7 88.2 87.3 103.1 26.5 120.1 96.0 95.0 103.7 14.2
24 137.5 112.7 84,0 111.4 26.8 117.4 122.6 99.2 113.1 12.3RAD51-3 0 100.6 •ioo.o 100.0 100.0 0.0 166.6 100.6 466.0 100.0 0.0
4 83.8 872 81.9 84.3 2.7 89.2 87.8 86.0 87.7 1.6
8 80.3 92.4 84.1 85.6 6.2 86.9 94.9 92.6 91.5 4.1
24 97.3 100.5 82.3 93.4 9.7 104.9 124.8 99.5 109.7 13.3RAD51-5 0 100.Ô 100.0 160.0 100.0 0.0 100.6 100.0 466.0 100.0 0.0
4 89.0 100.2 92.8 94.0 5.7 81.3 97.4 81.9 86.9 9.1
8 88.0 97.2 100.4 95.2 6.4 77.7 104.5 84.9 89.0 13.9
24 103.7 94.0 86.3 94.7 8.7 107.8 131.1 93.5 110.8 19.0DMC1 0 100.6 466.6 166.0 100.0 0.0 106.0 100.6 166.6 100.0 0.0
4 100.4 111.0 104.0 105.1 5.4 84.4 82.9 82.8 83.4 0.9
8 125.2 132.9 118.0 125.4 7.5 79.7 87.3 86.9 84.6 4.3
24 136.7 116.1 99.1 117.3 18.8 93.9 75.0 87.3 10.6
Table 3.7: The mRNA levels of RADSl and the 3 RADSlAWx genes in response to 10 pg.ml-1 
phleomycin. The results for the three repetitions of the DNA damage experiments (Expt 1, 2 and 3) 
carried out at 10 pg.ml-1 phleomycin are shown. The values represent the quantification of Northern blots 
probed with RADSl, RADS 1-3, RADSl-S or DMCl (GENE) and their subsequent quantification after re- 
probing with GPl-8 (GPI-8): the quantification value obtained for time 0 hours was regarded as 100% and 
all other values scaled accordingly. Averages (Avge) and the standard deviations (St dev) generated from 
the data are also shown.
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No significant change could be detected for the RAD51-5 mRNA levels in response to 
DNA damage. RADSl-3 appeared to be similar, although at 1 pg.mf' phleomycin a 
modest (-40%) increase may be apparent after 24 hours. The results for RADSl and 
DMCl appear to suggest that after exposure to 1 or 2 pg.mf* of phleomycin their 
mRNA levels increased by approximately 40 -70% after 24 hours. This result was 
perhaps expected for RADSC as it has been shown to be involved in DNA damage 
repair in T. brucei (McCulloch and Barry, 1999) but it should be noted that this is a very 
modest change. A putative increase in DMCl is surprising, in contrast, if this is 
functionally involved in meiosis-specific recombination. No evidence exists for DMCl 
acting in DNA damage repair in mitotic cells. To examine this question further, the 
mRNA levels of the open reading frames upstream and downstream of DMCl were 
analysed (Fig 3.19). It is assumed that, as is the case for most of the T. brucei genome 
(Vanhamme and Pays, 1995), DMCl is part of a multi gene transcription unit 
encompassing the surrounding genes. The downstream open reading frame is predicted 
to encode a replication licensing factor of the MCM family (MCM; Forsburg, 2004), 
while the upstream open reading frame (P-ORF) has no identifiable homologues. 
Because the expression of a replication licensing factor may be up-regulated in response 
to DNA damage, the blots were also probed with the next open reading frame 
downstream, tubulin-tyrosine ligase (TT-LIG; Erck et al., 2000), which was deemed 
unlikely to respond to DNA damage.
□
Figure 3.19: The open reading frames surrounding ------------------------------------------DMCl. The diagram, adapted from the T. brucei ---------t----------------------- r-----
genome database, represents the genomic environment 1445000  M 50000
surrounding DMCl. Yellow boxes: putative open I  —I I I
reading frame with predicted function. Orange box: TT-LIG MCM DMCl
putative open reading frame with no predicted function _________________________________
(referred to as P-ORF). TT-LIG: tubulin tyrosine ligase.
MCM: replication licensing factor of the MCM family.
Regions of each of the open reading frames, approximately 600 bp in length, were PCR- 
amplified from Lister 427 genomic DNA using Taq DNA polymerase and the primers 
specific for each open reading frame (named 5' and 3' for each gene; appendix 1). The 
Northern blots of the experiments carried out at 10 pg.ml'* phleomycin were stripped 
and re-probed with PCR products and quantified as described previously. The results of 
this analysis are shown in Table 3.9 and graphed in Figure 3.20.
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probe GENE GPI-8
Time
(hours)
Expt 1 Expt 2 Expt 3 Avge St dev Expt 1 Expt 2 Expt 3 Avge St dev
MCM 0 1(X).0 100.0 100.0 100.0 0.0 100.0 100.0 100.0 100.0 0.0
4 122.7 148.7 120.1 130.5 15.8 84.4 82.9 82.8 83.4 0.9
8 89.7 176.2 124.6 130.2 43.5 79.7 87.3 86.9 84.6 4.3
24 210.4 230.4 117.7 186.1 60.1 92.9 93.9 75.0 87.3 10.6
TTLIG 0 100.0 100.0 100.0 100.0 0.0 100.0 100.0 100.0 100.0 0.0
4 164.4 183.4 150.1 166.0 16.7 131.3 93.2 87.8 104.1 23.7
8 194.5 215.6 199.9 203.3 11.0 120.1 96.0 95.0 103.7 14.2
24 162.2 291.0 191.4 214.9 67.5 117.4 122.6 90.2 113.1 12.3
PORF 0 100.0 100.0 100.0 100.0 0.0 100.0 100.0 100.0 100.0 0.0
4 82.0 80.5 86.9 83.1 3.3 84.4 82.9 82.8 83.4 0.9
8 87.7 79.1 95.5 87.4 8.2 79.7 87.3 86.9 84.6 4.3
24 72.1 103.7 96.5 90.8 16.6 92.9 93.9 75.0 87.3 10.6
Table 3.8: The mRNA levels of the genes surrounding DMCl in response to 10 pg.ml ' phleomycin.
The results for the three repetitions of the DNA damage experiments (Expt 1, 2 and 3) carried out at 10 
pg.ml ’ phleomycin are shown. The values represent the quantification of Northern blots probed with the 
DNA replication licensing factor (MCM), tubulin-tyrosine ligase (TT-LIG) and the putative open reading 
frame (P-ORF) and their subsequent quantification after re-probing with GPI-8 (GPI-8). Quantification 
values obtained for time 0 hours was regarded as 100% and all other values scaled accordingly. Averages 
(Avge) and the standard deviations (St dev) generated from the data are also shown.
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Figure 3.20: The change in the mRNA level of the genes surrounding DMCl response to 10 pg.ml ' 
phleomycin. For each experiment the adjusted quantification values for GPI-8 were subtracted from the 
adjusted quantification value for the gene of interest. This value represented the change in mRNA level in 
response to DNA damage relative to an unchanged control mRNA. The average values obtained for each 
open reading frame and the standard deviations are shown.
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These results suggest that there was no change in the mRNA level for the putative open 
reading frame upstream of DMCl but that there was an approximate 100% increase 
(with significant variation) for both the putative DNA replication licensing factor and 
the putative tubulin tyrosine ligase after 24 hours. These values are greater than that 
observed for RAD51 and DMCl and while it is possible to conceive that the mRNA 
level of a DNA replication factor would be increased in response to DNA damage, it is 
harder to conceive that the same would happen to a tubulin-tyrosine ligase. The simplest 
explanation of them is that the modest increases in mRNA levels observed 
(approximately 40-100%) are not specific increases in response to phleomycin damage, 
but simply as a result of the variability of this assay. The increases, if they were real,
were in any case relatively insignificant changes in mRNA level when compared to 
those observed in other organisms. It is clearly possible that DNA damage expression 
changes in T. brucei are orchestrated at translation or protein stability levels. It was 
therefore decided that the analysis of the mRNA level in response to DNA damage is 
not a suitable method to predict a role for a gene in DNA damage repair in T. brucei.
3.9 Summary
As a result of searching the T, brucei genome database and sequence comparisons, five 
further R^D5i-like genes have been identified. One of them appears to encode the 
highly conserved enzyme Dmcl, whilst four others are more poorly conserved. All five 
genes have features consistent with RADSl-like function. So far, T. brucei is the only 
single-celled eukaryote outside of fungi to be examined for RADSl-related functions. 
The number of potential RÆD57-like genes identified in T. brucei^ however, is more 
akin to the number found in higher eukaryotes.
Three of the RA05i-like genes were chosen for further analysis, as analysis of all five 
was deemed beyond the scope of what is achievable during a PhD project. The 
remainder of this chapter concentrated on the initial characterisation of these genes. All 
three were shown to be single copy genes transcribed to putative ‘mature’ mRNA in 
Lister 427 bloodstream form cells. As antibodies were not available for any of the 
proteins, analysis of the mRNA level was analysed to assess the genes’ potential to be 
involved in DNA damage repair. We found no evidence for an increase in mRNA level 
in response to DNA damage, suggesting that all three might not be involved in DNA 
damage repair. However, RAD5C a gene already shown to be involved in DNA damage
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repair, also showed no clear increase in mRNA level in response to DNA damage. 
Therefore, it was concluded that æialysis of the mRNA level in T. brucei is not a 
suitable method for the definition of a genes’ function in DNA repair.
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-C h a p t e r  4
A n a l y s is  o f  t h e  r o l e s  o f  RAD51-3, RAD51-5 a n d  DMCl in
D N A  REPAIR, RECOMBINATION AND ANTIGENIC VARIATION.
4.1 Introduction
The only gene so far identified in T. brucei to have a role in antigenic variation is 
RADSl. T. brucei RADSl mutants have an increased sensitivity to DNA damaging II;ï
agents, a recombination defect (with both reduced efficiency and aberrant integrations 
taking place), and a VSG switching defect with both gene conversion and in situ ''imechanisms affected. However, recombination and switching do still occur, and 
therefore back-up pathways must exist for both processes. In yeast (Paques and Haber,
1999) and humans (Wiese et al., 2002), Rad51 operates with a number of cofactors or 
homologues that act to aid efficient recombination. As five RADSl-like genes have been 
discovered in T. brucei, the aim of this chapter is to analyse three of the RADSl-\\k.Q 
genes to determine their role in DNA damage repair, recombination and VSG switching 
in bloodstream form cells.
4.2 Generation of gene disruption mutants in the 3174.2 strain of T. brucei
Homozygous mutants of the RADSlAike. genes were generated using the same strategy 
that was used previously to generate radSl homozygous mutants in T. brucei 
(McCulloch and Barry, 1999). This approach does not create a classical ‘knock out’ 
mutant, where the whole of the open reading frame is removed, but a gene disruption 
where the core functional domains of the gene are removed. In this method 5' and 3' 
regions of the open reading frame were PCR-amplified, cloned and used as flanking 
sequence for recombination following transformation. The core of the gene was 
replaced with one of two antibiotic resistance markers, allowing the selection of 
constructs that have integrated into the genome and the disruption of both alleles {T. 
brucei is a diploid organism).
Mutation of RADS 1-3 and RADSl-S utilised this two-construct approach, but mutation 
of DMCl utilised a new method (see section 4.2.3). In all cases, the gene disruptions 
were designed to remove the central 5-8 core conserved domains, as discussed in 
chapter 3 (section 3.4). Moreover, all mutations were made in the T. brucei transgenic 
strain 3174.2 (McCulloch et al., 1997; Rudenko et al., 1996). This is a bloodstream 
stage derivative of Lister 427 (Melville et al., 2000), which allows analysis of VSG 
switching frequency and mechanisms (section 4.8).
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■{Oligonucleotide primers were designed for 5 ' (primers LHF FOR and REV; Appendix 
1) and 3' (primers RHF-For and RHF-Rev; Appendix 1) regions of the RÂD51-3 and 
RAD51-5 open reading frames (Fig. 4.1). The sequences were then PCR-amplified using 
Herculase DNA polymerase (Stratagene) and genomic DNA from 3174.2 T. brucei and 
subsequently cloned into pBC KS using the restriction sites contained within the 
primers (£b<?RJ, Hindill and Xho\\ Fig. 4.1) resulting in the production of pCP301 
{RAD51-3 flanks) and pCP302 {RAD51-5 flanks). Puromycin and blasticidin resistance 
cassettes, with flanking processing signals derived from the tubulin array to allow RNA 
trans-splicing (Vanhamme and Pays, 1995), were PCR-amplified using Herculase 
(primers pa5 ' and ap3 ') and plasmids pTBT and pTPT as substrates (supplied by M.
Cross; (Rudenko et ah, 1994)) and cloned into the Hpal restriction site introduced 
between the 5' and 3' regions. This generated the constructs ARAD51-3::PUR, 
ARAD51-5::PUR, ARAD51-3::BSD and MAD51-5::BSD (Figs. 4.2 and 4.3). The 
constructs were excised from pBC KS by restriction digestion with Notl and Apal and 
the resulting digested DNA phenolxhloroform extracted and ethanol precipitated. 
Approximately 5 pg of digested DNA (quantified by gel electrophoresis relative to Life 
Technologies 1 kb size ladder) was then used in each T. brucei transformation.
4.2,1 Generation OÏRAD51-3 mutants in the 3174.2 strain
Two transformations were carried out to generate two independent RAD51-3 
heterozygous cell lines using the ARAD51-3::PUR construct. To do this, 3174.2 cells 
were transformed using the protocol described in Section 2.4 and antibiotic-resistant 
transformants were selected for as described in Table 4.1, The generation of 
heterozygous mutants was confirmed by Southern analysis, carried out on E'coRI 
digested genomic DNA from puromycin resistant cell lines and probed with the RAD51- 
3 LHF (data not shown; see sections 4.2.5 and 4.2,6). Subsequently, the two 
independent heterozygous mutants (RAD51-3+/~ 1 and RAD51-3+1- 2) were transformed 
with the ARAD51-3::BSD construct in an attempt to generate two independent rad51-3 
homozygous mutants. Antibiotic transformants were selected as described in Table 4,1 
and these transformations resulted in the generation of two putative radSl-3 
homozygous cells {RAD51-3-1-1 miàRAD51-3-l- 2). Selection for homozygous mutants 
using both antibiotics was unsuccessful, and therefore the second round transformants 
were selected initially using only selection for the transformed resistance gene (BSD).
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Blasticidin-resistant transformants were subsequently placed on double drug selection 
before being considered a putative homozygous mutant (Table 4.1). The integration of 
the BSD marker was screened by PCR-amplification of the complete RAD51-3 open 
reading frame, using primers RAD51-3-Fox and RAD51~3-'Rev (Appendix 1) and Taq 
DNA polymerase, in double resistant cell lines (data not shown; see sections 4.2.5 and 
4,2.6). Despite a large number of double resistant transformant cell lines being 
generated (Table 4.1), only a small number of them were found to be putative rad51-3- 
/- mutants. This is probably as a result of integration of the blasticidin resistance gene 
into the tubulin array using homology found within ù\RAD51-3v.BSD.
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Cell line being Trans. Construct used Ceil No. Drug(s) and No. of No of correct
generated Number plated out concentration(s) transformants Integrations
Heterozygote 1 ARAD51-3WPUR 1.0X 10^ PUR 1.0 4 3
ARAD51-3:\PUR 1.0 X 10^ PUR 0.5 3 X
2 ARAD51-3V.PUR 1.0 X 10^ PUR 1.0 2 2
ARAD51-3::PUR 1.0X 10^ PUR 0.5 4 X
Homozygote 1 1 ARAD51-3::BSD 2.0X 10^ BSD 2.5 5 0
2 ARAD51-3::BSD 2.0 X 10^ BSD 1.75 & 0
PUR 0.5
Homozygote 2 1 ARAD51-3\\BSD 2.0 X 10^ BSD 2.5 3 2
2 ARAD51-3::BSD 2.0 X 10^ BSD 1.75 & 5 0
PUR 0.5
Homozygote 1 5 ARAD51-3::BSD 1.0X 10^ BSD 2.5 4 0
6 ARAD51-3::BSD 1.0X 10^ BSD 2.5 0
Homozygote 1 7 ARAD51-3-BSD 3.2 X 10^ BSD 2.5 38 0
8 ARAD51-3-BSD 3.3X 10" BSD 2.5 39 0
Homozygote 1 9 ARAD51-3::BSD 1.9X 10" BSD 2.5 2 4 (8 ) 3
10 ARAD51-3::BSD 1.6 X 10" BSD 2.5 18 (8 ) 3
11 ARAD51-3::BSD 1.4X 10" BSD 2.5 18(8 ) 1
Table 4.1: Transformations carried out during the generation of RADSl-S mutants. A list of the 
transformations carried out during the generation of two independent RADS 1-3 heterozygous and 
homozygous mutants. The table includes the constructs and drug selection used, the numbers of cells 
plated out, the number of those that were antibiotic resistant transformants and the number that had 
correctly integrated the construct. The generation of homozygous mutant cell lines selection initially 
utilised only selection for the transformed resistance gene - blasticidin (BSD), with the exception of 
homozygote transformations 2. Transformants were subsequently placed on double drug selection 
(blasticidin as listed and puromycin at 0.5 pg.ml"') before being considered a putative homozygous 
mutant. All drug concentrations listed are in pg.ml'’.Trans.: transformation. No.: Number. PUR: 
puromycin. X: transformants not analysed. (8): 8 of the transformants were analysed.
1 0 0
4.2.2 Generation of R A D S l-5  mutants in the 3174.2 strain
Two transformations were carried out to generate two independent RAD51-5 
heterozygous cell lines using the /aRAD51-5::PUR construct. Again, 3174,2 cells were 
transformed (see protocol section 2.4), antibiotic resistant transformants selected for as 
described in table 4.2 and screened by PCR-amplification of the entire RAD51-5 open 
reading frame. After 4 attempts, no putative RAD51-5 heterozygote mutants were 
obtained, with all transformants having integrated the PUR cassette into locations other 
than the RAD51-5 open reading frame. The drug concentration was, therefore, reduced 
and 4 subsequent transformations resulted in the generation of two independent putative 
heterozygous mutants. The generation of putative heterozygous mutants {RAD51-5 +/-1 
and RAD51~5+/- 2) was confirmed by PCR-amplification of the entire RAD51-5 open 
reading frame using primers RAD51-5-Vox and RJZ>57-i-Rev (Appendix 1) and Taq 
DNA polymerase (data not shown; see sections 4.2.5 and 4.2.6). Subsequent 
transformation of the putative RAD51-5-^l- 2 using the Ai64jD5i-5::BSD construct 
resulted in the generation of a putative rad51-5 homozygous mutant (Table 4.2), 
confirmed by PCR as described above, although most transformants again had 
integrated the BSD cassette outside of the RAD51-5 open reading frame. In contrast, 8 
transformations of the putative RAD51-5-\-l- 1 cell line failed to generate an independent 
rad51-5 homozygous mutant (Table 4.2). The blasticidin resistance cassette was always 
integrated into locations other than the RAD51-5 open reading frame, producing cells 
that were double resistant to both puromycin and blasticidin but were still heterozygous 
(data not shown). To overcome this problem, the ARAD51-5::BSD construct was 
redesigned to create ARAD51-5::BSD2 (Fig 4.3). In this construct, the blasticidin 
resistance gene was flanked by an actin intergenic region as the 3 ' processing signal, 
thereby preventing integration into tubulin.
1 0 1
îCell line being Trans. Cell No. Drug and No. of No of correct
generated number Construct used plated out concentration transformants Integrations
Heterozygote 1 ARAD51-5::PUR 1.0 X 10^ PUR 1.0 2 0
1.0 X 10" PUR 0.5 2 0
Heterozygote 2 ARAD51-5::PUR 1.0X 10" PUR 1.0 4 0
1.0X 10" PUR 0.5 2 0
Heterozygote 3 ARAD51-5::PUR 1.0X 10" PUR 0.5 7 0
1.0 X 10" PUR 0.25 4 0
Heterozygote 4 ARAD51-5\:PUR 1.0X 10" PUR 0.5 0
1 .0X 10" PUR 0.25 0
Heterozygote 5 ARAD51-5::PUR 1.0 X 10" PUR 0.5 0
1.0 X 10" PUR 0.25 2 1 c
Heterozygote 6 ARAD51-5-.:PUR 1.0 X 10" PUR 0.5 4 1
1.0 X 10" PUR 0.25 1 1
Heterozygote 7 ARAD51~5::PUR 2 .7X 10^ PUR 0.25 14 0
8 ARAD51-5::PUR 3.3 X 10" PUR 0.25 12 3
Homozygote 2 1 ARAD51-5:-.BSD 1.0X 10" BSD 2.5 12 1
2 ARAD51-5:\BSD 1.0X 10" BSD 2.5 12 0
Homozygote 1 1 ARAD51-5::BSD 2.3 X 10" BSD 2.5 27 0
2 ARAD51-5:.BSD 2.9 X 10" BSD 2.5 35 0
3 ARAD51-5:\BSD 2 .3X 10" BSD 2.5 27 0
Homozygote 1 4 ARAD51-5:\BSD 1.3X 10" BSD 2.5 18 0
5 ARAD51-5::BSD 1.7X 10" BSD 2.5 21 0
6 ARAD51-5::BSD 1.5 X 10" BSD 2.5 18 0
Homozygote 1 7 ARAD51-5::BSD2 2.0 X 10^ BSD 2.5 6 0
8 ARAD51-5::BSD2 2.0 X 10" BSD 2.5 12 0
Homozygote 2 3 ARAD51-5::BSD2 2.0 X 10" BSD 2.5 11 0
4 ARAD51-5::BSD2 2.0 X 10" BSD 2.5 8 0
Homozygote 1 9 ARAD51~5::BSD2 3.6 X 10" BSD 2.5 10 0
10 ARAD51-5:\BSD2 3 .0X 10" BSD 2.5 15 0
H om oz^ote 2 5 ARAD51-5:\BSD2 4 .0X 10" BSD 2.5 16 0
6 ARAD51-5:\BSD2 3 .6X 10" BSD 2.5 17 1
Hétérozygote 9 ARAD51-5V.PUR 4.0 X 10" PUR 0.25 4 0
10 ARAD51-5:\PUR 3.9 X 10" PUR 0.25 4 1
Homozygote 3 1 ARAD51-5::BSD2 3.6 X 10" BSD 2.5 12 2
2 ARAD51-5::BSD2 2 .6X 10" BSD 2.5 7 X
3 ARAD51-5:\BSD2 3.6 X 10" BSD 2.5 15 X
i
Table 4.2; Transformations carried ont during the generation of RAD51-5 mutants. A list of the 
transformations carried out during the generation of two independent RAD5Î-5 heterozygous and 
homozygous mutants. The table includes the constructs and drug selection used, the numbers of cells 
plated out, the number of those that were antibiotic resistant transformants and the number that had 
correctly integrated the construct. During the generation of homozygous mutant cell lines selection 
initially utilised only selection for the transformed resistance gene - blasticidin (BSD). Transformants 
were subsequently placed on double drug selection (blasticidin as listed and puromycin at 0.25 pg.ml ') 
before being considered a putative homozygous mutant. All drug concentrations listed are in |ig.ml‘‘. 
Trans.: transformation. No.: Number. PUR: puromycin. C: transformant lost due to contamination. X: 
transformants not analysed.
1 0 2
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To generate ARAD51-5::BSD2, the new blasticidin resistance cassette, with flanking 
tubulin and actin processing signals, was PCR-amplified from the construct pCPlOl 
(Conway et al., 2002b) using Herculase and the primers ^aS'-Hpal and ACT3'-^AI 
(Appendix 1). Due to the lack of appropriate restriction sites available for cloning the |
blasticidin cassette into pCP302, the ends of the PCR product were made blunt using the 
Klenow fragment of E. coli DNA polymerase (New England Biolabs) and ligated into ■ApCP302, which had been digested with EcoRY and treated with CIP (New England 
Biolabs), to create àRAD51-5: :BSD2 (Fig 4.3). DNA of this construct was prepared for 
transformation as described in section 4.2,
It was decided that both putative heterozygous mutants should be transformed using the 
new second round construct, despite the fact that one of them had already been used to 
generate a homozygous mutant, to ensure that both independent homozygous cell lines 
were equivalent. Transformations of the two putative RAD51-5+1- cell lines using 
ARAD51-5::BSD2 were carried out (as per protocol, Section 2.4) and antibiotic resistant 
transformants selected for as described in Table 4.2. Four transformations were carried 
out on each cell line which resulted in the generation of only one putative radSl-S 
homozygous mutant {RAD51-5-/- 2), confirmed by PCR as described above (data not 
shown; see Sections 4.2.5 and 4.2.6). Further analysis of the putative RAD51-5 
heterozygous cell line, RAD51-5-^E 1, showed that its genome contained two puromycin 
resistance markers, one in the disrupted RAD51-5 allele and another in the tubulin array 
(data not shown). Transformation of this cell line using the IaRAD51-5v.BSD2 construct 
resulted in it replacing the original disruption construct resulting in a cell line that was ||
double resistant to both blasticidin and puromycin but only RAD51-5-^!-. As a result, the 
generation of an independent rad51-5 homozygous cell line had to involve the 
generation of a new heterozygous cell line. The generation of a RAD51-5 heterozygous 
cell line, using AR4D51-5::PUR, and a rad51-5 homozygous cell line, using ÙJRAD51- 
5::BSD2, was carried out as described previously in this section. The transformations 
(table 4.2) resulted in the generation of a putative RAD51-5 heterozygous cell line 
{RAD51-5 +!- 1) and a putative md51-5 homozygous cell line {RAD51-5 -/- 1), 
confirmed by PCR as described above (data not shown; see sections 4.2.5 and 4.2.6).
4.2.3 Generation o îD M C l  mutants in the 3174.2 strain
A new method of gene disruption was attempted for the generation of DMCl mutants. 
This approach is based upon the work of Gaud et aL (1997) and Shen et al. (2001), who 
showed that homology-based integration of DNA can be achieved in T. brucei using as 
little as 42 bp of sequence homology. Testing this method of gene disruption would 
allow us to assess its suitability for routine use in the laboratory, as it would greatly 
reduce the time taken to generate mutants in the future. We therefore used PCR to 
amplify the blasticidin and bleomycin resistant cassettes and incorporated 50 bases of 
sequence derived from the 5' and 3' end of the DMCl open reading frame (Fig 4.4) into 
the two PCR primers (DMCi-PCR-K05' and DMC7-PCR-K03'; Appendix 1). PCR 
amplification using Herculase DNA polymerase and the plasmids pCPlOl (Conway et 
al., 2002b) and pRM481 (R. McCulloch, gift) as templates generated the products 
diagrammed in Figure 4.5, named ADMC1::BSD and M)MC1::BLE. Multiple PCRs 
were performed, the products pooled, purified using the Strataprep PCR purification kit 
(Stratagene) and approximately 5 pg of purified PCR product (quantified by gel 
electrophoresis relative to Life Technologies 1 kb size ladder) used in each 
transformation. Two transformations were carried out to generate two independent 
DMCl heterozygous cell lines using the ADMC1::BSD PCR product. Again, 3174.2 
cells were transformed (see protocol section 2.4), antibiotic resistant transformants 
selected for as described in Table 4.3 and screened by PCR. After two attempts no 
heterozygous mutants were generated, with integration of the construct occurring into 
unknown locations. Six subsequent transformations using a reduced drug concentration 
for selection resulted in the generation of putative heterozygous mutants (Table 4.3). 
Screens for the generation of heterozygous mutants was carried out by PCR- 
amplification of the entire DMCl open reading frame using primers DMCl-Vor and 
DMCl-Rsw (Appendix 1) and Taq DNA polymerase (data not shown; see Sections 4.2.5 
and 4.2.6).
Subsequent transformation of the putative DMCl heterozygous cell lines (named 
DMC1+/- 1 and DMC1+/- 2) using the ADMC1::BLE PCR product, however, failed to 
result in the generation of dmcl homozygous mutants (Table 4.3). In 10 
transformations, 266 transformants were screened by PCR (as described above) and 
none appeared to have integrated into the DMCl locus and have presumably 
recombined into non-homologous or partly homologous loci.
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Cell line being Trans. Cell No. Drug and No. of No. of correct
generated Number Construct used plated out concentration transformants integrations
Heterozygote 1 ADMCf ::SSD 1 .0 X 1 0 ’' BSD 10 0
1 .0 X 1 0 ’' BSD 5 3 0
2 ADMC1 ::BSD 1.0 X 10^ BSD 10 3 0
1.0 X 10^ BSD 5 0
Heterozygote 3 ADMC1 ::BSD 1.8X 10^ BSD 10 5 0
1.8 X 10^ BSD 2.5 5 0
4 ADMC1::BSD 1.7X 10^ BSD 10 3 0
1 .7 X 1 0 ’' BSD 2.5 4 4
Heterozygote 5 ADMC1::BSD 2 .0X 10^ BSD 2.5 0
6 ADMC1 ::BSD 2 .0 X 1 0 ’' BSD 2.5 0
Heterozygote 7 ADMC1 ::BSD 2.0 X 10^ BSD 2.5 0
Heterozygote 8 ADMC1 ::BSD 2.9 X 10’' BSD 2.5 11 0
9 ADMC1 ::BSD 2.2 X 10’' BSD 2.5 6 1
Homozygote 2 1 ADMC1 v.BLE 2 .4X 10^ BLE 0.5 17 0
2 ADMC1 "BLE 2.0 X 10^ BLE 0.5 15 0
Homozygote 1 1 ADMC1 ::BLE 1.0X 10^ BLE 0.5 0
2 ADMC1 "BLE 1.0X 10^ BLE 0.5 0
Homozygote 1 3 ADMC1 "BLE 3 .0X 10^ BLE 1.0 35 0
4 ADMC1 ::BLE 2.9 X 10^ BLE 1.0 34 0
Homozygote 2 3 ADMC1 "BLE 3.2X 10^ BLE 1.0 27 0
4 ADMC1 \:BLE 2 .7 X 1 0 ’' BLE 1.0 25 0
5 ADMC1 -.'.BLE 3.2 X 10’' BLE 1.0 30 0
6 ADMC1 "BLE 2.4 X 10^ BLE 1.0 26 0
Homozygote 1 5 ADMC1 \\BLE2 3.0 X 10^ BLE 1.0 20 6
Homozygote 2 6 ADMC1 "BLE2 2.2 X 10^ BLE 1.0 13 2
Table 4.3; Transformations carried out during the generation of DMCl mutants. A list of the 
transformations carried out during the generation of two independent DMCl heterozygous and 
homozygous mutants. The table includes the constructs and drug selection used, the numbers of cells 
plated out, the number of those that were antibiotic resistant transformants and the number that had 
correctly integrated the construct. The generation of homozygous mutant cell lines selection initialy 
utilised only selection for the transformed resistance gene - bleomycin (BLE). Transformants were 
subsequently placed on double drug selection (phleomycin (PLE) as listed and blasticidin at 2.5 pg.ml'*) 
before being considered a putative homozygous mutant. All drug concentrations listed are in pg.ml'*. 
Trans.: transformation. No.: Number. BSD: Blasticidin.
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Because of this, a gene disruption construct was made for mutating the second DMCl 
allele using the traditional method. The re-designed construct is essentially the same as 
the PCR based product, with the exception that it contains larger targeting flanks of 
DMCl sequence to aid integration of the construct into the correct location.
Primers were designed to amplify 5' (primers DMCl-LHF-For and -LHF-Rev;
Appendix 1) and 3' (primers Z)AfC7-RHF-For and DMCJ-RHF-Rev; Appendix 1) 
regions of the DMCl open reading frame. The 5' and 3' regions, 260 and 250 base pairs 
in size respectively, were PCR-amplified with Herculase DNA polymerase from 3174.2 
genomic DNA and subsequently cloned into pBC KS using the restriction sites 
contained within the primers (EcoRI, Hindill and Xhol\ Fig 4.4) resulting in the 
generation of pCP303. The bleomycin resistance cassette, with flanking tubulin and 
actin processing signals, was PCR-amplified from the construct pRM481 (R. 
McCulloch, gift) using Herculase DNA polymerase and the primers ^aS'-Hpal and 
A.Cï3'-Sphl, Due to the lack of appropriate restriction sites available for cloning the 
bleomycin resistance cassette between the targeting flanking sequences, the ends of the 
PCR product were made blunt using the Klenow fragment of E. coli DNA polymerase I 
and ligated into pCP303 (which had been digested with EcoBN and treated with CIP) to 
create ÙDMCl:\BLE2 (Fig 4.5). DNA of this construct was prepared for transformation 
as described in section 4.2.
Transformations of the putative DMC1+/- 1 and DMCl+l- 2 cell lines using 
ADMCl::BLE2 were carried out as described in Section 2.4 and antibiotic resistant 
transformants selected for as described in Table 4.3. One transformation was carried out 
on each cell line which resulted in the generation of 33 double resistant cell lines which 
were screened by PCR (as described above) showing 8 to be putative homozygous 
mutants (data not shown; see Sections 4.2.5 and 4.2.6), two of which were chosen 
{DMC1~I~ 1 and DMCl-l- 2), one from each DMCl+l- cell line.
4.2.4 Sub-cloning of the RAD51~3y RAD51-5 and DMCl mutants
Due to the time in culture differences between each of the heterozygous mutants, 
homozygous mutants and the wild type cells, each cell line was sub-cloned to ensure 
that, for each gene, all cell lines during analysis had been in culture for the same time 
post sub-cloning. For all three genes, each of the heterozygous and homozygous 
mutants along with wild type cells, previously grown in non-selective media to 10^
108
cells.ml'*, were plated out in selective media at 0.5 cells per well in 96 well plates. All 
of the cell lines were plated out in media containing hygromycin (5,0 pg.ml'^) and G418 
(2.5 pg.ml'^), and in addition, each of the heterozygous and homozygous mutants cell 
lines were plated out in media also containing the same antibiotics, at the same 
concentration, used during their generation. For each cell line three of the first wells to 
show growth were selected, grown up and stabilated. Stabilates from one of these 
selected cell lines were then used during further analysis of the RAD51-\Tk.Q genes, using 
a fresh stabilate for each assay.
4.2.5 Confirmation of the generation of mutants by Southern analysis
To confirm the generation of two independent heterozygous and homozygous mutants 
for each gene. Southern analysis was carried out on genomic DNA from each cell line, 
along with the 3174.2 parent. Genomic DNA was prepared from 25 ml of each cell line 
grown to approximately 2 x 10^  cell.ml'^ 5pg of DNA from each cell line was 
restriction digested for 6 hrs before being Southern blotted. The blots were then probed 
with the entire open reading frame of the appropriate gene, amplified by PCR from 
3174.2 genomic DNA using Taq DNA polymerase and primers Exp-For and Exp-Rev 
(see Appendix 1). The restriction enzymes used, and the expected fragment sizes, for 
each cell line are in listed in Table 4.4 (sizes are shown in base pairs). Fragment sizes 
were calculated from the gene sequences (Appendices 3-5), the gene disruption 
constructs (Figs. 4.2-3 and 4.5), the genome sequence surrounding the genes (Fig. 4.6) 
and is summarised in Figures 4.7-9.
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Cell line
Gene Enzyme Wild type +/- -/-
RAD51-3 BstXl 2404 3109 3109
2404 2857
RAD51-5 Spel 5465 5465 4077
4077 1940
1940 1760
DMCl EcoKl 3010 3010 2180
1991 1991
860 1475
860
Table 4.4: Predicted fragment sizes for Southern analysis. These are the predicted fragment sizes 
expected when genomic DNA from heterozygous and homozygous mutants for each gene and wild-type 
cells is digested with the appropriate enzyme (listed). Fragment sizes, shown in base pairs, were 
calculated from the gene sequences (Appendices 3-5), the gene disruption constructs (Figs 4,2-3 and 4.5), 
the genomic environment surrounding each gene (Fig 4.6) predicted by the T. brucei genome sequences 
(gene DB at Sanger) and is summarised in Figures 4.7-9.
Bsù(.l [847] 
Hypothetical Protein RAD57 [1585-3105] [3251] Hypothetical Protein
Tb RAD51-3
Signal peptide
Hypothetical protein
5pd  [788] \
Putative veside-assodated \
membrane protein
Hypothetical protein
Tb RAD51-5
SpA [6253]
RECA [4494-5660] Hypothetical protein
EcdM. [954]
Hypothetical Protein DMCIA [1465-2511] [3964]
FcoRI[5428]
Putative Replication Factor
Tb DMCl 1 kb
Figure 4.6: The genomic environment surrounding RAD51-3, RADSl-5 and DMCl. Diagrams 
representing the genomic environment surrounding the RAD51-3, RAD51-5 and DMCl open reading 
frames. The genome sequences were derived from the T. brucei genome database (compiled by Sanger 
and TIGR) and visualised using Vector NTI. The diagrams include the restriction enzyme sites, and the 
ORF positions, shown in bp relative to the sequence shown (figures in square brackets) used to calculate 
the predicted fragment sizes for Southern analysis of the heterozygous and homozygous mutants.
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Southern analysis of the putative RAD51-3 and DMCl mutants match the predicted 
fragment sizes (Fig. 4.10), indicating that the constructs have integrated into the correct 
locus, creating heterozygous and homozygous mutants for each gene. The blots were 
probed with the entire open reading frame and no band is discernable beyond the 
expected fragments, indicating that no intact open reading frame remains in the 
homozygous mutants. The fragments observed in the RAD51-5 mutants do not, 
however, match those predicted (Fig 4.10); the wild-type undisrupted fragment and the 
larger fragment(s) in the heterozygous and homozygous alleles are smaller than those 
predicted, but the smaller fragments in the heterozygous and homozygous alleles match 
the predictions. This is most likely explained by an Spel site that has been mis- 
sequenced upstream of RAD51~5 in the T. brucei genome database or a base difference 
between the 927 T. brucei strain sequenced and the 3174.2 strain. This Spel site must be 
approximately 3.2 kb upstream of RAD 51-5 to give the smaller fragment sizes that were 
observed. Despite this. Southern analysis suggests that the heterozygous and 
homozygous mutants for RAD51-5 have been disrupted as expected. In each case, the 
disruption of one copy of the gene can be seen in the heterozygous cell lines and no 
wild type RAD51-5 allele is retained in the homozygous cell lines.
4.2.6 Confirmation of the generation of mutants by Reverse Transcriptase-PCR
To confirm further the generation of homozygous mutants, Reverse Transcriptase-PCR 
(RT-PCR) was carried out. Total RNA was prepared from 25 ml of each cell line grown 
to approximately 2x10^ cells.mf^ (RNeasy kit, Invitrogen) of which 2pg was DNase I 
treated (DNase Amplification Grade, Life Technologies) before cDNA was generated 
using random oligonucleotides and reverse transcriptase (Superscript first strand 
synthesis system, Life Technologies). For each cDNA prepared, a reverse transcriptase 
minus reaction was carried out to control for any genomic DNA contamination that may 
be present.
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Figure 4.10: Southern analysis of the RAD51-3^ RAD51-5 and DMCl mutant cell lines. (A) RADS 1-3 
cell lines digested with BstXl, (B) RADS 1-5 cell lines digested with Spel and (C) DMCl cell lines 
digested with £coRI. 5 gg of genomic DNA of each cell line was restriction digested for 6 hrs before 
being run out on a 0.8% agarose gel. The DNA was Southern blotted before being probed with the entire 
open reading frame. The two independent heterozygous mutants are indicated by -+-/- 1 and 2 and the 
homozygous mutants are indicated by -/- 1 and 2. WT refers to genomic DNA from the untransformed 
3174.2 cells. The size of the fragment that corresponds to the undisrupted gene is shown (wt), as are size 
markers.
RAD51-3 
RNA Pol I
RAD51-5 
RNA Pol I
DMCl 
RNA Pol I
RT
Figure 4.11: Confirmation of the generation of mutants by RT-PCR. RT-PCR was carried out on 
cDNA generated form total RNA. RNA Polymerase I-specific primers were used to show the generation 
of intact cDNA. Primers specific for RADSl-3, RADSl-S or DMCl were used to assay expression o f the 
genes in wild type (WT) cells, heterozygous mutants (-*-/-) and homozygous mutants (-/-).
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RT-PCR was carried out using gene-specific primers to assay for the presence or 
absence of intact RNA corresponding to each gene in the mutants. For RAD51-3^ the 
primers iMD57-3-K05' and RAD51-3-YJ3>y (Appendix 1) were used which should give 
a product of 669 bp (Fig 4.11). For RAD51-5, the primers RAD51-5- LHF-For and 
RAD51-5-\52 (Appendix 1) were used which should give a product of 435 bp (Fig. 
4.11). For DMCl, the primers DA/Ü7-LHF-For and DMCl-\3\ (Appendix 1) were used 
which should give a product of 340 bp (Fig. 4.11). In each case, a specific product of 
the appropriate size was generated in the wild type and heterozygous cell lines. 
However, disruption of both alleles of the gene in the homozygous mutants resulted in 
no PCR product being generated, confirming that intact RNA for each gene is not 
transcribed in any of the respective homozygous mutants (Fig. 4.11).
4.3 Analysis of growth
The growth rate of the RAD51-3, RAD51-5 and DMCl cell lines were analysed for two 
reasons. Firstly, any observed defect in growth potentially relates to the importance of 
that gene in the completion of cell division, at least in the particular life cycle stage 
being studied. For example, it has been observed previously that radSl-l- mutants have 
a significantly increased population doubling time (McCulloch and Barry, 1999) 
relative to wild type cells, as do mrell-l- mutants (Robinson et al., 2002). In contrast, 
other genes involved in DNA repair reactions such as KU70 (Conway et at., 2002a), 
MHS2 and MLHl (Bell and McCulloch, 2003) do not show such growth impairment. 
Secondly, any in vitro or in vivo growth defect that we observe will need to be taken 
into account when carrying out and interpreting further assays, such as VS G switching.
4.3.1 Analysis of in vitro growth
in vitro growth analysis was carried out on each of the heterozygous and homozygous 
cell lines for each gene and compared with wild type 3174.2 cells. To do this, 5 ml 
cultures were inoculated at cell densities 5 x lO'’ or 1 x 10^  cells.ml'^ and counted using 
a haemocytometer (bright-line. Sigma) at 24, 48 and 72 hours subsequently. Two or 
three repetitions of each cell line were carried out, the results plotted on a semi-
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logarithmic scale (Fig. 4.12) and the doubling times for the heterozygous and 
homozygous mutants calculated and compared to that of the wild type cells (Table 4.5).
Cell line
Gene Wild-type 1 +/- 1 _/_ 2 +/- 2-/-
RAD51-3 8.6 8.4 15.7 8.7 15.0
RAD51-5 7.8 8.0 12.8 7.6 12.6
DMCl 8.0 8.1 8.3 8.0 8.0
Table 4.5: in vitro population doubling times for RAD51-3, RADS 1-5 and DMCl mutants. The
average doubling time for each of the independent heterozygous (+/-) and homozygous (-/-) mutants is 
displayed in hours. The table also includes the average doubling time for 3174.2 wild type (WT) cells.
From the growth curves it can clearly be seen that disruption of one allele of any of the 
genes, RAD51-S, RAD51-5 or DMCl, had no effect on growth, since all the 
heterozygotes grew at the same rate as 3174.2 wild type cells. Furthermore, the dmcl -/- 
cells, showed no growth defect when compared with either the wild type or DMCl +/- 
cells. In contrast, rad51-3-l- and radSl-S-l- showed marked increases in doubling time 
relative to 3174.2 wild type cells and their respective heterozygous mutants.
The calculated doubling time for the rad51-5-/~ cells was approximately 12.7 hrs, 
suggesting the mutant has caused a similar growth defect to that observed in radSl-l- 
mutants, which double in approximately 11 hrs (McCulloch and Barry, 1999). The 
rad51-3-f- mutants appeared to have an even greater growth defect, doubling in 
approximately 15.3 hours.
4.3.2 Analysis of in vivo growth
in vivo growth was analysed to determine if the growth defects that we observed in 
vitro are exacerbated or alleviated during growth in mice. This is particularly important 
when analysing the effect of loss of the RADSlAlke genes on VSG switching, as the 
number of cell divisions in the mouse bloodstream needs to be factored in when 
calculating the switching rate (see Section 4.8.1). /« vivo growth counts were carried out 
for each of the RAD51-3 and RAD51-5 mutant cell lines and 3174.2 wild-type cells. The 
DMCl mutant cell lines were not analysed.
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ICR mice were infected with 1 x 10^  T. brucei, previously grown in culture, via 
interperitoneal injection, and the density of trypanosomes was then determined every 24 
hours up to a maximum of 120 hours. To do this, a small volume of blood was removed 
from the tail of each mouse into heparin-coated capillary tubes (Hawksley) of which 1 
jil samples were then diluted in 99 pi of 0.85% ammonium chloride. This lyses 
preferentially the red blood cells, allowing the T. brucei cells to be counted using a 
haemocytometer (bright-line, Sigma). The results were plotted on semi-logarithmic 
graphs (Fig. 4.13) and the doubling time for the heterozygous and homozygous mutants 
calculated and compared to that of the 3174.2 wild type (Table 4.6). Note that for each 
cell line, only a single mouse infection was performed, meaning that each set of data 
represents a single experiment.
4
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Cell line
Gene Wild-type 1 +/- 1 -/- 2 4-/- 2-/-
RAD51-3 5.5 5.5 8.7 5.5 7.8
RAD51-5 5.5 5.3 9.5 5.1 9.8
Table 4.6: in vivo doubling times for RAD51-3 and RADSl-S mutants. The doubling time for each of 
the heterozygous (+/-) and homozygous (-/-) mutants is displayed in hours. The table also includes the 
doubling time for 3174.2 wild type (WT) cells.
The population doubling times for all of the cell lines appear to be quicker in vivo when 
compared with the in vitro data. The wild type and heterozygous cell lines all appear to 
double in 5-5.5 hours, compared with 7.6-B.7 hours seen in vitro. The rad51-3~l~ 
mutants appeared to have a slightly less severe growth defect in vivo compared with the 
data derived from growth in culture. The average population doubling time in vivo of 
the two lines (8.25 hrs) is a 1.5-fold increase relative to the wild type and RAD51-3-^f~ 
mutants (assuming an average doubling time of 5.5 hrs). In contrast, in vitro the radSl- 
3-/- mutants doubled, on average, every 15.35 hours, which represents a 1.8-fold 
increase relative to the wild type and RAD51-3 +/- mutants (average of 8.57 hrs). 
Conversely, the rad51-5-/~ mutants appear to have a slightly more pronounced growth 
defect in vivo. The average population doubling time in vivo of the two lines (9.65 hrs) 
is a 1.8 fold increase relative to the wild type and RAD51-5+1- mutants (assuming an 
average doubling time of 5.3 hrs). in vitro the rad51-5-l- mutants doubled, on average, 
every 12.7 hours, which represents a 1.6-fold increase relative to the wild type and 
RAD51-5 +/- mutants (average of 7.8 hrs). The in vitro population doubling times will 
be used during the calculations of the VSG switching frequency (see Section 4.8.1), as
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more repetitions have been carried out and it is therefore likely that the data is more 
accurate.
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Figure 4.13; Analysis of the growth oi RAD51-3 and RADSl-S mutants in vivo. Mice were infected 
with 1 X 10  ^ trypanosomes, previously grown in culture, via interperitoneal injection. The density of 
trypanosomes was then recorded every 24 hours up to a maximum of 120 hours. One experiment was 
carried out for each of the heterozygous (+/-) and homozygous (-/-) mutants and wild type (WT) cells and 
the results plotted on semi-logarithmic scale graphs, represent. A: RADS 1-3. B: RADS 1-5.
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4.4 Analysis of the cell cycle in the R A D 51-3^ R A D 5U S  and D M C l  mutants
Given that mutation OÎRAD51-3 and RAD51-5 leads to increased population doubling, 
we wished to determine if the disruption had affected the cell cycle. The increased 
population doubling could be explained either by each mutant cell taking longer to 
complete the cell cycle, or increased numbers of cells that fail to complete cell division 
in the mutants. Kinetoplastids have a unique feature that allows for definition of the cell I
cycle point of individual cells by DNA stains. This is because the DNA contained 
within the mitochondrion (kinetoplast) and the nucleus is replicated in distinct synthesis 
phases. Kinetoplast replication begins before, and is shorter that, nuclear replication, 
resulting in the completion of kinetoplast division before the nuclear DNA enters 
mitosis (McKean, 2003). Cells in G1 phase of the cell cycle contain 1 nucleus and 1 
kinetoplast (IN IK). Kinetoplast division, which results in cells with 1 nucleus and 2 
kinetoplasts (IN 2K), occurs prior to mitosis, during which time the cells have 2 nuclei 
and 2 kinetoplasts (2N 2K). Completion of cell division forms two INIK cells in G1 
phase. This means that even asynchronous cultures can have their cell cycle stage 
accurately determined (McKean, 2003; Fig 4.14).
To examine the cell cycle, we used 4',6-Diamidino-2-phenyindole (DAPI) stain, which 
binds to DNA and fluoresces under UV light, to analyse the DNA content of fixed T. 
brucei cells (see Section 2.13.1). Comparison of the homozygous mutant cells with the 
heterozygous and wild-type cells will, therefore, determine if any mutant has a affected 
the cell cycle. The RAD51-3, RAD51-5 and DMCl strains were grown in vitro to a 
density of approximately 1 x 10^  cells.ml'\ 1 ml of this was centrifuged, the cells 
washed twice with PBS and then resuspended in 1 ml of PBS. 10 pi samples were then 
spotted onto multi-spot microscope slides (C.A.Hendley Ltd.) and allowed to air-dry.
The trypanosomes were then fixed by soaking in methanol for 5 minutes at room 
temperature and again allowed to air dry before vectashield with DAPI (Vector 
Laboratories Inc.) was added, a coverslip positioned and the slide sealed with clear nail 
varnish. Differential interference contrast (DIC) was then used to visualise intact cells 
and UV used to visualise DAPI (see Section 2.13 for further details). 2 counts of 
approximately 100 cells for each cell line were carried out (one of which was 
independent and conducted blind by R. McCulloch). The counts were added and the 
percentages of cells with each discernable DNA content calculated (Figs. 4.15-17).
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Nucleus (N) 
Kinetoplast (K)
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G1 SK ] G2
IN IK IN IK 1N2K 2N 2K 2N 2K
Figure 4.14: Ceil cycle of T. brucei. The diagram shows the timing differences between the replication 
and division of the nucleus and kinetoplast during the cell cycle. Trypanosomes start the cell cycle 
containing 1 nucleus and 1 kinetoplast (IN IK). Kinetoplast synthesis (SK) then begins, which is shorter 
than, and starts prior to, nuclear synthesis (SN), meaning that kinetoplast division (D), which results in 
cells that have 1 nucleus and 2 khietoplasts (IN 2K), has completed before nuclear mitosis (M) starts. 
Nuclear mitosis, where cells have 2 nuclei and 2 kinetoplasts (2N 2K), occurs prior to cytokinesis (C) and 
marks the end of DNA replication and division and divides the cell to generate two progeny (IN IK), 
which restart the cell cycle. Figure adapted from McKean (2003).
For all three of the /L4£>i7-like genes their mutation appeared to have no effect on the 
cell cycle (Figs. 4.15-17). In all cases, the numbers of cells in each cell cycle stage were 
equivalent in the wild types, heterozygous mutants and homozygous mutants. The 
growth defect appears not, therefore, to be a consequence of any of the mutants stalling 
at a discernible stage during the cell cycle. The same appears to be the case for radSl-l- 
T. brucei. The cells described as ‘other’ in this assay are those that have a DNA content 
that does not fall into one of the expected categories. This can take the form of too many 
nuclei or kinetoplasts, or an absence of one or both. These cells can arise due to defects 
during DNA replication, or occur as a result of inappropriate segregation of the nuclei 
and kinetoplasts during cell division. These cells appear to account for approximately 2- 
4% of a 3174.2 wild type population and appear not to increase in number as a result of 
disruption of RAD51-3y RAD51-5 or DMCL
122
Cell cycle stage
Cell line 1N1K 1N2K 2N2K Other
Wild type 155 25 15 5
131 23 9 8
Total 286 48 24 13
1 +/- 157 38 17 5
122 22 12 9
Total 279 60 29 14
1 -/- 168 28 12 7
96 17 3 4
Total 264 45 15 11
2+/- 160 24 26 5
101 16 17 6
Total 261 40 43 11
2 -/- 144 37 19 8
117 28 8 9
Total 261 65 27 17
RAD51-/- 190 19 13 3
145 17 8 5
Total 335 36 21 8
PL 60
B  IN IK 
B  IN 2K
□  2N 2K
□  Other
Wild type 1 +/- 1 - /-  2 + / -  
Cell line
2 -/- RAD51-/-
Figure 4.15; DAPI analysis of the RAD51-3 mutants. The DNA content of the 2 RAD51-3 
heterozygous (+/-) and homozygous (-/-) mutant cell lines was visualised by DAPI and compared with 
rads I homozygous (-/-) mutants and wild type (WT) cells. The numbers of cells counted, in two 
experiments for each cell line, are tabulated (INlK: 1 nucleus, 1 kinetoplast; 1N2K: 1 nucleus, 2 
kinetoplast; 2N2K; 2 nuclei, 2 kinetoplast; Other: cells that did not fall into the previous categories). The 
average percentages of the two experiments are graphed, including standard deviations generated from 
the two data sets.
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Cell cycle stage
Cell line 1N1K 1N2K 2N2K Other
Wild type 83 20 7 4
88 20 2 1
Total 171 40 9 5
1 +/- 79 20 12 4
74 32 2 2
Total 153 52 14 6
1 -/" 65 31 14 3
75 18 4 2
Total 140 49 18 5
2+1- 88 15 6 3
76 16 2 5
Total 164 31 8 8
2 ■/• 73 32 8 2
76 39 11 3
Total 149 71 19 5
Wild type
té
m
Cell line
B  IN IK 
I IN 2K
□  2N 2K
□  Other
Figure 4.16: DAPI analysis of the RAD51-5 mutants. The DNA content of the 2 RAD5J-5 
heterozygous (+/-) and homozygous (-/-) mutant cell lines was visualised by DAPI and compared with 
wild type (WT) cells. The numbers of cells counted, in two experiments for each cell line, are tabulated 
(INlK: 1 nucleus, 1 kinetoplast; 1N2K: 1 nucleus, 2 kinetoplast; 2N2K: 2 nuclei, 2 kinetoplast; Other; 
cells that did not fall into the previous categories). The average percentages of the two experiments are 
graphed, including standard deviations generated from the two data sets.
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Cell cycle stage
Cell line 1N1K 1N2K 2N2K Other
Wild type 85 15 5 4
46 9 2 3
Total 131 24 7 7
1 +/. 66 20 14 6
38 10 4 3
Total 104 30 18 9
1 "7" 70 24 6 5
51 10 6 4
Total 121 34 12 9
2+1- 82 13 6 7
47 17 5 3
Total 129 30 11 10
2 -/• 88 20 9 5
42 10 5 2
Total 130 30 14 7
Wild type
S 6 0
Cell line
m IN IK 
I IN 2K
□  2N 2K
□  Other
Figure 4.17: DAPI analysis of the DMCl mutants. The DNA content of the 2 DMCl heterozygous (+/- 
) and homozygous (-/-) mutant cell lines was visualised by DAPI and compared with wild type (WT) 
cells. The numbers of cells counted, in two experiments for each cell line, are tabulated (INlK: 1 nucleus, 
1 kinetoplast; 1N2K: 1 nucleus, 2 kinetoplast; 2N2K: 2 nuclei, 2 kinetoplast; Other: cells that did not fall 
into the previous categories). The average percentages of the two experiments are graphed, including 
standard deviations generated from the two data sets.
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4.5 Analysis of DNA damage sensitivity in the R A D 51-3 , RAD 51~5  and D M C l
mutants
To analyse whether or not the RAD51-\ïkQ genes have a role in DNA repair a DNA 
damage assay was carried out by plating out cells in increasing concentrations of methyl 
methane sulphonate (MMS). MMS is a méthylation agent that is capable of modifying 
DNA at a number of different sites, resulting in the generation of lethal and mutagenic 
lesions (Sedgwick, 2004). Each strain, previously grown to a density of 1 x 10^  
cells.mf^, was plated at one cell per well in five 96 well plates, each plate containing a 
different concentration of MMS: 0, 0.0001, 0.0002, 0.0003 and 0.0004%. Four 
repetitions for each strain were carried out. The number of wells containing a 
trypanosome population after 20 days of growth for each strain at each MMS 
concentration was counted and compared with the number of wells to grow through on 
the 0% MMS control plate for that strain. The number of wells to grow through on the 
no MMS control plates was averaged and counted as 100%; the results for that strain on 
the MMS-containing plates was then expressed relative to 100%, therefore removing 
any error due to plating efficiency.
The results observed for the RAD51-3 (Fig 4.18) and RAD51-5 mutants (Fig. 4.19) were 
very similar, with the disruption of one allele of either gene having no effect on the 
sensitivity to MMS when compared to wild-type cells. The homozygous mutants, 
however, displayed a marked increase in sensitivity, since no (or very limited) cell 
growth occurred at 0.0003% MMS, whereas the wild type and heterozygous mutants 
showed between 60 and 80% survival rates. Moreover at 0.0001% and 0.0002% MMS, 
here the wild type and heterozygous mutants showed between 80-100% survival, the 
homozygous mutants showed between 40-80% and 10-40% survival respectively. This 
result is very similar to that observed in rad51-l- cells (McCulloch and Barry, 1999) 
suggesting that both RAD51~3 and RAD51-5 have functions in DNA damage repair that 
are comparable with RADSL
1 2 6
0.0001 0.0002 0.0003 0.0004
MMS concentration (%)
0.0001 0.0002 0.0003
MMS Concentration (<Vb)
0.0004
■  Wild type
■  Heterozygote 
□  Homozygote
Figure 4.18: Analysis of DNA damage sensitivity in the RADSl-3 mutants. Each strain was plated at 
one cell.weir* in five 96 well plates, each plate containing a different concentration of MMS: 0, 0.0001, 
0.0002, 0.0003 and 0.0004%. Four repetitions for each strain were carried out. The average number of 
wells to grow through for each strain at each MMS concentration was calculated and compared to the 
average number of wells to grow through on the 0% MMS control plate for that strain. Standard deviation 
is indicated and the data is presented for the two independent (1 and 2) RAD51-3 heterozygous and 
homozygous mutants compared to 3174.2 wild type cells.
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0.0001 0.0002 0.0003MMS concentration (%) 0.0004
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3  60
0.0001 0.0002 0.0003MMS Concentration (%) 0.0004
■  Wild type
■  Hétérozygote 
□  Homozygote
Figure 4.19: Analysis of DNA damage sensitivity in the RADSI-S mutants. Each strain was plated at 
one cell.weir' in five 96 well plates, each plate containing a different concentration of MMS: 0, 0.0001, 
0.0002, 0.0003 and 0.0004%. Four repetitions for each strain were carried out. The average number of 
wells to grow through for each strain at each MMS concentration was calculated and compared to the 
average number of wells to grow through on the 0% MMS control plate for that strain. Standard deviation 
is indicated and the data is presented for the two independent (1 and 2) RAD5J-5 heterozygous and 
homozygous mutants compared to 3174.2 wild type cells.
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0.0001 0.0002 0.0003MMS Concentration (%) 0.0004
0.0001 0.0002 0.0003MMS Concentration (%)
0.0004
■  Wild-type
■  Hétérozygote 
□  Homozygote
Figure 4.20: Analysis of DNA damage sensitivity in the DMCl mutants. Each strain was plated at one 
cell.weir* in five 96 well plates, each plate containing a different concentration of MMS: 0, 0.0001, 
0.0002, 0.0003 and 0.0004%. Four repetitions for each strain were carried out. The average number of 
wells to grow through for each strain at each MMS concentration was calculated and compared to the 
average number of wells to grow through on the 0% MMS control plate for that strain. Standard deviation 
is indicated and the data is presented for the two independent (1 and 2) DMCl heterozygous and 
homozygous mutants compared to 3174.2 wild type cells.
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DMCl y on the other hand, appears to have no detectable role in MMS damage repair, 
since neither of the heterozygous or homozygous mutant lines generated showed an 
increase in DNA damage sensitivity (Fig 4.20). DMC1+/- 2 and dmcl-/- 2 (the later 
mutant derived from the former) appeared to show increased resistance to MMS, since 
at 0.0004% MMS (and perhaps at 0.0003% MMS) they showed greater survival than 
the wild type cells. This finding is not a result of the loss of DMCl, however, as no 
further increased resistance to MMS following the disruption of the second copy of the 
gene is observed. During the generation of DMCl+l- 2, we hypothesise that a mutation 
must have arisen resulting in resistance to MMS. This is not unprecedented, as mutants 
with increased resistance to MMS have been described during research into fields as 
diverse as mismatch repair (Glaab et al., 1998), amino acid biosynthesis (Kafer, 1987) 
and p53 function (Kuo et al., 1997). It is also theoretically possible that a component of 
the putative entry pathway of MMS into T. brucei has been mutated resulting in 
decreased uptake of the mutagen and therefore an increased resistance. However, 
whether or not such a MMS pathway exists is unclear. The putative secondary mutation 
generated during the disruption of DMCl was not characterised here and it was judged 
that it was unlikely to affect further assays (see below) as any random mutation is 
unlikely to have occurred in a gene involved in the recombination pathways we are 
studying, and due to the fact that the increased resistance is only slight, with the cell 
lines becoming sensitive to MMS at the higher concentrations used.
4.6 Analysis of recombination efficiency in the R4D5U3^ RADSl-5 and DMCl 
mutants
To examine the function of the RAD51-\\ke genes in T. brucei recombination, a 
transformation assay was used. This represents the only assay currently available to 
examine homologous recombination efficiency and demonstrated the importance of 
RAD51 in T. brucei recombination (Conway et al., 2002b; McCulloch and Barry, 
1999). The recombination assay involved the transformation of a bleomycin or 
puromycin resistance marker, flanked by tubulin intergenic sequences 240 bp and 330 
bp in size, into the strains of interest (Fig. 4.21). The construct is integrated into the 
tubulin array by homologous recombination and, therefore, the number of transformants 
reeovered directly relates to the efficiency of recombination in that strain. In wild type 
T. brucei, transformed DNA containing homology with the genome appears to virtually
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always be recombined by HR, rather than NHEJ (Conway et al., 2002a; Conway et al., 
2002b)
The transformation constructs were excised from the plasmid backbone by restriction 
digestion reactions, which were subsequently phenohchloroform extracted, ethanol 
precipitated and resuspended in sterile H2O. The transformation construct Tub-PUR- 
Tub was excised from pTPT (R. McCulloch, gift) by Notl and Apal restriction digestion 
and the Tub-BLE-Tub construct was excised from pRM450 (R. McCulloch, gift) by 
Notl and Apal digestion. Approximately 5 pg of digested DNA was used per 
transformation, hi each transformation, 5 x 10^  cells of each cell line were 
electroporated, as described in Section 2.4. The transformed cells were recovered, in all 
cases in non-selective media, for three generation times and 5 x 10^  wild type and 
heterozygous mutant cells were plated out over 24 wells in 1.5 mis of antibiotic 
selective media per well. The dmcl-/- cell lines, where a recombination defect was not 
expected, were plated out as described for the wild type and heterozygous mutants. In 
contrast, the radSl-S and radSl-S homozygous mutants were plated out at 2 x 10^  cells 
over 48 wells in 1.5 mis of antibiotic selective media per well, again allowing 3 
generations for recovery and taking into account the increased doubling times (see 
Section 4.3.1). 3 transformations of each of the heterozygous and homozygous cell lines 
were carried out, along with 3 wild type control transformations. The RAD51-3 and 
RAD51-5 cell lines were transformed with Tub-BLE-Tub and selected with 2 pg.ml"  ^of 
phleomycin, whereas the DMCl cell lines were transformed with Tub-PUR-Tub and 
selected with 1 pg.ml"  ^of puromycin.
/ / p a p a   1 M i — - j z z z z : ]  / /  Tubulin array
antibiotic marker
Figure 4.21; Integration of the recombination assay construct. The construct contains tubulin 
intergenic regions flanking a resistance marker. The construct is integrated into the tubulin array by 
homologous recombination, acting on the tubulin flanks, which results in an a-tubulin open reading frame 
being replaced with the resistance marker. Read through transcription in the tubulin array provides 
expression of the resistance cassette, which contains no promoter.
The number of wells containing antibiotic resistant transformants were counted after 14 
days of growth and used to calculate the recombination efficiency (expressed as the
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number of transformants per 10^  cells plated out). These data are shown in Figure 4.22 
and tabulated in Table 4.7.
Cell line
Gene 1 +/- 1 -/- 2+/- 2-/-
RAD51-3 1.0 3.8 1.0 9.0
RAD51-5 1.0 7.2 0.9 6.4
DMCI 0.9 1.1 1.0 0.9
Table 4.7: Recombination efficiency of the RADSl-3, RADSl-5 and DMCI mutants. The table shows 
the fold reduction in the average recombination efficiency of each of the heterozygous (+/-) and 
homozygous (-/-) mutants when compared to the average recombination efficiency of 3174.2 wild type 
cells. Values of 1 represent a recombination efficiency in that cell line equivalent to wild type cells, 
values of less than 1 indicates a greater recombination efficiency, and values greater than 1 indicate lesser 
efficiency.
There is a clear reduction in recombination efficiency in the rad51-3 and rad51~5 
homozygotes (Fig. 4.22). In the rad51-3-/- cells, homozygous mutant cell line 1 showed 
a 3.8-fold reduction relative to wild type and its cognate heterozygote, while line 2 
showed a 9-fold reduction (assuming an average transformation efficiency of 4.67 in 
10^  cells for the wild type and heterozygous mutants in this experiment). Whether or not 
this difference is simply a statistical artefact or reflects genuine differences between the 
two mutants is unclear. The two rad51-5-1- cell lines showed comparable 6.7 and 7.7- 
fold reductions in transformation efficiency (assuming an average transformation 
efficiency of 4.38 in 10^  cells for the wild type and heterozygous mutants in this 
experiment). These reductions are not as severe as that observed in radSl-l- mutants 
where a 7 to 16-fold reduction in homologous recombination efficiency is observed for 
a range of constructs (Conway et al, 2002b). This suggests that the roles of RAD51-3 
and RAD51-5 may not be as central as that of RAD51 in the process of homologous 
recombination, although the general efficiencies of transformation are higher in this 
present work. The dmcl-f- cell lines showed no defect in recombination compared to 
wild-type cells. Here, the wild type transformation efficiency is somewhat lower than 
that observed in the RAD51-3 and RAD51-5 experiments; this is probably because Tub- 
PUR-Tub was used rather than Tub-BLE-Tub. Either the antibiotic selection alters the 
level of transformant growth, or slight differences in the size of the transformed 
constructs subtly affect recombination efficiency.
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A number of transformants from each of the mutants were analysed by drug resistance |
and Southern analysis to determine the integration location of the transformed 
constructs. The construct can integrate by homologous recombination into three
■ ipossible locations depending on the cell line being analysed. These are: the tubulin 
array (see Fig. 4.21), the 221VSG ES and the mutated copy of the R A D 5 1 gene.
These locations each contain the processing signals from the tubulin array identical to 
those contained within the constructs being used to test recombination efficiency. The 
same processing signals were used in the AiL4T)5i-5::PUR first round gene disruption 
construct (Fig. 4.3), both RAD51-3 constructs (Fig. 4.2) and were also used in the 
generation of the transgenic 3174.2 strain when the hygromycin resistance marker was 
integrated into the 5' end of the VSG221 ES (Fig. 4.28) to allow VSG switching analysis 
(Section 5.9). Determining the antibiotic resistance or sensitivity of the transformants 
can therefore assess replacement of the markers by the recombination construct.
One transformant from each wild type, heterozygous mutant and dmcl homozygous 
mutant transformations and four from the rad51~3 and radSl-S homozygous 
transformations, were selected for further analysis. The transformants were passaged 
into selective media containing either hygromycin (5.0 pg-mf^), puromycin (0,25 
pg.mT^) for RAD51-3 and RAD51-5 heterozygotes or blasticidin (2.5 pg.ml"') for the 
RAD51-3 homozygotes.
The same transformant cell lines were also subjected to Southern analysis. 5 pg of 
genomic DNA from each transformant was restriction digested with /fr’wdlll before 
being separated by electrophoresis on a 0.8% agarose gel, which was then Southern 
blotted and probed with the bleomycin resistance open reading frame (in the case of the 
RAD51-3 an RAD51-5 transformations) or the puromycin resistance open reading frame 
(for the DMCl transformations).
Together, the results of these two assays determine the integration locus. None of the 
transformant cell lines had integrated the constructs by means other than homologous 
recombination (Figs. 4.23-25). Despite the rad51~3-I- and rad51-5-l- mutants having 
reduced recombination efficiency, all of the integration events analysed had occurred at 
one of the three available regions of homology described above. This result is slightly 
different to that observed in radSl-f- cells (Conway et aL, 2002b), where low levels of 
aberrant integrations, relying on 5-15 bp of sequence homology, take place in these 
assays. This may suggest that the roles of RAD51-3 and RAD51-5 in recombination are 
not as important as that of RAD51. Unsurprisingly, given that dmcl-l- mutants 
displayed no defect in recombination, all integration had occurred by sequence
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homology. In some cases the transformants displayed two bands in the Southerns: this is 
as a result of two transformants being selected for in the same well, resulting in a 
polyclonal population. Genomic DNA was prepared from transformants, after selection 
using the transformed resistance cassette, in the absence of further drug selection, 
meaning that there was no selection against polyclonal populations. In all cases, the 
polyclonal populations occurred in wild type cells or mutant cell lines without a 
recombination deficiency, suggesting that in those cell lines the recombination 
efficiency may actually be higher than calculated previously (Fig. 4.22).
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4.7 Generation of re-expression cell lines
In order to examine the effect of the iL4D57-like genes on VSG switching, the 
generation of re-expression cell lines was necessary to prove that any defect observed 
was purely as a result of loss of the functional gene and not a secondary mutation. One 
of the two independent homozygous mutants of RAD51-3 and RAD51-5 were used to 
generate a re-expression cell line. A re-expression cell line for DMCl was not 
generated, as loss of this gene had no defect in any of the assays carried out thus far and 
we deemed it unlikely that it would not have a role in VSG switching.
4.7.1 Generation of RAD51-3 and RAD51-5 re-expression cell lines
The RAD51-3 and RAD51-5 genes were PCR-amplified from 3174.2 genomic DNA 
(primers RAD51-3-Voï and RAD51-3-Kqn, or RAD51-5-Vor and RAD51-5-Rm) using 
Herculase DNA polymerase, restriction digested {RAD51-3 was digested with EcdRN^ 
and RAD51-5 was digested with .EcoRI) and made blunt using the Klenow fragment of 
E. coli DNA polymerase before being ligated into the plasmid pRM481 (R. McCulloch, 
gift), which had been F^coRV-digested and CIP treated (Fig 4.26), This resulted in the 
generation of pRM481::iL4DJ7-3 and pRM481::R^D57-5. Insertion of RAD51-3 or 
RAD51-5 into pRM481 allows the genes to be inserted into the tubulin array, where 
they are transcribed from the endogenous transcription. Splicing and polyadenylation is 
provided by the 5' actin and 3' tubulin intergenic sequences, rather than the natural 
processing of the genes.
The constructs were excised from the plasmid backbone by restriction digestion with 
Notl and Apa\ and the resulting digested DNA phenol:chloroform extracted and ethanol 
precipitated. Approximately 5 pg of digested DNA (quantified by gel electrophoresis 
relative to life technologies 1 kb size ladder) was then used in each T. brucei 
transformation. Two transformations of 5 x 10^  cells were carried out on rad51-3-(- 2 
with pRM481::7MD57-3 and rad51-5-1- 1 with pRM481 : :7L4D57-J using the protocol 
described in section 2,4. Antibiotic resistant transformants were selected for by plating 
out 2 X 10^  rad51-3-1- cells and 3 x 10^  rad51-5-1- cells from each transformation at 2 
pg.ml'^ phleomycin, and 1 x 10^  cells were plated out over 12 wells with 1.5 mis per 
well. 5 putative RAD51-3 re-expressers and 5 putative RAD51-5 re-expressers were 
generated.
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The generation of re-expresser cell lines was confirmed by PCR-amplification of the 
entire open reading frame using Taq DNA polymerase and primers Exp-For and Exp- 
Rev (data not shown; see Section 4.7.2) and one was chosen for each gene (named 
RAD51-3-l-l-^ andiMD57-5-/-/+).
4.7.2 Confirmation of the generation of RAD51-3 and RAD5US re-expression cell 
lines
To confirm that pRM481::i?/4D57-J and pRM481::Æ4DJ7-d had integrated as expected 
in the RAD5U3-f-U and RADS 1-5-1-1+ cell lines. Southern analysis was conducted in 
the same manner as that used during the generation of the respective mutants (Section 
4.4.5). Genomic DNA fi*om wild type cells and the progenitor heterozygous and 
homozygous cell lines used to generate the re-expression line were also subjected to 
Southern analysis to allow direct comparison (Fig. 4.27). The extra fragments observed 
in the re-expression cell lines correspond to expected integration of pRM481::Rz(D57-5 
and pRM481::764D57-5 into the tubulin array, since they are of the sizes expected: 
RADS 1-3, 341 Obp; miàRADSl-S, 7910bp.
4.7.3 in vitro growth of the RAD51-3 and RAD5US re-expression cell lines
Analysis of in-vitro growth of the RADS 1-3-1-!+ and RADS1-S-I-I+ cells was carried out 
to determine if transcription of the genes alleviated the growth defect that was observed 
in the homozygous mutants (Section 4.3.1). The assay was carried out in the same 
manner as described in Section 4.3.1. Three repetitions of the growth assay were carried 
out for each re-expresser, and two repetitions of wild type cells for comparison (Fig. 
4.27). In both cases, the re-expresser cell lines had population doubling times essentially 
equivalent to that of wild-type cells. The wild types doubled in 7.7 hrs, RADS1-3-I-I+ in
8.2 hrs and RADS1-S-I-I+ in 7.9 hrs.
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Figure 4.27; Generation of the RADSl-3 and RADSl-5 re-expression cell lines. A: Southern blots of 
3174.2 wild type (WT) cell and either RAD51-3 or RAD51-5 heterozygous (+/-), homozygous (-/-) and re­
expression (-/-/+) genomic DNA probed with the respective open reading frame. For RAD51-3 the DNA 
was digested with fis/XI and for RAD51-5 the DNA was digested with Spe\. The size of the fragment that 
corresponds to the undisrupted gene is shown (wt), as are size markers. B: Cell counts of 3174.2 wild type 
cells (WT) compared with RAD5I-3 and RAD51-5 re-expressers (-/-/+) over 72 hours. Standard deviations 
are shown.
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4.8 Analysis of V SG  switching in the R A D 51-3, R A D S  1-5  and D M C l  mutants
VSG switching assays were carried out to determine if the disruption of any of the 
RAD51-\\kQ genes had any effect on antigenic variation. The ability to carry out this 
analysis is as a result of the generation of the mutant cell lines in the transgenic 3174.2 
strain. This trypanosome strain contains a modified active expression site, into which 
antibiotic resistance markers for hygromycin and G418 have been inserted (Fig 4.28), 
which allows its use in experiments to determine the VSG switching frequency and the 
relative contributions of gene conversion and in situ switching mechanisms. The exact 
conditions used in this assay are described in Sections 2.4 and 4.8.1-2, but a general 
description is given below. Growth on both hygromycin and G418 ensures that all cells 
express the modified expression site and hence the VSG221 protein. These cells were 
used to immunise mice against VSG221.
The RAD51-3, RAD51-5 and DMCl cell lines, previously grown on hygromycin and 
G418, were removed from antibiotic selection for 9 generation times, thereby allowing 
VSG switching to take place, before injection into immunised mice. 24 hrs after 
injection, surviving trypanosomes, those that had not been killed by immune lysis as a 
result of switching their VSG coat, were recovered from the mice and plated out over 96 
wells. After a maximum of 4 weeks the number of wells that showed trypanosome 
growth were counted and the VSG frequency estimated (Section 4.8.1). In addition to 
this, cells from a number of wells showing growth had their drug sensitivities assessed 
and genomic DNA was isolated from the switched trypanosomes for PCR analyses. The 
results of the PCR-amplification of the VSG221 gene and the antibiotic markers, 
together with the switched variants sensitivity or resistance to hygromycin and G418, 
allowed us to determine the switching mechanism utilised in that cell line (Section 
4.8.2).
4.8.1 Analysis of VSG switching frequency in the RAD51-3, RAD51-5 and DMCl 
mutants
When analysing the VSG switching of the wild type 3174.2 cells, all the heterozygous 
mutants and the dmcl-l- mutants, 4x10^ ceils were injected into the immune mice. For 
the radS 1-3-1- and radS 1-5-1- mutants, where a switching defect was expected, 8 x 10^  
cells were injected in an attempt to increase the number of switching events per mouse,
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making the assay more accurate. In each cell line this was achieved by inoculating 25 
ml of media (2 x 25ml for the radS 1-3-1- and radSl-S-l- mutants) with 1x10^ cells 
which, after 9 generation times, reached a density of approximately 2x10^ cell.mf \  By 
ensuring that all the wild type, heterozygous and homozygous mutants have the same 
time scale to allow VSG switch variants to arise, variability in the assay is minimised as 
much as possible. All individual switching experiments used independently grown 25 
ml populations of cells allowed to undergo VSG switching.
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The VSG switching frequency was calculated for each cell line in each mouse as 
follows: the number of wells showing growth for each mouse was first multiplied by 2.5 
to calculate the number of switched cells in the total blood volume (the total blood 
volume of a mouse is taken as 2 ml, and 2 x 0.4 ml of blood was used to isolate 
switched variants). This number was then divided by the of number of generation times 
that had occurred during the 24 hour period following infection in the immunised 
mouse, thus determining the number of switched cells in the injected sample. Finally, 
the number of cells that were injected was taken into account and the number of 
switched variants per 10^  cells injected was determined. These results are shown in 
Tables 4.8, 4.10 and 4.12. Statistical analysis was also carried out on the results to 
determine if any observed differences were significant or not (Tables 4.9, 4.11 and 
4.13). It should be noted that, in calculating the number of generations the switched 
variants underwent in each mouse, the in vitro population doubling times were used 
(refer to Table 4.5, Section 4.3.1), meaning that the longer generation times of the 
radSl-S and rad51-5 homozygous mutants is taken into account. As has been argued, 
these data were used in preference to the in vivo population doubling times (Table 4.6, 
section 4.3.2), as they are more accurate.
From these results, it appears that only one of the RAD51-Vik.Q genes is involved in VSG 
switching. Despite the apparently equivalent importance of RAD51-3 and RAD51-5 in 
previous DNA repair and recombination assays, the radSl-S-i- mutants showed a 
reduced VSG switching frequency relative to wild type or heterozygous mutants, 
whereas the rad51-5-l- mutants did not (Fig. 4.29). The observed switching frequencies 
in the wild type and heterozygous mutants were comparable with that described 
previously (Bell and McCulloch, 2003; McCulloch and Barry, 1999; Robinson et aL, 
2002): around 5 switched variants in 10^  cells, although there was considerable 
variation. The rad51-5-1- mutants also showed this rate and statistical analysis 
confirmed there was no statistical difference (p>0.05). In contrast, the rad51-3-l- 
mutants switched at a lower rate: this was, on average, 0.5-1.5 switched variants per 10^  
cells, but varied from 0.1-2.6. In fact, in a number of experiments, no switched variants 
were recovered, suggesting that the frequency may be at the threshold of detection with 
the number of cells being injected.
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RAD51-3 1 +/“ 1 -/- 2 +/- 2-1- 2 -/-/+
Wild type 0.442 0.052 0.661 0.073 0.133
1 +/- 0.008 0.702 0.014 0.117
1 -/- 0.012 0.258 0.003
2 +/- 0.021 0.1052-1- 0.046
Table 4.9: Statistical analysis of the VSG switching frequencies in the RADSl-3 mutants. P values 
are shown for two sample T-tests comparing the VSG switching frequencies o f 3174.2 wild type cells 
(wild type), the two RAD51-3 heterozygous mutants (1 +/- and 2 +/-), the two homozygous mutants (1 -A 
and 2 -/-) and the RAD5I-3 re-expresser (-/-/+).
f
These negative experiments were not, however, included in the frequency calculation or 
statistical examination, which suggest that the reduction in VSG switching is significant 
(p<0.05). Comparing the switch frequency of either rad51-3-l- mutant lines to that of 
the wild type cells was on the verge of significance (p values of 0.05 and 0.07), whereas 
comparison with the heterozygous mutants from which they were derived, and to the re- 
expresser, always suggested a significant effect.
Unsurprisingly, given the lack of an observable function for DMCl in DNA repair or 
recombination in 3174.2 bloodstream form cells, no effect was observed on VSG 
switching frequency by mutating the gene. For reasons that are unclear, the observed 
switch frequencies in this experimental set were nearly uniformly higher (around 10 
switched variants in 10^  cells) than the RAD51-3 or RAD51-5 experiments, but 
disruption of DMCl had no effect.
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Cell line No. of wells Switch freauencv Averaae St Dev
(out of 192) (per 10  ^cells)
Wild type 149 11.6
84 6.6
D
78 6.1 8.1 3.1
1 +/- 93 7.3
127 9.9
84 6.6
63 4.9
9 0.7
96 7.5 6.1 3.1
2+1- 152 11.9
139 10.9
104 8.1
31 2.4
76 5.9
33 2.6 7.0 4.0
1 -/- 4 0.4
2 0.2
0
0
0
1 0,1
16 1.7
1 0.1 0.5 0.7
2 -/. D
27 2.8
0
0
0
2 0.2
4 0.4
25 2.6 1.5 1.4
2 -/“/+ 56 4.4
40 3.1
43 3.4 3.6 0.7
Table 4,8; The VSG switching frequencies of the RAD51-3 mutants. The numbers of wells showing 
growth are shown for each of the switching assays carried out on wild type 3174.2 cells, each independent 
RAD51-3 heterozygous (1 +/- and 2 +/-) and homozygous mutant (1 -/- and 2 -/-) and the RAD51-3 re­
expression cell line. The table also includes the calculated switching frequency for each experiment, the 
average switching frequency for each cell line and the standard deviation (St Dev). D: death of the mouse 
during the experiment. 0: no wells showed growth.
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Cell line No. of wells Switch freauencv Average St Dev
(out of 192)
Wild type 107 8.4
50 3.9 6.1 3.1
1 +/- D
31 2.4
17 1.3 1.9 0.8
2+/- 26 2.0
69 5.4
14 1.1 2.8 2.3
1 V" 0
62 4.8
29 2.3 3.6 1.8
2 -/- 0
114 8.9
24 1.9 5.4 5.0
1 -/“/+ 10 0.8
45 3.5
14 1.1 1.8 1.5
Table 4.10; The VSG switching frequencies of the RAD51-5 mutants. The numbers of wells showing 
growth are shown for each of the switching assays carried out on wild type 3174.2 cells, each independent 
RAD51-5 heterozygous (1 +/- and 2 +/-) and homozygous mutant (1 -/- and 2 -/-) and the RAD51-5 re­
expression cell line. The table also includes the calculated switching frequency for each experiment, the 
average switching frequency for each cell line and the standard deviation (St Dev). D: death of the mouse 
during tlie experiment. 0: no wells showed growth.
RAD51-5 1 +/- 1 -/- 2+1- 2 -/- 1 -/-/+
Wild type 0.315 0.497 0.424 0.886 0.322
1 +/“ 0.431 0.560 0.499 0.956
1 -/- 0.730 0.706 0.454
2 +/- 0.617 0.5662-1- 0.500
Table 4.11; Statistical analysis of the VSG switching frequencies in the RAD51-5 mutants. P values 
are shown for two sample T-tests comparing the VSG switching frequencies of 3174.2 wild type cells 
(wild type), the two RAD51-5 heterozygous mutants (1 +/- and 2 +/-), die two homozygous mutants (1 -/- 
and 2 -/-) and the RAD5I-5 re-expresser (-/-/+).
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Cell line No. of wells Switch freauencv Averaae St Dev
(out of 192)
Wild type 165 12.9
175 13.7 13.3 0.6
1 +A D
83 6.5
161 12.6 9.5 4.3
2+1- 146 11.4
164 12.8
142 11.1 11.8 0.9
1 -/- 184 14.4
178 13.9
162 12.7 13.6 0.9
2-1- 174 13.6
164 12.8
164 12.8 13.1 0.5
Table 4.12: The VSG switching frequencies of the DMCl mutants. The numbers of wells showing 
growth are shown for each of the switching assays carried out on wild type 3174.2 cells and each 
independent DMCl heterozygous (1 +/- and 2 +/-) and homozygous mutant ( IV-  and 2 -/-). The table 
also includes the calculated switching frequency for each experiment, the average switching frequency for 
each cell line and the standard deviation (St Dev). D: death of the mouse during the experiment.
DMC1 1 +/- 1 -A 2+1- 2-1-
Wild type 0.437 0.626 0.146 0.712
1 +A 0.410 0.604 0.456
1 -A 0.080 0.370
2 +/- 0.158
Table 4.13: Statistical analysis of the VSG switching frequencies in the DMCl mutants. P values are 
shown for two sample T-tests comparing the VSG switching frequencies of 3174.2 wild type cells (wild 
type), the two DMCl heterozygous mutants (1 +/- and 2 +/-) and the two homozygous mutants (1 -/- and 
2 -A),
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4.8.2 Analysis of VSG  switching mechanism in the R A D 51-3 , R A D 5 1 -5  and D M C l
mutants
The 3174.2 cell line allows us to distinguish three different types of switching event that 
results in the expression of a novel VSG: in situ switching, VSG gene conversion and 
expression site gene conversion (Fig. 4.28). Cell lines that have carried out an in situ 
switch are sensitive to both hygromycin (Hyg^) and G418 (G418^) as the resistance 
genes are no longer expressed, but PCR products are still obtained for each of the 
markers (Hyg+, Neo+, 221+) as no loss of sequence occurred during the switch. Cell 
lines that have carried out an expression site gene conversion are also both Hyg^ and 
G418®, but here PCR products are not obtained for any of the markers (Hyg-, Neo-, 
221-) as they have been removed and replaced by sequence from another expression 
site. The third type of switching event, VSG gene conversion, results in cells that are 
hygromycin resistant (Hyg^) but G418^. VSG gene conversion involves the replacement 
of the sequence from the 70-bp repeats to the 3' end of VSG221 with sequence from 
another expression site; this removes the Neo and VSG221 markers, but leaves the Hyg 
intact (Hyg+, Neo-, VSG21-).
Where possible, at least 10 switched variants from each cell line and from each mouse 
were analysed to determine their switching mechanism (refer to Sections 2.4.2). The 
antibiotic resistance or sensitivity of each switched variant was scored using 
hygromycin (5.0 pg.ml"^) or neomycin (2.5 pg.ml'^). PCR-amplification of the 
hygromycin (primers Hygro-5' and Hygro-3'; Appendix 1), neomycin (primers Neo-5' 
and Neo-3'; Appendix 1) and VSG221 (primers VSG221-5' and VSG221-3'; Appendix 
1) open reading frames within the modified expression site was used to determine the 
presence, or absence, of each of the genes in the VSG221 expression site. RNA 
polymerase I (primers Pol-5' and Pol-3'; Appendix 1) reactions were carried out to 
control for the presence of intact genomic DNA. Together, the results for the antibiotic 
selection and PCR were used to determine the switching mechanisms used in each 
RAD51-\fkQ mutant and are shown in Figures 4.30-32. It appears that disruption of none 
of the 3 RADSl-WkQ genes had a major effect on the type of switching event that can be 
used. There is substantial variability in this work but, in general, in the wild type cells in 
situ switching and expression site gene conversion occurred at relatively similar 
frequencies and VSG gene conversion, to replace just the VSG221 gene and the 
upstream neomycin marker, were relatively rare. Very small numbers of events that do 
not conform to these events were also detected, but these are very rare.
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Given this variability, it is very difficult to determine if any slight shift in the relative 
use of the switching events resulted from the disruption of the RAD51-\ikQ genes. It is 
more appropriate to attempt to define a m^or shift in switching mechanism, for 
example if the cell line showed a total loss of ability to carry out gene conversion 
switches. With this in mind, all of the mutations appear to have no effect on the VSG
■ 'Iswitch mechanism. For the rad51-5 and dmcl homozygous mutants, the lack of altered 
switching frequency is reflected in a lack of alteration in switch mechanism. For radSl- 
3-!- mutants, the reduced VSG switch frequency is not reflected in an altered pattern of 
switch mechanism. This is most readily explained by an equal reduction in all the VSG 
switching mechanisms following the disruption of RAD51~3.
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In situ ES GC VSG GC other TotalWild type 9 1 0 0 10Total 9 1 0 0 102 8 0 0 101 +/. 4 2 2 1 91 9 0 0 10Total 7 19 2 1 290 1 0 0 11 */* 3 11 2 0 160 1 0 0 1Total 3 13 2 0 186 1 3 0 10
2+1- 7 3 0 0 101 6 3 0 10Total 14 10 6 0 300 1 0 0 12 ■7“ 3 0 0 0 320 3 0 0 23Total 23 4 0 0 2710 0 0 0 102 -1-1+ 4 5 0 1 107 1 1 1 10Total 21 6 1 2 30
B In Situ
ESGC
□  VSG GC
□  Other
WT 1 + / -  1 - / -  2 + / -  2 - / -  1 - / - /  +
Figure 430: Analysis of switching events in the RAD51-3 mutants. In the table (top) the type of 
switching mechanism used in a number of putatively clonal switched variants, from each of the RAD5J-3 
cell lines and 3174.2 wild type cells, is indicated. The data are shown for the individual experiments 
detailed in the text. The graph (bottom) shows the tabulated data averaged for each cell line, and standard 
deviations are indicated (except for the wild type cells as switched variants from only one mouse were 
analysed). For both parts, the following nomenclature is used: In situ: in situ transcriptional switch. ES 
GC: expression site gene conversion. VSG GC: VSG gene conversion. Other: unknown. WT: wild type. 
+/-: heterozygous mutant. -/-: homozygous mutant. /-/-+: re-expression cell line.
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In situ ES GC VSG GC other TotalWild type 3 6 0 1 102 4 3 1 10Total 5 10 3 2 201 +/- 6 4 0 0 106 4 0 0 10Total 12 a 0 0 201 -/- 7 3 0 0 1010 0 0 0 10Total 17 3 0 0 200 6 3 1 10
2+1- 3 6 0 1 107 3 0 0 10Total 10 15 3 2 302 -/- 6 4 0 0 108 1 1 0 10Total 14 5 1 0 201 -1-1+ 9 0 0 1 107 2 1 0 10Total 16 2 1 1 20
B In Situ
■ ES GC
□ VSG GC
□ Other
WT 1 +/- 1 -/- 2 +/- 2 -/- 1 -/-/+
Figure 431: Analysis of switching events in the RAD51-S mutants. In the table (top) the type of 
switching mechanism used in a number of putatively clonal switched variants, from each of the RAD5J-5 
cell lines and 3174.2 wild type cells, is indicated. The data are shown for the individual experiments 
detailed in the text. The graph (bottom) shows the tabulated data averaged for each cell line, and standard 
deviations are indicated. For both parts, the following nomenclature is used: In situ: in situ transcriptional 
switch. ES GC: expression site gene conversion. VSG GC: VSG gene conversion. Other: unknown. WT: 
wild type. +/-: heterozygous mutant. -/-: homozygous mutant. /-/-+: re-expression cell line.
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In-situ ES GC VSG GC other TotalWild-type 5 3 2 0 101 6 3 0 10Total 6 9 5 0 201 +/- 3 5 2 0 105 4 1 0 10Total 8 9 3 0 206 4 0 0 101 ■/* 5 1 4 0 105 2 2 1 10Total 16 7 6 1 305 1 4 0 10
2+1- 5 3 2 0 105 2 2 0 9Total 15 6 8 0 297 3 0 0 102 -/- 6 2 1 1 108 2 0 0 10Total 21 7 1 1 30
100
* ^ m s
WT 1 +/- 1 -/- 2 +/- 2 -/-
mIn Situ
■ ES GC
□ VSG GC
□ Other
Figure 432: Analysis of switching events in the DMCl mutants. In the table (top) the type of 
switching mechanism used in a number of putatively clonal switched variants, from each of the DMCl 
cell lines and 3174.2 wild type cells, is indicated. The data are shown for the individual experiments 
detailed in the text. The graph (bottom) shows the tabulated data averaged for each cell line, and standard 
deviations are indicated. For both parts, the following nomenclature is used; In situ; in situ transcriptional 
switch. ES GC: expression site gene conversion. VSG GC: VSG gene conversion. Other: unknown. WT: 
wild type. +/-: heterozygous mutant. -/-: homozygous mutant.
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4.9 Summary
The aim of this chapter was to determine \îRAD51-3, RAD51-5 or DMCl had any roles 
in DNA damage repair, recombination or VSG switching in 427 bloodstream form T. 
brucei. To do this, a reverse genetics approach was taken and homozygous mutants 
generated for each gene. All three genes could be made mutant, indicating that none of 
the genes are essential in this life-cycle stage, as had been found for RAD51 (McCulloch 
and Barry, 1999). Mutation of two of the genes, RAD51-3 and RAD51-5, caused a 
growth defect, observed by an increased population doubling time in vitro and in vivo. 
The cause of this is unknown, but is not explained by arrest of the cells at a defined 
stage of the cell cycle. The gene that showed no growth defect on mutation, DMCl, 
displayed no phenotypes consistent with the encoded protein contributing the DNA 
damage repair, recombination or VSG switching, at least in bloodstream form cells. 
RAD51-3 and RAD51-5 in contrast, were shown to be impaired in their ability to repair 
MMS induced DNA damage and to integrate transformed DNA constructs into their 
genome. Both phenotypes are consistent with the encoded proteins contributing to T. 
brucei DNA repair and homologous recombination. Perhaps the most surprising 
finding, given the similar roles for RAD51-3 and RAD51-5 in T. brucei general repair 
and recombination, is that RAD51-3 mutants were found to be impaired in VSG 
switching, while RAD51-5 mutants were not. The RAD51-3 mutants, like RAD51., 
appeared to have an equal reduction in both in situ transcriptional switching and gene 
conversion switching.
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5.1 Introduction
The presence of DSBs has been shown in a number of organisms to cause cell cycle 
checkpoint arrest and the visible relocalisation of recombination enzymes to form 
putative repair complexes known as foci (Gasior et al,, 1998; Haaf et al., 1995; Haaf et 
al., 1999; Lisby et al,, 2001; Lisby et al., 2003a; Lisby et al., 2003b; Lisby et al., 2004; 
Lisby and Rothstein, 2004; Lukas et al., 2003; Maser et al., 1997; Melo et al., 2001; 
Raderschall et al., 1999). The formation of foci was first observed in meiotic yeast cells 
in which Rad51 and Dmcl were shown to co-localise in what was postulated to be 
recombination intermediates (Bishop, 1994). It was later shown that Rad52 and RPA 
foci also co-localise with Rad5l during meiosis, and that RPA foci formed during late 
Gi and S phases (Gasior et al., 1998), Yeast repair foci are also formed in mitotic cells, 
either as spontaneous events or in response to induced DNA damage. Here, the 
formation of RadSl and Rad52 foci is limited to the S and Gg phases, suggesting that 
the repair of the DSBs are regulated in a cell cycle dependent manner (Lisby et al., 
2003a; Lisby et al., 2004). The observation that Rial foci (presumably as the RPA 
complex) are formed in Gi cells (Lisby et al., 2004) indicates that DSBs arise and can 
be processed at any stage of the cell cycle, but the repair appears to be cell cycle 
limited, Rad52, Rad55 and Rad57 are essential for the formation of RadSl foci in yeast 
meiotic cells. In contrast, only Rad52 appears to be involved in the formation of DNA 
damage-induced Rad51 foci (Gasior et al., 1998; Lisby et al., 2004), and this response 
to DNA damage is combined with an increase in the expression of Rad51 (Mercier et 
al., 2001). Analysis of yeast Rad52 sub-nuclear localisation showed that the formation 
of spontaneous foci is almost exclusively limited to budded cells, suggesting that they 
are formed due to DNA damage generated during replication (Lisby et al., 2001; Lisby 
et al., 2003b), In contrast, exogenous generation of DSBs by exposure to y-irradiation 
resulted in a dramatic increase in the numbers of cells containing foci (Lisby et al., 
2001). Together, these data indicate that repair foci are responsible for repairing DSBs 
generated in a number of ways, Rad52 foci were also shown to contain multiple DSBs, 
as the number of foci present in yeast cells is always lower than the number of DSBs 
generated (Lisby et al., 2003b), This led the authors to postulate that the aggregation of 
recombination and checkpoint proteins at a few repair centres may help facilitate the 
coordination of the DNA damage response.
As in yeast, the formation of Rad51 foci in humans (Haaf et al., 1995), and Rad51 or 
Rad52 foci formation in mice (Liu and Maizels, 2000), has been demonstrated to be
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dramatically increased in response to DNA damage. In contrast to yeast, however, the 
formation of RadSl foci in response to DNA damage in CHO cells was not combined 
with increased expression of RadSl (Bishop et al., 1998; Mercier et al., 2001). These 
data suggest that DNA repair foci observed in mammalian cells are purely a result of the 
redistribution of pre-existing protein. Further analysis of this redistribution showed that 
RadSl formed foci at sites of single strand DNA (Raderschall et al., 1999).
In mammalian cells, as in yeast meiosis, loss of the RadSl paralogues can have 
deleterious effects on the formation of RadSl foci, CHO cell lines deficient in the 
RadSl paralogues Xrcc2 and Xrcc3 were shown to have a deficiencies in RadSl foci 
formation that were recovered by the transformation of plasmids expressing either 
Xrcc2 or Xrcc3 (Bishop et al., 1998; O'Regan et al., 2001). It was later shown that 
Xrcc3 is recruited to the sites of DSBs at an early stage of the repair process and 
independently of RadSl (Forget et ah, 2004). Takata et al (2001) shows that RadSlC, 
RadSlD, Xrcc2 and Xrcc3 also contribute to RadSl foci formation in chicken DT40 
cells. It therefore appears that Xrcc3 in mammalian cells may be acting in a similar 
manner to RadS2 in yeast, in that it acts early in the DNA damage response. It appears 
that vertebrate RadSl-like proteins, unlike RadSS and RadS7 in yeast, act in RadSl foci 
formed mitotic cells, hi mice the formation of RadS 1 foci was observed to occur at a 
rate slower than that of RadS2 foci (Liu and Maizels, 2000). In fact, analysis of the 
diffusion rates of RadSl, RadS2 and RadS4 in mammalian nuclei showed all three to 
have different mobilities (Essers et al., 2002), suggesting that they are not components 
of a preassembled DNA repair holo-enzyme in the absence of DNA damage, but are 
able to diffuse foeely within the cell. This appears to be confirmed by the finding that 
RadSl, RadS2 and RadS4 are able to diffuse into or out of foci formed in response to 
DNA damage (Essers et al., 2002).
In keeping with the apparent distinction between spontaneous and induced RadS2 foci 
and yeast, the formation of mammalian RadSl foci differs depending on the source of 
DNA damage. Human cells containing a truncation of the breast cancer tumour 
suppressor gene Brca2 display an absence of RadS 1 foci in response to y-irradiation. 
However, similar levels of S-phase, or spontaneous, RadSl foci formation is observed 
in the same cells before and after exposure to y-irradiation (Tarsounas et al., 2003; 
Tarsounas et al., 2004a). These results suggest that there are distinct pathways for the 
assembly of RADS 1 foci in response to stalled replication forks or to irradiation.
So far this project has analysed the roles of T. brucei RADS 1-3, RADSl-S and DMCl 
on an individual basis. The aim of this was to determine which of the three proteins had
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roles in DNA repair, recombination and antigenic variation. Now that roles have been 
identified for RAD51-3 and RAD51-5 in repair and recombination, and for RAD5I-3 in 
antigenic variation, the question arises: do these proteins interact with RAD51? The aim 
of this chapter is to start to determine the interactions, if any, between the RAD51-\\kQ 
genes. This question was addressed in two ways. Firstly, in situ hybridisation assays 
were carried out to assess the ability of each of the R/fDjf-like gene mutants to 
influence the formation of RAD51 foci. Secondly, attempts were made to over-express 
each of the iLTDii-like genes in a rad51-l- mutant background. This was intended to |
examine if any of the RAD51-like proteins can compensate for the loss of RAD51, 
especially in response to DNA damage, indicating that they may be capable of 
catalysing DNA strand exchange independently of RAD51.
5.2 in situ hybridisation
As a means to examine the function of T. brucei RAD51-3 and RAD51-5 in the 
regulation of RAD51 expression, this chapter exploits recent unpublished work by 
Katherine Norrby, which demonstrates that T. brucei RAD51 localises in sub-nuclear 
foci following damage. Since the work I will describe is reliant on these findings of K, 
Norrby, a summary of this analysis is provided in the following section to clarify my 
later work.
To analyse whether or not T. brucei forms RAD51 foci in response to DNA damage as 
has been described in yeast and mammals, in situ hybridisation was carried out on Lister 
427 wild type bloodstream form cells using rabbit polyclonal antisera raised against T. 
brucei RAD51 expressed in E. coli (referred to as ‘anti-RAD51 antiserum’) and 
secondary hybridisation using a goat derived anti-rabbit IgG with FITC conjugate 
(Sigma; referred to as ‘FITC conjugate’).
The cells were grown, from a starting density of 1 x 10^  cells,mf\ in HMI-9 containing 
a range of phleomycin concentrations for 18 hours and then examined under a 
microscope for the presence or absence of foci (section 2.14,2; details of this analysis 
are described in Section 5.2,2). The results show that wild type cells in the absence of 
DNA damage showed predominantly RAD51 staining throughout the cell (Fig 5.1), 
with no evidence for nuclear localisation. It seems likely that this cytoplasmic 
localisation of RAD51 is genuine and not due to substantial cross reaction of the 
antiserum, since very little staining was seen in rad51-(- cells.
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Western analysis carried out using total protein extracts from wild type and radSl-l- 
cells showed that the anti-RAD51 antiserum recognises primarily RAD51 in 
bloodstream form cells, since there was very limited hybridisation in radSld- extract 
(Fig 5.2): Some minor cross-reaction with an unidentified protein species of around 80 
kDa was apparent. In response to DNA damage, RAD51 was observed to co-localise 
with the nucleus and to form foci. Increasing the phleomycin concentration, up to 5 
pg.mf’, resulted in increased numbers of cells with sub-nuclear foci and an increase in 
the number of foci within those cells (Table 5.1). At 0.2 and 0.5 pg.mf* phleomycin
42.2 -  48.1% of cells formed 1 or more RAD51 foci, with approximately 27 -  32% of 
cells containing 2 - 4  foci. Increasing the concentration of phleomycin to 1.0 and 2.0 
pg.mf* resulted in 74 -  87.7% of cells forming 1 or more RAD51 foci, with 
approximately 45 -  50% of cells containing 2 - 4  foci. However, increasing the 
concentration fiuther, to 5.0 pg.mf' of phleomycin, resulted in undetectable RAD51 
expression, presumably because the level of DNA damage is so great that it has started 
to affect transcription.
4 7 ,5 -
3 2 .5 -
anti-RAD51
anti-metacaspase
Figure 5.2: Western of wild type and radSl-l- 
bloodstream T. brucei probed with the anti-RAD51 
antiserum. Total protein extracts from wild type Lister 427 
bloodstream form cells and from 427 rad51-/- bloodstream 
form cells is shown after hybridisation with anti-RAD51 
antiserum. Size markers are indicated and a loading control 
with antisera against metacaspaseS (J. Mottram and M. 
Helms, gift) is shown.
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RAD51 wild type 
RAD51 - / -
Number o f foci (% )
IPLEl 0 1 2 3 4 5 6 M0 99.0 0.0 0.0 0.0 0.0 0.0 0.0 1.00.2 57.8 14.7 14.7 10.1 1.8 0.9 0.0 0.0
0.5 51.9 13.5 13.5 5.8 12.5 1.0 1.0 1.01 26.0 16.3 16.3 11.5 17.3 5.8 1.0 5.82 12.3 14.2 14.2 32.1 3.8 0.9 0.0 22.60 99.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0
Table 5.1: RAD51 foci formation in wild type and radSl-l~ 427 bloodstream form cells. The
percentage of cells containing RAD51 foci, the numbers of foci are shown at varying concentrations of 
phleomycin (PLE). Concentrations of phleomycin are in pg.ml M: more than 6 foci. homozygous 
mutant.
It is possible that the RAD51 foci that were observed may simply result from an 
increase in expression of RAD51 in response to DNA damage, resulting in punctuate 
staining in the nucleus, rather than re-localisation of RAD51 to the nucleus. I have 
already shown that RAD51 mRNA does not increase in response to DNA damage 
(section 3.8), but to examine if the same is true for the RAD51 protein, a Western was 
carried out (by Richard McCulloch) on total protein from 427 bloodstream form cells 
exposed to increasing concentrations of phleomycin (Fig. 5.3). These results indicate 
that RAD51 protein levels also do not increase in response to DNA damage.
RAD51 wild type
0 .2  0 .5  1.0 2 .0  5 .0
RAD51
m e ta c a s p a s e  5
  RAD51-h
10 0  p g .m l'i PLE
Figure 53: Western of protein extracts from cells exposed to phleomycin induced DNA damage.
Lister 427 bloodstream form cells were exposed to increasing concentrations of phleomycin (PLE) as 
indicated and total protein extracts probed with anti-RAD51 antiserum; anti-metacaspase 5 antiserum was 
used as a loading control.
This work demonstrates that in situ hybridisation analysis is a viable approach to assess 
whether or not RAD51-3 and RAD51-5 have roles in RAD51 function. By exposing 
rad51-3 and rad51-5 homozygous mutant cell lines to DNA damage, the contribution of 
the protein products to the formation of foci can be determined. This would address 
directly the question of whether or not RAD51-3 and RAD51-5 operate in the same
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fDNA damage repair pathway as RAD51. Given that the DMCl mutants have no 
discernable defects in repair or recombination function, at least in bloodstream form 
cells, the contribution of DMCl to the formation of RAD51 foci was not examined.
5.2.1 Assessing the phleomycin sensitivity of RAD51-3 and RAD51-S mutants
It has already been shown that rad51-3 and rad51-5 homozygous mutants have 
increased sensitivity to the alkylating agent MMS (section 4.5). To examine if this DNA 
damage phenotype is also the case for phleomycin a simpler sensitivity assay was 
carried out. Wild type cells and RAD51-3 or RAD51-5 heterozygous and homozygous 
mutant cell lines were plated out at 10^  cells.ml'^ in a total volume of 1 ml, in varying 
concentrations of phleomycin and cell counts carried out at 18 and 42 hour time points 
(Table 5.2). It appears that over the time course of this assay, the expected increase in 
phleomycin sensitivity of the rad51-3 and rad51-5 homozygous mutants relative to the 
wild type cells and heterozygous mutants was not discernable. In all cases, increasing 
the concentration of phleomycin showed an increasing extent of cell death and the 
amount of increased cell death or growth retardation after 42 hrs compared with 18 
hours are comparable. The lower cell concentrations of the homozygous mutants 
observed in all conditions are most readily explained by their longer generation times 
(Section 4.3.1). It is possible, therefore, that the rad51-3 and md51-5 homozygous 
mutants are no more sensitive to the DNA damage caused by phleomycin and show a 
distinction in this form of DNA repair relative to that which is required after exposure to 
MMS. Indeed, such a situation has also been seen previously in T. brucei, since mrell- 
l- mutants do not display increased sensitivity to MMS, relative to wild type cells and 
heterozygous mutants, but are more sensitive to phleomycin (Robinson et ah, 2002). 
Nevertheless, the assay used in this work is not the same as the MMS survival assay 
used previously (Section 4.5) or in the MREll analysis (Robinson et ah, 2002), as it 
uses higher concentrations of damaging agent and scores the amount of cell death rather 
than the ability of individual cells to survive the treatment. For this reason, we have 
assumed that the rad51-3 and rad51~5 homozygous mutants do display increased 
phleomycin sensitivity in examining RAD51 foci formation and examined foci 
formation at 2 phleomycin concentrations.
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such a severe growth defect as the radSl-S-l- mutants (Section 4.3.1).
5.2.2 in situ hybridisation analysis of RAD51 in RAD51-3 and RAD51-5 mutants.
To examine the localisation of RAD51 following phleomycin damage, 5 ml cultures of 
all cell lines were set up at 10^  cells.mf^ at 1,5 pg.ml’^  phleomycin and additional 
cultures were set up for radS 1-3-1- cells at 0.3 pg.mf^ and radSl-S-!- cells at 0.5 pg.ml" 
After 18 hours growth, 1.5 mis of cells were spun down at 1500g for 10 mins, 
resuspended in 1ml of PBS to wash out residual HMI-9, spun down again and 
resuspended in 40 pi of PBS. 20 pi samples were then smeared on a microscope slide 
and allowed to air dry before being fixed and permeabilised by soaking in methanol for 
10 mins. The slides were then washed in PBS containing 0.2% Tween-20 (PBS-T) for 5 
mins before being moved to a humid chamber. 1ml of anti-RAD51 antiserum, diluted 
1:500 in PBS containing 1% Tween-20 and 3% BSA (PBS-T-BSA), was added to the 
slide and left to hybridise for 90 mins at room temperature. The slides were rinsed with 
PBS-T-BSA and soaked twice in fresh batches of PBS-T-BSA for 5 mins before being 
returned to the humid chamber, at which point 0.5 ml of the FITC conjugated goat- 
derived anti-rabbit IgG, diluted 1:100 in PBS-T-BSA, was added to the slide and left in 
the dark to hybridise for 30 mins at room temperature. The slides were then rinsed with 
PBS-T-BSA and soaked twice in fresh batches of PBS-T for 5 mins before one drop of 
vectashield with DAPI (Vector laboratories) was placed on the slide, a coverslip added 
and sealed with nail varnish. Slides were visualised the same day and counts of 100-120 
cells were carried out and scored for the number of sub-nuclear foci that were visible. 
From these data, the percentages of each cell line containing 0 -  6, or more (M), 
discernable foci were calculated (Tables 5.3 and 5.4).
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Firstly, in situ hybridisation analysis, for all of the cell lines, was conducted at a 
phleomycin concentration of 1.5 pg.ml'l This concentration resulted in growth arrest, 
or slight population death, in all of the cell lines and is in the range known to induce 
RAD51 foci formation in wild type cells (section 5.2). Secondly, to ensure that the 
rad51-3 and rad51-5 homozygous mutants were not damaged beyond the point at which 
RAD51 foci form, lower drug concentrations were also used: 0.3 pg.mf^ for rad51-3-1- 
and 0.5 pg.ml'^ for rad51-5-/-. These concentrations gave comparable levels of cell 
death or growth retardation relative to the wild type cell and heterozygous mutants.
Presumably a higher concentration is needed for radSl-S-l- mutants, as they do not have
Wild Type 
RAD51-3 + /-  1 
RAD51-3 - /-  1 
RAD51-3 - /-  1 
RAD51-3 + /-  2 
RAD51-3 - /-  2 
RAD51-3 - /-  2
Number of fod  (% )[PLE] 0 1 2 3 4 5 6 M1.5 35.0 28.2 21.4 10.3 3.4 3.4 0.9 0.9
1.5 27.4 30.8 18.8 15.4 6.0 1.7 0.0 0.0
0.3 81.7 7.3 5.5 5.5 0.0 0.0 0.0 0.0
1.5 63.8 18.1 12.1 3.4 2.6 0.0 0.0 0.01.5 22.2 26.5 18.8 14.5 4.3 1.7 0.9 1.7
0.3 59.0 19.7 12.0 4.3 0.9 0.9 0.0 0.01.5 52.1 24.8 8.5 0.9 1.7 0.9 0.0 0.9
Table 53: RAD51 foci formation in wild type cells and RAD51-3 mutants. Percentages of cells that 
show foci and the number of foci at given concentrations of phleomycin (PLE) are shown. Concentrations 
of phleomycin are in pg.ml'. M: more than 6 foci. +/-: heterozygous mutant. homozygous mutant.
Wild Type 
RAD51-5 + /-  1 
RAD51-5 - /-  1 
RAD51-5 - /-  1 
RAD51-5 + /-  2 
RAD51-5 - /-  2 
RAD51-5 - /-  2
Number of fod  (% )[PLE] 0 1 2 3 4 5 6 M1.5 22.3 16.1 24.1 17.9 11.6 4.5 1.8 1.81.5 19.8 24.3 33.3 14.4 5.4 1.8 0.9 0.0
0.5 67.3 18.3 16.3 5.8 1.0 0.0 0.0 0.0
1.5 59.5 18.0 9.0 2.7 0.9 0.9 0.0 0.9
1.5 27.9 32.4 19.8 13.5 2.7 4.5 3.6 3.60.5 64.0 22.5 7.2 3.6 0.9 0.0 0.9 0.91.5 64.9 23.4 3.6 1.8 2.7 0.0 0.0 0.0
Table 5.4: RAD51 foci formation in wild type cells and RAD51-S mutants. Percentages of cells that 
show foci and the number of foci at given concentrations of phleomycin (PLE) are shown. Concentrations 
of phleomycin are in pg.ml'. M: more than 6 foci. +/-: heterozygous mutant. homozygous mutant.
From these results it can be seen that loss of functional RAD51-3 and RAD51-5 results 
in a reduced capacity for RAD51 foci formation. A reduction in the number of cells 
with visible RAD51 foci, and a concomitant increase in the number of cells without foci 
were apparent in the rad51-3-I- and rad51-5-l- mutants relative to the wild type and 
heterozygous cells. This was true at either the lower or higher concentrations of 
phleomycin used in the homozygous mutants. Moreover, the number of foci in the 
homozygous mutant cells was also reduced: only very small numbers of cells were seen 
with greater than 3 -4  foci (Tables 5.3 and 5.4).
The RAD51 foci that formed in wild type cells were generally clear and distinct, with 
the majority of cells containing 1 - 3  foci (examples are shown Fig. 5.4). In contrast, 
while, the RAD51-3 and RAD51-5 heterozygous cell lines exhibited qualitatively the 
same RAD51 foci as wild type cells, the foci in the homozygous cell lines were clearly 
different (Fig. 5.5). The foci formed in the rad51-5-/- cell lines, in general, were much 
less well-defined with a significant level of cytoplasmic RAD51 staining remaining 
(Figs. 5.5 and 5.6). Indeed, in many cases (such as in Fig. 5.6D) the level of cytoplasmic 
RAD51 staining was such that the foci observed were exceptionally faint. In the radSl-
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3-1- cell lines, these observations were also apparent, although the cells tended to show 
less cytoplasmic localisation and more distinct foci (e.g. Fig. 5.7), though still not as 
clearly as in the wild type or RAD51~3+/- cells.
These results suggest that both proteins facilitate the movement of RAD51 into sub- 
nuclear foci following phleomycin-induced DNA damage. The increased cytoplasmic 
staining in the radS 1-3-1- and rad51-5-i- mutants may suggest, furthermore, that 
RAD51 is transferred from the cytoplasmic in to the nucleus in this reaction, either by 
RAD51-3 or RAD51-5 directly, or by other factors. We cannot exclude however, that 
the cytoplasmic staining results from cross reaction of the anti-RADS 1 antiserum with 
another unidentified protein and that this is more apparent when trying to visualise the 
fainter sub-nuclear RAD51 foci in the homozygous mutants.
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5.3 Complementation of ra d S l -/-
rad51~}~ cells have been shown to have DNA damage sensitivity, a recombination 
defect and a reduced level of VSG switching. However, all of these processes do still 
occur, albeit at a reduced level. This suggests that other enzymes are capable of 
catalysing homologous recombination in the absence of RAD51. In an attempt to 
determine if RAD51-3, RAD51-5 or DMCl can fulfil this function, attempts were made 
to over-express each gene in rad51-!~ cells. The over-expression cell lines could then be 
analysed for any reduction in the defects caused by the loss of RAD51, indicating that 
the RAD51-like proteins can operate as independent enzymes in homologous 
recombination.
To attempt this complementation of rad51-/~ mutants, the inducible expression system 
comprising the plasmids pLewl3 (Wirtz et al., 1999) and pHD789 (Irmer and Clayton, 
2001) kindly donated by C. Clayton (Fig. 5.8) was chosen. This system, which utilises 
T7 RNA polymerase and the tetracycline repressor/operator system, allows inducible 
over-expression from any cloned gene. The construct pLewl3 expresses the tetracycline 
repressor, T7 RNA polymerase and neomycin phosphotransferase (providing selection 
of transformants that have integrated the plasmid into the T. brucei tubulin array 
following electroporation). Integration into the tubulin array results in constitutive 
expression of the tetracycline repressor and T7 RNA polymerase. pLewl3 
transformants are next transformed with pHD789, a construct which integrates in to the 
rRNA spacer and contains the T7 RNA polymerase promoter, the tetracycline operator 
and the gene to be over-expressed. pHD789 transformants are selected for using a 
hygromycin resistance marker. When double transformant cells are grown in the 
absence of tetracycline, the repressor binds to the operator, blocking transcription from 
the T7 promoter. Addition of tetracycline to the culture media results in a release fi'om 
the transcriptional block, thereby allowing T7 polymerase to transcribe any gene of 
interest.
5.3.1 Attempted generation of RADSl-S.^ RADSl-S and DMCl over-expression 
cell lines
The pLewl3 construct was linearised by restriction digestion with Noil and the DNA 
then phenohchloroform extracted and ethanol precipitated. 5 pg of digested plasmid
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was used in each of three transformations of 5 x 10^  rad51 -/- cells, carried out as 
described in Materials and Methods Section 2.4. Antibiotic resistant transformants were f
first selected using 2.5 pg.ml'^ of G418 and 1 x 10^  cells were plated out over 12 wells 
using 1.5 mis HMI-9 per well. Since no transformants were obtained from this 
approach, the experiment was repeated in exactly the same way except that a slightly 
reduced level of G418 (2 pg.ml'^) was used for selection. Following this approach, a 
total of 3 transformants were generated. The low fi*equency of transformation is almost 
certainly a consequence of the radSl mutation, since a transformation efficiency 
approximately 4-fold greater was seen with pLewl3 in wild type cells (data not shown).
Genomic DNA was extracted from all three putative rad51-l- pLewl3 transformant cell 
lines and subjected to restriction digestion using Notl. The digested DNA was 
subsequently separated by gel electrophoresis in a 0.8% agarose 1 x TBE gel, Southern 
blotted and probed with a fragment of the neomycin resistance gene (generated by PCR 
using Taq DNA polymerase and primers Neo-5' and Neo-3'; Appendix 1).
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Figure 5.9: A Southern of three putative radSl-l- pLewl3 
transformants. Genomic DNA was digested with Notl and probed 
with a fragment of the neomycin resistance gene. Size markers (in 
kbp) are shown
Correct integration of the pLewl3 construct should be seen via the neomycin gene- 
containing fragment of approximately 9.3 kb in size, since Notl should be recreated in 
the integrated p tubulin open reading frame (Fig. 5.8) and the plasmid precisely excised 
by restriction digestion. The fragment sizes, seen in figure 5.9, do not match those 
predicted, meaning that the integration of the pLewl3 construct is anomolous, almost 
certainly a result of the inactivation of RAD51. Most likely, the transformants integrated 
part of the construct using internal sequence homology due to the numerous 5' and 3' 
processing signals present within the construct. The actin sequence annotated by the T. 
brucei genome sequencing initiative was checked to see if the neomycin resistance gene 
had replaced one of the actin genes using the 5' and 3' un-translated regions for 
homologous recombination. This had not happened, however, as replacement of one of 
the actin genes would result in a Notl digestion fragment of more than 20 kb, much 
larger than the 4.6-4.7 kb band observed.
Due to time limitations, further attempts at the correct integration of the pLewl3 
construct in rad51 -/- cells and the subsequent transformations with pHD789 containing 
RAD51-3, RAD51-5 and DMCl (which have been generated; data not shown) were not 
attempted. It is conceivable that this approach remains viable, however, despite the 
technical problems associated with generating the appropriate lines of radSl-l- cells.
5.4: Summary
The aim of this chapter was to try to determine whether or not RAD51-3 and/or 
RAD51-5 interacts with RAD51, now that roles in DNA damage repair and homologous 
recombination have been identified for these proteins. The first part of this chapter 
involved an examination of the formation of RAD51 foci in T. brucei. 427 bloodstream
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form cells were examined for RAD51 sub-cellular localisation, before and after DNA 
damage, in RAD51-3 and RAD51-5 mutants. From this, it appears that both genes 
appear to be involved in the regulation of the movement of RAD51 to sub-nuclear foci. 
In both RAD51-3 and RAD51-5 mutants there was a reduction in the number of cells 
exhibiting foci and a reduction of the number of foci within those cells. In addition, in 
the cells that contained foci, a higher level of cytoplasmic RAD51 localisation was 
apparent, and the foci formed were less distinct than those formed in wild type cells. 
Whether or not RAD51-3 and RAD51-5 are involved in the same pathway as RAD51 is 
a question that cannot be answered by this analysis.
In the second part, attempts were made to over-express RAD51-3, RAD51-5 and DMCl 
in order to determine if any of them could complement rad51-/-. Over-expression 
constructs were generated for all three genes and test transformations were successful 
using wild type cells. However, we were not able to generate pLewl3 transformants in a 
radSl -/- background. As a result of this, the experiment was abandoned due to time 
constraints.
M.
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6.1 Introduction
The overall aim of this project was to identify -like genes present in the T. brucei 1
genome» and to examine their functions. Blast searches of the T. brucei genome 
database, using S. cerevisiae Rad51, T. brucei RAD51 and E, coli RecA sequences as 
queries, identified five putative RAD51~\\\lq genes in addition to the canonical, 
previously characterised RAD51 (McCulloch and Barry, 1999). This number of 
potential RAD51-related functions, which is approximately 50% greater than that found 
in S. cerevisiae (Krogh and Symington, 2004), is not a peculiarity of T. brucei, as 
orthologues of these genes can also he identified in T. cruzi. Interestingly, one of the 
putative iMZ)57-related genes, which we have named RAD51-5 (below), could not be 
found in L. major.
The assignment of the five genes as being likely to encode functions in DNA 
recombination and repair is based upon the identification of sequence motifs that are 
characteristic of RadSl, RecA and RadA proteins in eukaryotes, bacteria and archae 
respectively (Brendel et al., 1997; Pellegrini et al,, 2002; Shao and Grishin, 2000; Story 
et al,, 1993). For three of the genes, genetic analysis was conducted to assign roles in 
the repair of induced DNA damage, homologous recombination and antigenic variation 
in Lister 427 bloodstream stage T. brucei. From these analyses, the broad conclusions 
(which are discussed further below) are as follows: no discernable function could be 
ascribed to one gene that is highly related to RAD51 {DMC1)\ two more distantly 
related genes {RAD51-3 and RAD51-5) were shown to have clear roles in DNA repair 
and in promoting a RAD51 response to induced DNA damage; and surprisingly,
RAD51-3, but not RAD51-5, had a detectable role in antigenic variation.
6.2 The role of DMCi
DMCl was shown to have no detectable functions in 427 bloodstream form cells in the 
processes of DNA damage repair, homologous recombination and antigenic variation, 
despite that fact that the gene is expressed in this life cycle stage, to generate apparently 
mature mRNA (Section 3.8.1), and can be disrupted (Section 4.2). One possible 
explanation for this is that DMCl does have roles in these processes but acts as a minor 
co-factor or in a minor pathway, meaning that the assays used could not detect this. 
Another possibility is that DMCl functions in general recombination, and repair, but in
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life-cycle stages that we have not analysed. It should be possible to analyse the potential 
functions of DMCl in procyclic cells, as these can be readily cultured, but RAD51 
appears to play a central function in recombination in this stage (McCulloch and Barry, 
1999). A final possibility is that DMCl plays no roles in general repair and 
recombination in monomorphic cells, but may assume a central role in pleomorphic 
cells. Pleomorphic cells display distinct features of cellular differentiation compared to 
monomorphic cells (generating non-dividing short stumpy forms in a density dependent 
manner; (Matthews et al., 2004; Tyler et al., 2001; Vassella et al., 1997) and, notably, 
display elevated fi*equencies of antigenic variation (Turner and Barry, 1989). Perhaps, 
then, DMCl assumes a more central function than RAD51 in catalysing VSG switching 
in pleomorphic cells. Indeed, preliminary work suggests that the impairment of VSG 
switching caused by RAD51 disruption in monomorphic T. brucei cells is not found in 
the same mutants in the ILTat 1.2 cell line of pleomorphic cells (P. Burton, PhD thesis). 
To examine this, DMCl gene disruption could be carried out in this T. brucei cell line. 
The most likely explanation for the lack of a discernable role for DMCl in Lister 427 
bloodstream stage cells, however, is that it has a meiosis-specific function. Sequence 
comparisons and phylogenetic analysis suggests that T. brucei DMCl is most closely 
related to the RadSl homologue Dmcl, which has been shown in a number of 
organisms to have a meiosis-specific function (Bishop et al., 1992; Ding et al., 2001; 
Doutriaux et al., 1998; Fukushima et al., 2000; Gupta et al., 2001). In yeast, mutation of 
dmcl has been shown to result in a defect in reciprocal recombination and 
synaptonemal complex formation during meiosis suggesting that it is involved in DNA 
strand exchange (Bishop et al., 1992). The observations that dmcl mutants have 
reduced levels of interchromosomal recombination and increased levels of 
intrachromosomal recombination (Bishop et al., 1992), and that RadSl foci form in 
dmcl mutants, whereas Dmcl foci fail to form in rad51 mutants (Bishop, 1994), 
suggests that the role of Dmcl may be to direct recombination to occur between 
homologous chromosomes and not sister chromatids. In mice, dmcl knockout mutants 
are viable but sterile, with reproductive organs smaller than normal (Masson and West,
2001). Much of the biochemical analysis of the function of Dmcl has been carried out 
using purified recombinant human Dmcl (Masson and West, 2001), Human Dmcl has 
been shown to bind single strand DNA and double stranded DNA as a linear array of 
stacked octomeric rings (Masson et al., 1999; Passy et al., 1999), and to exhibit weak 
strand transfer activity, with a S' - 3' preference (Masson et al., 1999).
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Surprisingly, the expression of Dmcl is not always limited to cells undergoing meiosis. 
Two rice Dmcl homologues have been identified that appear to be differentially 
expressed during meiosis and mitosis, suggesting that their function may not be limited 
to meiotic recombination (Kathiresan et aL, 2002). Despite this observation, no mitotic 
role for rice Dmcl has been described to date. In fact, in most organisms other than rice, 
including humans, mice and yeast (Fukushima et aL, 2000; Gupta et al., 2001; Yoshida 
et al., 1998), the expression of Dmcl is meiosis specific.
T. brucei has been shown to be able to undergo genetic exchange. The first evidence for 
this was the production of hybrid trypanosome strains by the co-transmission of two 
parental strains through tsetse flies (Jenni et al., 1986). Observations of the segregation 
of genetic markers in these transmissions, the increased frequency of chromosomal 
recombination in hybrids relative to parental strains, and the generation of hybrids with 
either 2N or 3N DNA content, but not intermediate amounts, all suggest that meiotic 
division is involved, despite the fact that a cell stage with haploid DNA content has not 
been detected (Gibson, 2001). Our analysis of all the RAD51-\ikQ genes was carried out 
in monomorphic bloodstream form cells that cannot be transmitted through tsetse flies 
and enter the life-cycle stage where genetic exchange is proposed to take place (Gibson 
and Whittington, 1993; Tait et al., 1989). If T. brucei DMCl is indeed meiosis-specific, 
the absence of any discernable phenotypes for DMCl mutants is not surprising.
One difficulty with this interpretation is that we can detect DMCl mRNA (Section
3.8.1). The simplest explanation for these data is that, although DMCl is transcribed, 
the regulation of its expression is post-transcriptional. To date, we have not tested if 
DMCl is expressed at the protein level, because of the lack of any antibody directed 
against the protein. Western or in situ hybridisation analysis would allow us to 
determine whether or not DMCl is expressed in Lister 427 bloodstream form cells. If 
DMCl does function in T. brucei genetic exchange, it might be expected that it would 
be expressed at the protein level only in epimastigote cells. This could be tested by 
Western analysis of whole cell extracts of transgenic epimastigote cells containing an 
epitope-tagged copy of DMCL Alternatively, if a DMCl antibody was available. 
Western analysis of wild type epimastigote cells could be conducted. As it has been 
shown in yeast, Dmcl forms foci during meiosis (Shinohara et al., 2000), as RadSl 
does in mitotic and meiotic cells (Lisby et al., 2004; Shinohara et al., 2000), in situ 
hybridisation could also be carried out. This would avoid potential problems of large 
numbers of epimastigote cells required to run Western analysis. If DMCl does act in 
meiosis, another expectation would be that T. brucei DMCl and RAD51 foci should be
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observed to co-localise, as this has been seen in other organisms (Masson et aL, 1999;
Masson and West, 2001; Shinohara et aL, 2000) and the two proteins appear to act in 
strand exchange. To more definitively test that DMCl has a meiosis-specific function is 
more complex. This would require disruption of DMCl in two fly-transmissible strains 
of T. brucei and their co-transmission through flies. If DMCl is involved in genetic 
exchange, mini-satellite analysis of the progeny (MacLeod et aL, 1999) could 
theoretically be used to determine if the mutation of DMCl caused a reduction in the 
ratio of recombinant genotypes relative to the parental genotypes, compared to the ratio 
obtained after the co-transmission of two DMCl wild type strains. The co-transmission 
of two parental strains is required so that genetic exchange results in a genotypic 
change. This work has a number of problems. Transmission of a single parental stock 
has a very low efficiency and, as a result, the successful co-transmission of two parental 
strains is likely to be even less efficient although it has been observed (MacLeod et aL,
1999). Another difficulty is the generation of the DMCl mutant cell lines in fly- 
transmissible T. brucei cells. The generation of DMCl mutants in Lister 427 
bloodstream for cells, regarded as the easiest strain to work with, was much more 
laborious than first thought. Therefore, the generation of mutants in fly-transmissible 
strains, which are more difficult to work with, may prove to be an arduous process.
6.3 RAD5U3 and RAD51-5
6.3.1 The roles of RAD51-3 and RAD51-5 in DNA repair and recombination
The genetic analysis in this project has identified two further factors, beyond RAD51, 
that are central to T. brucei DNA repair and recombination: RAD51-3 and RAD51-5. 
The DNA damage sensitivities observed in radS 1-3 -/- and radS1-5 -/- 427 bloodstream 
stage mutant cells, relative to their heterozygote antecedents and wild type cells, were 
similar to each other and possibly to that of rad51 -/- mutants (McCulloch and Barry, 
1999). In contrast, the observed defects in homologous recombination in rad51-3 -I- and 
rad51-5 -/- cells appeared not to be as severe as those observed in rad51 -/- cells. These 
results may indicate that the roles of RAD51-3 and RAD51-5 are not as essential as that 
0 Î RAD51 in DNA repair and recombination. However, comparisons between the DNA 
damage sensitivities observed in rad51-3 -/- and rad51-5 -/- mutant cells compared with 
those observed in rad51 -/- cells is not straightforward, as the DNA damage assays
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carried out were slightly different. Those carried out for RAD51-3 and RAD51-5 were 
DNA damage survival assays, following the ability of single cells to grow out in the 
presence of MMS, In contrast, those carried out for RAD51 were simply growth curves 
in the presence of MMS (McCulloch and Barry, 1999). Similarly, the DNA 
transformation assays to measure the recombination efficiencies of the RAD51-3 and 
RAD51-5 mutants are difficult to compare with the RAD51 analysis, as different 
researchers have conducted them at different times. The question of the extent of the 
severity of DNA damage repair and recombination defects in the RAD51-3 and RAD51- 
5 mutants is important as it directs us towards understanding their potential functions. If 
RAD51-3 and RAD51-5 are not as essential as that of RAD51 in these processes it may 
suggest that they act as co-factors of RAD51. For instance, Rad55 and Rad57 mutants 
in S. cerevisiae have mild repair and recombination defects relative to RadSl 
(Symington, 2002). Moreover, over-expression of Rad51 can alleviate these defects 
(Hays et aL, 1995) and in fact, some mutations of Rad51 can partially by-pass the 
requirement for Rad55 and Rad57 in DNA repair (Fortin and Symington, 2002). In a i
similar manner, mutation of any of the five vertebrate Rad51-liko genes {Rad51B^
Rad51C, Rad51D, Xrcc2 and^rcc5) in chicken DT40 cells appears to create less severe 
repair and recombination defects than mutation of Rad51: whereas the Rad51-like 
mutants are viable, Rad51 mutants are lethal (Takata et al., 2001), and, expression of 
human Rad51 in the DT40 Rad51-\ik.Q mutant appeared to suppress the phenotypes. 
However, whereas there is direct biochemical evidence for the S. cerevisiae Rad55/57 
heterodimer aiding in the process of RadSl nucleoprotein filament formation and strand 
exchange (Johnson and Symington, 1995; Sung, 1997b), the same direct involvement of 
the vertebrate RadSl-like proteins has not been determined.
As an alternative to T. brucei RADS 1-3 or RADSl-S functioning as RADSl co-factors, 
we can consider whether or not the proteins might operate as RADS 1-independent 
enzymes in a different pathway of recombination. We already know that at least one 
back-up pathway of recombination operates in the absence of RAD 51 in T. brucei 
(Conway et al, 2002b), and acts upon short stretches of imperfect sequence homology 
(Conway et al, 2002b). However, this appears to be a relatively minor pathway as it has 
never been seen in RADS 1 -proficent T. brucei cells, and the frequency of recombination 
in the absence of RADS 1, when this pathway is revealed, is around 10-fold less than the 
wild type cells. The severity of the impairment of recombination in the RAD51-3 and
-
RAD51-5 mutants ( 4 - 9  fold; Section 4,6) seems incompatible with either of them 
directing microhomology-dependent recombination. Nevertheless, it is interesting to
note that in RAD51, RAD51-3 or RAD51-5 mutants the observed patterns of most 
plasmid integrations are consistent with homologous recombination (see Section 4.6;
T. brucei Addressing this question would require the generation of double mutants of 
RAD51, RAD51-3 and RAD51-5, and perhaps the other 764Z)5i-like genes not analysed 
in this project. The best evidence we currently have that RAD51-3 and RAD51-5 
function in aiding T. brucei RAD51 comes from in situ hybridisation analysis (see 
below).
The DNA repair and recombination phenotypes observed in rad51~3 -I- and rad51-5 -/- 
mutant cells would appear to suggest that they are more central to general repair and 
recombination in T. brucei than either MREll or KU70/80. m rell -/- cell lines were 
found to have, at best, a slightly increased DNA damage sensitivity, and a 3-4 fold 
reduction in recombination relative to the wild type and MREll +/- cells (Robinson et 
aL, 2002; Tan et ah, 2002). T. brucei ku70 -/- or ku80 -!- mutants display no detectable 
DNA damage sensitivity or recombination defect (Conway et aL, 2002a; Janzen et aL, 
2004). These findings are in keeping with the suggestion that homologous 
recombination, including the functions of RAD51-3 and RAD51-5, is the main route of 
DNA repair in T. brucei. Whether or not rad51~3 -/- and rad51-5 -/- mutant cells show 
gross chromosomal rearrangements or telomere defects, as has been described for the 
mrell -/- and ku70 -/- mutants respectively, remains to be determined. However, it has 
been shown that mutation of RAD51-like genes in chicken DT40 cells causes 
chromosome abnormalities (Takata et al., 2001), and it has been suggested that human 
RAD51D has a role in telomere protection (Tarsounas et al., 2004b).
Given the very similar DNA repair and recombination defects in RAD51-3 and RAD51- 
5 mutants, an important question is do the two proteins operate in the same or distinct 
pathways, and do they act with each other or have separate roles? In order to attempt to 
answer this question, RAD51 in situ hybridisation analysis in response to DNA damage 
was carried out in the RAD51-3 and RAD51-5 mutants. The results of this analysis 
appeared to show that both contribute to the reorganisation of RAD51 sub-cellular 
localisation into discrete RAD51 foci following phleomycin-induced DNA damage. A 
reduced percentage of cells displaying RAD51 foci, and a reduced average number of 
foci per cell, was observed in both rad51-3 -/- and rad51-5 -/- mutant cells. This 
suggests that both proteins contribute to an evolutionarily conserved pathway of RAD51 
relocalisation in response to DNA damage, and that these RAD51 foci represent DNA
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(Conway et al., 2002b). We cannot, therefore, exclude that a RAD51-independent 
pathway of recombination, reliant on longer stretches of homology, does indeed exist in |
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repair centres that have been described in yeast and mammals, in both mitotic and 
meiotic cells (Gasior et al., 1998; Haaf et al., 1995; Haaf et al., 1999; Lisby et al, 2001; 
Lisby et al., 2003a; Lisby et al., 2003b; Lisby et al., 2004; Lisby and Rothstein, 2004; 
Lukas et al., 2003; Maser et al., 1997; Melo et al, 2001; Raderschall et a l, 1999). We 
have not, however, determined whether the foci are centres of multiple DNA breaks, as 
has been suggested for other organisms (Lisby et a l, 2001).
RAD51 foci could still be observed in both the radSl-S and rad51-5 -/- cell lines. 
This could mean one of two things. First, the ‘residual’ foci could arise in response to 
spontaneous, rather than induced, DNA damage, and this may not require the actions of 
RAD51 co-factors. Spontaneous DNA damage results from the natural metabolism of 
the cells, which can result in the production of reactive oxygen species or DSBs created 
during DNA replication and transcription (Kupiec, 2000). Induced damage, on the other 
hand, is caused by an external source, such as, UV irradiation, MMS or phleomycin. It 
been shown in mammals that the formation of DNA damage-induced Rad51 foci 
requires the actions of Brca2 and the Rad51 paralogues, whereas the formation of 
spontaneous foci has no such requirement (Tarsounas et al, 2003). In yeast, it has been 
shown that Rad51 foci do not form in rad52 mutant cells, whereas mutation of rad54, 
rad55 and rad59 has no effect on the formation of Rad51 foci (Lisby et al, 2004). This 
is direct contrast to vertebrate cells, where mutation of any of the Rad51 -paralogues 
results in a failure to form Rad51 foci (Tarsounas et al, 2003). In addition, Rad52 in 
yeast has been shown to form foci in response to induced and spontaneous DNA 
damage (Lisby et al, 2001). An alternative possibility for the residual RAD51 foci in T. 
brucei RAD51-S and RAD51-5 mutants is that that the DNA damage response system in 
T. brucei is degenerate, and RAD51-3 and RAD51-5 contribute to distinct pathway, 
which lead to the formation of repair centres.
From the in situ hybridisation results, we can conclude only that RAD51-3 and RAD51- 
5 operate in broadly the same capacity in aiding RAD51 foci formation. We cannot 
make any predictions regarding their biochemical functions, nor whether those 
functions are the same or distinct. For example, it is conceivable that one of the T. 
brucei proteins might be a signalling protein, to identify DNA damage, whilst the other 
directly interacts with RAD51. This could be addressed by testing their interactions with 
RAD51 using either yeast two-hybrid analysis or by co-immunoprecipitation 
experiments. RAD51-3 and RAD51-5 might also be involved in separate repair 
complexes, with potentially over-lapping functions. Such a scenario would place the T. 
brucei RAD51-like protein complement in the context of mammalian cells, where at
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least two complexes of RadSl paralogues have been identified (Liu et al,, 2002; Masson 
et al, 2001a; Masson et a l, 2001b; Wiese et al, 2002; Fig. 1.9), rather than the single 
Rads5/57 heterodimer found in yeast (Symington, 2002). Testing of this prediction 
could be achieved by the generation of RAD51-3 and RAD51-5 double mutants, or 
testing interactions amongst the RADS 1-like proteins using yeast two-hybrid or co- 
immunoprecipitation analyses. Finally, RADS 1-3 and RADS 1-5 might operate at 
entirely distinct steps in the pathway of RADS 1 foci formation, and indeed in DSB 
repair. Biochemical characterisation of the purified enzymes activities would most 
rigorously define whether or not this was the case. The observation that T. brucei 
rad51-3 -I- mutant cells show a reduced frequency of VSG switching, whereas rad51-5 
-/- mutant cells do not, may lend credence to this possibility (see below).
6.3.2 The roles of RAD51-3 and RAD51-5 in antigenic variation
Perhaps the most surprising observation from this work is that, despite RAD51-3 and 
RAD51-5 mutants having very similar DNA repair and recombination phenotypes, only 
RAD51-3 mutants display a defect in antigenic variation. The most convenient 
explanation for this result is that VSG switching is a highly variable process, and the in 
vivo assay used to analyse the switching frequency has failed to detect a role for 
RAD51-5, or that RAD51-5 has a less important function than RAD51 or RAD51-3 in 
this reaction and the assay is too insensitive to detect a small reduction in VSG 
switching in radSl-S -/- mutants. It is difficult to address the former possibility, but it 
seems unlikely that RAD51-5 is less important than RAD51-3 in RAD51 function. In 
the in situ hybridisation analysis, the rad51-5 -/- mutants appeared, if anything, to have 
a more severe defect than the rad51-3-/~ mutants during RAD51 foci formation (Section
5.2.2). It is also unlikely that the RAD51-3 mutants have a more severe growth defect 
that could serve to artificially identify a VSG switching defect, since the RAD51-5 
mutants showed at least as significant a level of growth impairment in the in vivo 
growth assay as the RAD51-3 mutants (Section 4.3.2).
An alternative explanation for these data is that T. brucei antigenic variation is carried 
out by a specific or unusual form of homologous recombination that utilises only a 
discrete subset of proteins from the general DNA repair and recombination machinery. 
Perhaps T, brucei has evolved a specialised homologous recombination pathway for the 
process of antigenic variation to avoid alterations to the genome during the movement
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of VSGs. This suggestion of a specialised homologous recombination machinery is lent /
weight by the observation that MREll, like RAD51-5, has no detectable function in
antigenic variation, despite contributing to DNA repair and recombination (Robinson et
.a i, 2002). Similarly, although mismatch repair is known to constrain T. brucei 
homologous recombination to occur only between sufficiently related DNA sequences, 
it appears not to constrain antigenic variation (Bell et al., 2004). If correct, this |
hypothesis would suggest distinct roles for RAD51-3 and RAD51-5 in RAD51- 
catalysed strand exchange. Recent analysis of the functions of the Rad51-like genes in 
vertebrates is compatible with this suggestion. As has been described previously, the 
RadSl-like proteins in vertebrates appear to exist in two, and perhaps three, sub-cellular 
complexes (Liu et al., 2002; Masson et al., 2001a; Masson et al., 2001b; Wiese et al.,
2002). There are now suggestions that these may have functions beyond simply directly 
loading the RAD51 nucleoprotein filament onto single strand DNA, as the yeast 
Rad55/57 heterodimer is thought to do (Sung, 1997b). Xrcc3 in mammals has been 
shown to act very early in the pathway of DSB repair, based on the findings that Xrcc3 
re-localises to DNA DSBs within 10 minutes, independently of RadSl (Forget et al.,
2004). The fact that RadSlC forms a complex with Xrcc3 (Masson et al., 2001a) would 
make it another suitable candidate to have an early role in DSB repair. RadSlC has been 
shown to be closely associated with a Holliday junction resolution and branch migration 
activity identified in mammalian cell extracts (Liu et al., 2004), suggesting that it can 
act at late steps of homologous recombination, following RadSl-catalysed strand 
exchange. Finally, RadSlD is thought to act at telomeres, and whether this is related to 
RadSl functioning is unclear (Tarsounas et al., 2004b).
If the regulation of homologous recombination in T. brucei operates in a manner more :
akin to mammalian recombination, with the RADS 1-like proteins having functions 
beyond those of simply co-factors, then it is conceivable that RADS 1-3 and RADS 1-5 
will have non-equivalent functions in antigenic variation. For example, RADS 1-5 may 
function in either late or early steps in homologous recombination that are by-passed 
during the process of antigenic variation. Perhaps J! brucei RADS 1-5, like human 
RadSlC, is needed mainly for Holliday junction processing, and this intermediate is not 
used during VSG switching, as has been suggested by two models for SDSA (Barry,
1997; Borst et al., 1996). Unfortunately, this suggestion seems incompatible with the 
role of RADS 1-5 in promoting T. brucei RADSl foci formation. Alternatively, RADSl- 
5 may act early to prepare DNA breaks for RADS 1 binding, and specific breaks initiate 
VSG switching that by-pass this function (see below). In contrast to this, RADS 1-3 may
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fimction, as it Rad55/57 does in yeast, to directly aid the formation of T. brucei RAD51 
nucleoprotein filaments, a process retained by the antigenic variation recombination 
machinery, and therefore explains the reduction in VSG switching observed in rad51-3 
-/- mutants cells.
Currently we know essentially nothing about the initiation of T. brucei VSG switching. 
The high rate of switching in pleomorphic T. brucei cells has prompted Barry (1997) to 
suggest that a 70-bp repeat-specific endonuclease must create breaks which direct VSG 
recombination. Alternatively, Borst (1996) suggested that VSG switching relies on 
random DNA breaks. It is clear from a number of organisms that specific enzymes to 
catalyse DNA breaks can initiate directed forms of homologous recombination. For 
example, meiotic recombination, driven by RadSl and Dmcl, is directed to specific 
sites of DSBs created by the enzyme Spoil (Keeney et al., 1997; Romanienko and 
Camerini-Otero, 2000). Indeed, two Spoil homologues have been identified in the T. 
brucei genome (R. McCulloch, pers. comm.); the possibility that this duplication has 
created one enzyme for VSG switching and one for meiosis seems remote, however, 
since T. cruzi and L. major both contain two Spol 1 homologues also. In S. cerevisiae 
mating type switching, homologous recombination is directed to the MAT locus by 
cleavage via the HO endonuclease (Haber, 2002). In both cases, the DSBs appear to be 
processed by Mrell/RadS0/Xrs2(Nbsl) to facilitate recombination. However, initiation 
by enzyme directed DSBs is not universal. In S. pombe, mating type switching is 
initiated by a combination of replication fork pausing and an unidentified single-strand 
lesion (Dalgaard and Klar, 2001; Vengrova and Dalgaard, 2004). The genetic 
components that contribute to S. pombe mating type switching have not been 
determined. It remains possible, therefore, that VSG switching could have an initiating 
event that by-passes the function of MREll in DSB processing, and potentially 
RAD51-S.
Other, more speculative, possibilities for the non-involvement of RADSl-S or MREll 
in catalysing VSG switching can be considered. The ESB may have evolved to regulate 
or limit the number of recombination proteins that gain access to the active BBS 
(Navarro and Gull, 2001), or that a specialised antigenic variation homologous 
recombination machinery evolved because of this unusual structure. The ESB may 
perform the role of global regulator of VSG switching, only allowing particular 
recombination reactions to occur within it, and perhaps co-ordinating VSG switches 
with DNA replication. It is also possible that base J present within the inactive BBSs 
(van Leeuwen et al., 1997) plays a role in VSG switching, although it is hard to predict
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how a modified base would affect VSG switching or regulate homologous 
recombination,
A more extreme hypothesis to explain the complex picture of factors which act, and do 
not act, in antigenic variation may be that VSG recombination during switching is not 
directly catalysed by RAD51. It may be that RAD51 acts purely in a regulatory, or 
signalling, capacity and controls a wholly novel, as yet uncharacterised, recombination i
machinery. If this were the case, then presumably RAD51-3 acts in conjunction with 
RAD51 in such a role, which has no requirement for RAD51-5. However, a role of this 
nature for RAD51 is unprecedented, making it an unlikely possibility. Indeed, the 
available evidence suggests that M rell, as well as a number of repair kinases, act to 
signal damage and co-ordinate DSB repair, with Rad51 functioning purely in a catalytic 
function (Lisby et al., 2004).
6.4 RAD51-3 and a role for homologous recombination in in situ switching?
In the analysis of VSG switching in radSl -/- cells, McCulloch and Barry (1999) 
identified a perplexing result: the reduced frequency of antigenic variation appeared not 
only to be caused by reduction in VSG recombination, but also by reduced 
transcriptional, or in situ, switching. The results for the RAD51-3 mutant analysis has 
identified an identical phenotype, since the ratio of VSG or ES gene conversions 
relative to in situ switches is not changed, despite the reduction in VSG switching 
frequency (Section 4.8.1). On the face of it, these data makes the involvement of 
recombinational proteins in in situ switching a more likely possibility.
So, is in situ switching actually a form of homologous recombination catalysed by 
RAD51, and perhaps RAD51-3? The answer to this is almost certainly ‘no’. Previous 
analyses of in situ switches, despite occasionally finding DNA rearrangements, have 
seen no consistent DNA rearrangements (Horn and Cross, 1997) and in some cases no 
detectable rearrangements (Navarro and Cross, 1996), Furthermore, the VSG promoter 
has been changed to the rDNA promoter (Rudenko et al., 1995) and antibiotic makers 
have been inserted around the promoter (Chaves et al., 1999; Navarro and Cross, 1996), 
without these sequences changing during switching, therefore ruling out gene 
conversions.
An alternative explanation for the RAD51 and RAD51-3 mutant phenotypes may be that 
in situ switching occurs by a homology sensing mechanism, perhaps functioning to
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facilitate the movement of a silent BBS into, and the active BBS out of, the ESB. Very 
little is known about the function of the ESB (Chaves et al., 1998; Navarro and Gull,
2001), and to date we cannot even say whether it has a direct role in regulating VSG 
switching, or is simply the site of BBS transcription. The possibility that RAD51 and 
RAD51-3, and hence homologous interactions, contribute to in situ switching is perhaps 
supported by the finding that the process appear to be a co-ordinated, rather than a 
spontaneous, event. The evidence for this is two-fold. First, the insertion of two 
antibiotic markers in different BBSs allowed for the selection of in situ switches, and 
the isolation of an unstable double resistant phenotype, in which transcription rapidly 
switched between the two BBSs (Chaves et al., 1999). Second, using three marked 
BBSs, it was determined that putative switch intermediates involving three BBSs are 
never recovered (Ulbert et al., 2002a). These results suggest that circumstances in 
which two BBSs are transcribed probably represents a natural intermediate that occurs 
during in situ switching. Furthermore, the process appears to be coordinated, as only 
two BBSs are ever involved, the one being inactivated and the one being activated 
(Chaves et ah, 1999; Ulbert et al., 2002a). Direct analysis of the potential roles of 
RAD51 and RAD51-3 in in situ switching should be feasible. For instance, using a 
strain with two BBSs marked with antibiotic genes to select for in situ switching events 
(Chaves et al., 1999), and generating RAD51 or RAD51-3 mutants in that strain, would 
allow us to genetically define the roles of RAD51 and RAD51-3. Co-localisation of 
RAD51 or RAD51-3 with a GFP-tagged BBS (Navarro and Gull, 2001) could assess the 
likelihood of RAD51 and RAD51-3 associating with the ESB. Finally, a role for 
RAD51 or RAD51-3 in in situ switching could be defined using the T. brucei strain that 
allows for isolating putatively switching intermediates between two BBSs (Ulbert et al., 
2002b) if mutants fail to form intermediates.
6.5 The DNA damage response in T. brucei
The analysis of gene and protein expression following DNA damage in this thesis 
suggests that there is no increased quantity of RAD51, RAD51-3, RAD51-5 or DMCl 
mRNAs following phleomycin treatment, and no up-regulation of RAD51 at the protein 
level. This is an unusual result as most micro-organisms, including L. major (McKean 
et ah, 2001) and P. falciparum (Bhattacharyya and Kumar, 2003), induce RAD51 
expression in response to DNA damage. Many different DNA damaging agents can
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result in the increased expression of the proteins involved in DNA repair, including 
ionising and UV-irradiation, and chemicals such as MMS, mitomycin C, phleomycin
.J  ■'and MNNG (Kupiec, 2000). The increase in expression resulting from exposure to one ■Iof these agents can occur at the RNA or the protein level. RadSl RNA and protein 
levels increase 3-6 fold in S. cerevisiae following exposure to y-rays and MMS (Basile 
et al,, 1992; Shinohara et al., 1992), whilst, in S. pombe a 3 -  5 fold increase in RNA 
level has been described (Jang et al., 1994). In response to UV and MMS E. coli and }STetrahymena thermophila also show increases in RNA and protein levels, 15-fbld and 
30 -  100 fold respectively (Campbell and Romero, 1998; Little and Mount, 1982;
Walker, 1984).
Up-regulation of RadSl is not universal, however, as no evidence for this has been 
found in mammals (Tarsounas et al., 2004a), some archae (Komori et ah, 2000) and 
Neisseria gonorrhoeae (Black et al., 1998). The explanations for this appear to be 
variable. Mammals appear to favour NHEJ over homologous recombination, at least in 
G1 cells, to repair DNA damage, probably accounting for the lack of increased RadSl 
expression in response to DNA damage. The archae that do not increase expression of 
RadA in response to DNA damage are thermophilles and are therefore probably 
constantly exposed to DNA damaging conditions and requires a consistently high level 
of expression of RadA. The lack of regulation of RecA in Neisseria possibly results 
from a switch in the way that DNA damage is repaired, a suggestion based on the 
observations that the RecA and NER proteins do not respond to DNA damage (Black et 
al, 1998).
So, why does T. brucei appear not to regulate RAD51 expression in response to DNA 
damage when a highly related kinetoplastid, L. major, does so? It seems unlikely that T. 
brucei is subject to high levels of environmental DNA damage, and a more likely 
explanation lies in antigenic variation. If antigenic variation utilises RADSl in the 
catalysis of VSG switching, which can occur at high rates in bloodstream stage cells 
(Turner and Barry, 1989), then RADSl protein levels may need to be maintained at 
higher levels that if it were only required for DSB repair. The induction of VSG 
switching may be seen as a form of continuous DNA damage and, hence, T. brucei has 
lost the mechanism to respond to induced damage by increased expression of RADS 1, 
such as occurs in L. major and P. falciparum. In performing the in situ hybridisation 
analysis of RADS 1 localisation an interesting finding emerged which may be related to 
this. It appears that bloodstream stage cells appeared able to continue their progression 
through the cell cycle, despite being exposed to DNA damage. In other organisms,
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exposure to DNA damage agents causes an arrest at the G2/M boundary (Paques and 
Haber, 1999), Richard McCulloch carried out DAPI analysis on bloodstream stage cells 
exposed to increasing concentrations of phleomycin, and found no evidence for an 
alteration of the ratio of parasite cell types in different life cycle stages (Fig. 6.1 A). 
Interestingly, when he carried out the same assay using procyclic cells, the pattern of 
cell cycle forms did alter (Fig 6.IB), with a reduction in cells undergoing division (2 
nuclei and 2 kinetoplast; 2N 2K), a reduction in G1 phase cells (IN IK), a large 
increase in abnormal cells and a small increase in cells that had completed kinetoplast 
division (IN 2K). This seems compatible with a transient block at the G2/M phase 
boundary, something not seen in bloodstream form cells.
The explanation for the above data could either be that bloodstream stage cells arrest at 
any stage of the cell cycle, or traverse through cell division with un-repaired DNA 
damage. In an attempt to address this question, microscopic images of wild type 
bloodstream form cells exposed to phleomycin were searched for cells that were in the 
process of nuclear division (Fig. 2). RAD51 foci could be readily detected in all life 
cycle stages, including examples with dividing nuclei, and the foci appeared to be 
segregated. Clearly, this result depicts fixed cells, and imaging of RAD51 in live, 
dividing cells would be required to confirm it. However, it suggests the possibility that 
bloodstream stage cells generate DSBs during VSG switching, and do not arrest as this 
could result in immune destruction. Furthermore, it would infer that bloodstream stage 
cells cannot distinguish between generalised DNA damage and that needed for VSG 
switching, implying that VSG switching would be a component of general homologous 
recombination, and not a specialised RAD51-independent reaction. Perhaps also they 
have an undefined checkpoint response to DNA damage removed or down-regulated, 
and are therefore predisposed to continue the cell cycle.
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6.6 Further experiments
The results presented in this thesis leave a number of questions unanswered. Suggested 
below are a number of experiments that could be carried out in the future to attempt to 
start answering those questions. Had more time been available, the over-expression 
experiments described in Chapter 5 would potentially have helped define the roles of 
the RAD51~\ikQ genes, by determining whether any of RAD51-3, RAD51-5 or DMCl 
can complement a RAD51 defect and hence catalyse strand exchange. All of the 
constructs for this analysis were generated, but the reduced recombination efficiency of 
the radSl -/- cells proved too big a hurdle to allow the completion of this experiment. 
One possible way around the recombination deficiency of radSl-!- mutant cells would 
be to generate the over-expression cell lines in wild type cells and subsequently 
generate rad51-!~ mutants.
At the outset of this project, one of the aims was to identify any RAD51-V(kQ genes 
present in the T. brucei genome. This resulted in the identification of 5 further RAD51- 
like genes, only 3 of which have been functionally analysed during this project. 
Functional characterisation of the two remaining RAD51A.^q genes must be viewed as a 
priority. Such characterisation, along the lines described in this thesis, would give a 
fuller picture of DNA repair, recombination and antigenic variation in T. brucei.
As I have argued in this discussion, it is possible that RAD51-3 and RAD51-5 have 
distinct functions in repair and recombination, and there may be multiple repair 
complexes, analogous to those in mammalian cells. Yeast 2-hybrid analysis or co- 
immunoprecipitation, involving all the RAD51-like genes, would be necessary to 
address this question.
Finally, purification of the iL4£)Ji-like proteins would be a valuable step to allow 
biochemical characterisation of their activties. The purified proteins could be used to 
assay for specific functions in DNA repair and homologous recombination. Assays to 
examine DNA strand exchange, DNA binding and ATP hydrolysis are well established 
(Kowalczykowski and Eggleston, 1994), and would lead to a more accurate picture of 
how the RAD51-like proteins are involved in repair, recombination, and antigenic 
variation in T. brucei.
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Appendix 1 : A list of the oligonucleotides used for PCR.
Primer Name Sequence Restriction Sites
aP 3 ' - H p a l CCGTTAACCT ATTTTCTTTG ATGAAAGGG
h C T 3 ' - S p h I S p h I
Pa 5 ' ~Hpa  I CCGTTAACTG GGTCCCATTG TTTGCCTC Hpa I
DM Cl-Dl GTAACGGCTC TCTTTCGC
DMC1-D2 CGCACGAGCA TCAGATGC
DMC1-D3 CCTGAGCGGA TTAAGCCC
D M C l-For CAGATATCGT ATGCAGCACG TGGGAACG E c o R V
DM C l-L H F-For GATACACTAG AATTCACTCT ACGCATGAGG ACG E C O Rl
DM Cl-LH F-Rev GGTAAGCTTG TTAACCTCTG TTGCAGGTAA GCC H i n d l l l Hpa I
DM C1-PCR-K03’ CGCTGATCCC
TTGAGGCATG
CCCGTCCTTT
TATTTTATGG
GCGCAGCGAC
CAGCAACG
AGTCGCGTCG
DM C1-PCR-K05' GGACAACTCT
GAGATTGACC
ACGCATGAGG
TGGGTCCCAT
ACGCGGCGCA
TGTTTGCCTC
CACCATCATG
DM Cl-Rev CAGATATCGT ACTCACGTGC GTCAACAATC CC E c o RV
DM Cl-RH F-For ACGAAGCTTG ATATCATTTT TCTGGCAGAG GGG Hindi 11 EcoRV
DM Cl-RH F-Rev ACTGGCAGAC TCGAGTACAC ACGCGCTGAT CCC X h o I
D M Cl-Ul CGCCTCCGTA ATTGACATGC
HYGRO-3' CTATTCCTTT GCCCTCGGAC
HYGRO-5' ATGAAAAAGC CTGAACTCAC C
MCM-3' GGAATAAAAG GACTCGGG
MCM-5' GTGATTTATC ACCACGGC
N EO -3' TCAAGAAGGC GATAGAAGGC
N EO -5' CGCATGATTG AACAAGATGG
P O L I-3 ' CATGCGCCTG TGGTTCAGCA TAGC
P O L I-5 ' CAGGAGGATC GTTCGGCACC TTGGC
P -O R F -3 ' TCGAGACAAC TTGAAGGC
P -O R F -5 ' GTCAACAGCA TTATAGCC
R A D S l-F o r CAGAATTCGT ATGAACACTC GCACCAAAAA TAAGAAACG Eco RI
RAD51“ R ev CAGAATTCGT CTAGTCCCTA ACGTCTCCC E g o  RI
R A D 5 1 -3 -F o r CAGATATCGT ATGTCCGTGG AGCAATGC E c o RV
R A D 5 1 -3 -K 0 3 ' CCGTGACTTT CAATAACGCC
R A D 5 1 -3 -K 0 5 ' TGTAACAACA CTTTGCCG
R A D 51-3-L H F -F or GATACACTAG AATTCCAATG CTCCTCACTT ACCCC Eco RI
R A D 51-3-L H F“ Rev GGTAAGCTTG TTAACAAGAA TATCAAGACT CCGGC Hindi 11 Hpa I
R A D 5 1 -3 -R ev CAGATATCGT TCAAAGAGTG GGTCGG EcoRV
R A D 51-3-R H F -F or ACAAAGCTTG ATATCCAAAT GGCACACGTA TGGGG Hindlll EcoRV
R A D 51-3-R H F -R ev ACTGGCAGAC TCGAGAGTGG GTCGGAAAAC ATCGC X h o  I
R A D 5 1 -5 -F o r CAGAATTCGT ATGTCTGTGT GTCCTCC E c o R I
R A D 51-5-L H F -F or GATACACTAG AATTCATGTC TGTGTGTCCT CCACC E c o  R I
R A D 51-5-L H F -R ev GGTAAGCTTG TTAACAACAC CTCCAGGACT GTCCC Hindlll H p a l
R A D 5 1 -5 -R ev CAGAATTCGT TCAGGGTAAA AAGATGTTTC CC ECO RI
RA D 51-5-R H F R ev ACTGGCAGAC TCGAGATACG TGTTTTGCAG CCCCG X h o  I
R A D 51-5-R H F -F or ACAAAGCTTG ATATCTCTGT TGGTGGTAGT GTGGC Hindlll ECORV
R A D 51-5-U 2 GGGATTGAGA GAGGACGGG
T T -L IG -3 ' AACCTTTTGG TAAGGGCC
TT“ LIG“ 5 ' ATTCATCGAG TGAGAGCC
V S G 2 2 1 -3 ' TGTATCGGCG ACAACTGCAG
V S G 221-5* ATGCCTTCCA ATCAGGAGGC
I
I
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Appendix 2: Accession numbers.
T.b RAD51 AF174136
RAD51-3 Tb11.02.0150 
RAD51-4 Tbi 1.02.4880 
RAD51-5 Tbi 0.389.1770 
RAD51-6 Tb03.5L5.340
DMC1 Tb09.211.1210
Lm RAD51 061127
RAD51-3 LmjF33.2490
RAD51-4 LmjF11.0230 
RAD51-6 LmjF29.0450
DMC1 061128
T.c RAD51 TcOO. 1047053508817.50* 
TcOO. 1047053503801.30 
RAD51-3 TcOO.1047053504153.220 
RAD51 -4 TcOO.1047053503613.30 * 
TcOO.1047053511165.60 
RAD51-5 TcOO.1047053511837.50* 
TcOO.1047053510123.30 
RAD51-6 TcOO. 1047053508075.20* 
TcOO. 1047053509643.80 
DMC1 TcOO.1047053510729.110
TcOO.1047053506885.310
P.f
E.c
C.j
N.g
B.s
S.l
S.a
U.m
H.s
S .c
S.p
A.t
RAD51 AF452489
DMC1 AF356553
RECA P03017
RECA P42440
RECA P21152
RECA PI 6971
RECA P48294
RECA 002350
RAD51 UM03290
REC2 UM03095
O.s
D.m
RAD51
RAD51C
RAD51L1
RAD51L3
XRCC2
XRCC3
DMC1
RAD51
RAD55
RAD57
DMC1
RPH51
RPH55
RPH57
DMC1
RAD51
RAD51Ca
RAD51CP
XRCC3a
XRCC3P
DMC1
mtRECA
ctRECA
DMC1A
DMC1B
RAD51
RAD51C
RAD51D
SPNB
SPND
006609
043503
015315
075771
043543
043542
014565
X64270
Z46796
M65061
M87549
Z22691
AF053410
AB024744
AB008545
U43528 
AB062456 * 
AB073493 
AB062455 * 
AB073492 
U76670 
AY072877 
M98039
AF265548
AF265549
BAA04580 
NP„610466 
NP_5773302 
NP_476740 
FBgn0003482 %
The accession numbers for the RadSl and RecA genes used during homology and 
phylogenetic analysis. The sequences were obtained from Trypanasoma brucei (T.b), 
Leishmania major (L.m), Plasmodium falciparum (P.f), Trypanasoma cruzi (T.c), 
Escherichia coli (E.c), Campylobacter jejuni (C.j), Neisseria gonorrhoeae (N.g), 
Bacillus subtilis (B.s), Streptomyces lividans (S.l), Staphylococcus aureus (S.a), 
Ustilago maydis (U.m), Homo sapiens (H.s), Saccharomyces cerevisiae (S.c), 
Schizosaccharomyces pombe (S.p), Arabidopsis thaliana (A.t), Oryza sativa (O.s) and 
Drosophila melanogaster (D.m). Depicts which of the two near identical copies were 
included in the phylogenetics, oo: Sequence was unobtainable therefore was not included 
in the phylogenetics.
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Appendix 3: The gene sequence of R A D S  1-3
The RAD51-3 specific primers and the restriction site of the enzyme used during copy 
number analysis are shown.
FOR_________  \  LHF FOR \
ATGTCCGTGGAGCAATGCTCCTCACTTACCCCTTCCCTAAAGGCAAAATTGCAAAACGCC
1  +  +  +  +  +  + 60
TACAGGCACCTCGTTACGAGGAGTGAATGGGGAAGGGATTTCCGTTTTAACGTTTTGCGG
M S V E Q C S S L T P S L K A K L Q N A
GGTTTCCTGTGGCTTAGAGATTTATGTCGGTGTGCTCAAGGCGGTGTTGAAACAACATTC
6 1  +  +  +  +  +  + 120
CCAAAGGACACCGAATCTCTAAATACAGCCACACGAGTTCCGCCACAACTTTGTTGTAAG
G F L W L R D L C R C A Q G G V E T T F
AACGTAGGAAAGTTTTTGGATGACTCTCACCTCAATGCTGCGGCGAAGCGCCTACAGCAG
1 2 1  +  +  +  +  +  + 1 8 0
TTGCATCCTTTCAAAAACCTACTGAGAGTGGAGTTACGACGCCGCTTCGCGGATGTCGTC
N V G K F L D D S H L N A A A K R L Q Q
AATTGTTCACAACTCACACACACAGAGGCGATTGAGACGGCTCGAGTCGTTTTACCTTCC
1 8 1 ------------------- + --------------------+ --------------------+ ------------------- + --------------------+ -------------------- + 2 4 0
TTAACAAGTGTTGAGTGTGTGTGTCTCCGCTAACTCTGCCGAGCTCAGCAAAATGGAAGG
N C S Q L T H T E A I E T A R V V L P S
GCTGTTTGCAGGACTCCTGCTATTCGTACGTTACGAGAATTGCTCGATGCTGAGGCAACC
2 4 1  — — — --------H — — — — — — — -----1--— -----------H — — — — — — — — — 4-----— — — — — — 4-------_ _ _ _ +  3 0 0
CGACAAACGTCCTGAGGACGATAAGCATGCAATGCTCTTAACGAGCTACGACTCCGTTGG
A V C R T P A I R T L R E L L D A E A T
KO 5'__________ ^
AAGGGCATAGAAAATGTAACAACACTTTGCCGGAGTCTTGATATTCTTTTGGGTGGTGGA
3 0 1  -------------+ -------------- 4------------- 4---------------4-------------- 4--------------4- 3 6 0
TTCCCGTATCTTTTACATTGTTGTGAAAÇGGCCTCAGAACTATAAGAAAACCCACCACCT\  LHF REV
K G I E N V T T L C R S L D I L L G G G
TTGCAAGTGGGAACCCTTACGGAGATTTGTGGACCCCCGGGAGTTGGTAAAACACAACTG
3 6 1  ------------------- 4-------------- 4-------------- 4-------------- 4-------------- 4-------------- 4- 4 2 0
AACGTTCACCCTTGGGAATGCCTCTAAACACCTGGGGGCCCTCAACCATTTTGTGTTGAC
L Q V G T L T E  I C G P P G V G K T Q L
TCAATGCAGCTGGCGGTGAATTGCGTTTTGCCGAAGGAACTTGGTGGGTTACAGGGCGGG
4 2 1  -------------+ ------------- + ------------- + ------------- 4-------------- 4-------------- 4- 4 8 0
AGTTACGTCGACCGCCACTTAACGCAAAACGGCTTCCTTGAACCACCCAATGTCCCGCCC
S M Q L A V N C V L P K E L G G L Q G G
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TGTTTGTTTATTGACACGGAGGGGAGCTTTTTACCTGAACGGTTTCGGGAGATTGCATCA
4 8 1  ------------------- + --------------------+ --------------------+ --------------------+ --------------------+  + 5 4 0
ACAAACAAATAACTGTGCCTCCCCTCGAAAAATGGACTTGCCAAAGCCCTCTAACGTAGT
C L F I D T E G S F L P E R F R E  I A S
GCTGCCGTGGGGCATGTGAGGGAAATCGTACTACAACGTGAGAAAGAAGGACTCGGAGCA
5 4 1  ------------------- + --------------------+ --------------------+ --------------------+ --------------------+  + 6 0 0
CGACGGCACCCCGTACACTCCCTTTAGCATGATGTTGCACTCTTTCTTCCTGAGCCTCGT
A A V G H V R E  I V L Q R E K E G L G A
GGTAATGTTGGGGTGACAAACGAGGAAAACGGTGTGAGGCAGGCATCTTTCCTCAATGGT
6 0 1   +  +  +  +  +  + 6 6 0
CCATTACAACCCCACTGTTTGCTCCTTTTGCCACACTCCGTCCGTAGAAAGGAGTTACCA
G N V G V T N E E N G V R Q A S  F L N G
GCGATGAATGAGGTGACAGCAGAGCAGACGTGCACCACGTCCTCAGTAGAATCTCGCAAG
6 6 1 ------------ ------------------------------h— — — --------- H----- ———------- 4-------------------------  — — — — 4- 7 2 0
CGCTACTTACTCCACTGTCGTCTCGTCTGCACGTGGTGCAGGAGTCATCTTAGAGCGTTC
A M N E V T A E Q T C T T S S V E  S R K
AGGGGAAGGGTTGAGGCTGCGGTCCCACCCCCGCTTGGTGCAATAGTTGGCTCTTTCACA
7 2 1  ------------------- 4---------------------+ --------------------4-------------- 4-------------- 4- 4- 7 8 0
TCCCCTTCCCAACTCCGACGCCAGGGTGGGGGCGAACCACGTTATCAACCGAGAAAGTGT
R G R V E A A V P P P L G A I V G S F T
GTAGATTATATTCTTCAGCGAACACAGTACGTTCGCGTGTTGGATGTAGTGTCTCTTATG
7 8 1  -------------4--------------- 4-------------- 4---------------4-------------- 4- 4- 8 4 0
CATCTAATATAAGAAGTCGCTTGTGTCATGCAAGCGCACAACCTACATCACAGAGAATAC
V D Y I L Q R T Q Y V R V L D V V S L M
BarrkW
GCACTGCTGAACGGACTTCCCGCGTACATTGCCTCCCACCCAGGGATCCGAATGGTGATC
8 4 1  ------------- 4---------------4-------------- + --------------4-------------- 4- 4- 9 0 0
CGTGACGACTTGCCTGAAGGGCGCATGTAACGGAGGGTGGGTCCCTAGGCTTACCACTAG
A L L N G L P A Y I A S H P G I R M V I
ATCGACTCTATCGCATTTCCCTTTCGCTCTTTATTGCAGTTGAACGTCAACTCCAACAGT
9 0 1  -------------------- 1----------------------1----------------------1----------------------1----------------------1--------------- —— 4- 9 6 0
TAGCTGAGATAGCGTAAAGGGAAAGCGAGAAATAACGTCAACTTGCAGTTGAGGTTGTCA
I D S  l A F P F R S L L Q L N V N S N S
GGTGGCGTTACTGAAAGTCACGGGGCGGTGGGCAAGAGCGTGGCCGGCGTTGATGACTCA
9 6 1 -------------------- 1----------------------1----------------------1----------------------1--------------------- 1- H 1 0 2 0
CCACCGCAATGACTTTCAGTGCCCCGCCACCCGTTCTCGCACCGGCCGCAACTACTGAGT
\  RÔT"
G G V T E  S H G A V G K S V A G V D D S
200
ACCGGCATGAACAGTGGCATTCCGACGTCTAGACAACTTGGCTGGCAGCGCGCAAGGTTG
1 0 2 1   +  +  +  +  +  + 1 0 8 0
TGGCCGTACTTGTCACCGTAAGGCTGCAGATCTGTTGAACCGACCGTCGCGCGTTCCAAC
T G M N S G I  P T S R Q L G W Q R A R L
CTATTCAGATGTGGACAGCTACTGCAGGATCATGCACGAGAGTTGAACCTCTGTATTGTA
1 0 8 1 ------------------- 1------------------- 1------------------- 1------------------- 1------------------- 1------------------1- 114 0
GATAAGTCTACACCTGTCGATGACGTCCTAGTACGTGCTCTCAACTTGGAGACATAACAT
L F R C G Q L L Q D H A R E L N L C I V
RHF FOR_________ \
GTGAGTAATCAAATGGCAACACGTATGGGGGATATTCGTGGTGTGGATGGCGGTTTCCGG
1 1 4 1 -------------------- 1-------------------- 1-------------------- 1-------------------- 1-------------------- 1-------------------1- 1 2 0 0
CACTCATTAGTTTACCGTTGTGCATACCCCCTATAAGCACCACACCTACCGCCAAAGGCC
V S N Q M A T R M G D  I R G V D G G F R
ACTCTTGTGCCAGCTCTAGGCGATTCATGGGCGTACGCCCTCTCCACACGTCTTCTTCTT
1 2 0 1  — — — — — ------ 1-— — — — ----------------------------------------- -— 4-— — — -------------— — 4—— — — — — — — — — 4"— 1 2 6 0
TGAGAACACGGTCGAGATCCGCTAAGTACCCGCATGCGGGAGAGGTGTGCAGAAGAAGAA
T L V P A L G D S W A Y A L S T R L L L
ACTCATCAGCACGATGTGCTGCATCACAATGAAATAGAAAAGCGAGGAGAGAAGTGCCAT
1 2 6 1  --------------1-------------- 1-------------- 1-------------- 4---------------1-------------- 1- 1 3 2 0
TGAGTAGTCGTGCTACACGACGTAGTGTTACTTTATCTTTTCGCTCCTCTCTTCACGGTA
T H Q H D V L H H N E  l E K R G E K C H
GACAACATGGTGTTCGTGATGCCGTCAGGACAGGATAGTACCACCAGCTGCAACGATTCT
1 3 2 1 -------------------- 1----------------------1--------------------- 1--------------------- 1----------------------1----------------------!■ 1 3 8 0
CTGTTGTACCACAAGCACTACGGCAGTCCTGTCCTATCATGGTGGTCGACGTTGCTAAGA
D N M V F V M P S G Q D S T T S C N D S
GATGGCGGAAGTGGTAGCAAGCGGCTTCATGCAGCTCAGCACCGTGTGGCACGGCTCGTA
1 3 8 1  ------------------- 4-------------- 4-------------- 4-------------- 4-------------- 4-------------- 4- 1 4 4 0
CTACCGCCTTCACCATCGTTCGCCGAAGTACGTCGAGTCGTGGCACACCGTGCCGAGCAT
D G G S G S K R L H A A Q H R V A R L V
AAAAGCCCCGCACAGCCGCAGGGACAGTGTTGTTTTTCCATAAGTCATAGAGGTGTGCGC
1 4 4 1  ------------------- 4-------------- 4-------------- 4-------------- 4-------------- 4-------------- 4- 1 5 0 0
TTTTCGGGGCGTGTCGGCGTCCCTGTCACAACAAAAAGGTATTCAGTATCTCCACACGCG
K S P A Q P Q G Q C C F S  I  S H R G V R
GATGTTTTCCGACCCACTCTT
1 5 0 1  ------------------- 4--------------------- + -  1 5 2 1
CTACAAAAGGCTGGGTGAGAA RHF REV ^ ---------- rI v
D V F R P T L
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Appendix 4: The gene sequence of R A D S  1-5
The RAD51-5 specific primers and the restriction site of the enzyme used during copy 
number analysis are shown.
FOR LHF FOR \  \
ATGTCTGTGTGTCCTCCACCATGGACTGGGATGACGGCGGAGGAGATTTCACAGAGGCTT
1  +  +  +  +  +  + 60
TACAGACACACAGGAGGTGGTACCTGACCCTACTGCCGCCTCCTCTAAAGTGTCTCCGAA
M S V C P P P W T G M T A E E I S Q R L
GCGCTACTCACTTCGCAAACTATTTTGCAGCATGACCTGAACCGTAGGTTCACACAACAC
CGCGATGAGTGAAGCGTTTGATAAAACGTCGTACTGGACTTGGCATCCAAGTGTGTTGTG
A L L T S Q T I L Q H D L N R R F T Q H
GCGGTATTTTCAACTGGCTCAGAGGAACTTGACCGGTTGTTGCCCGACGGCGGGATGACG
1 2 1  +  +  +  +  +  + 1 8 0
CGCCATAAAAGTTGACCGAGTCTCCTTGAACTGGCCAACAACGGGCTGCCGCCCTACTGC
A V F S T G S E E L D R L L P D G G M T
TGCGGGACAGTCCTGGAGGTGTTTGGTCCGCCATCAGGAGGGAAATCCCGCCTTGTGCGC
1 8 1 ------------------- + --------------------+ ------------------- + --------------------+ --------------------+  + 2 4 0
ACGCCCTGTCAGGACCTCCACAAACCAGGCGGTAGTCCTCCCTTTAGGGCGGAACACGCG \  LHF REV
C G T V L E V F G P P S G G K S R L V R
EccR^JCGCATGATATCTTCATTTGCGGCACAGGGTGCGTTAGAGTGGACGACTAGAGGGGTTGAT 
GCGTACTATAGAAGTAAACGCCGTGTCCCACGCAATCTCACCTGCTGATCTCCCCAACTA 
R M I  S S F A A Q G A L E W T T R G V D
GTGGGAATATGCGACGGCAGCCCATCGAAGGGACTGGAGGTACAGCAAGAATGTCTGAGG
3 0 1  ------------------- + --------------------+ --------------------+ ------------------- + --------------------+ -------------------- + 3 6 0
CACCCTTATACGCTGCCGTCGGGTAGCTTCCCTGACCTCCATGTCGTTCTTACAGACTCC
V G I C D G S P S K G L E V Q Q E C L R
GCGAGAGCAGAGGAATGTTGCAGACCACGTGAGTGGTGTGTTTTCTACGTCTTGTCTGAC
3 6 1  ------------------- + ------------------- + --------------------+ --------------------+ --------------------+ -------------------- + 4 2 0
CGCTCTCGTCTCCTTACAACGTCTGGTGCACTCACCACACAAAAGATGCAGAACAGACTG
A R A E E C C R P R E W C V F Y V L S D
CCGTCCTCTCTCAATCCCCGTCATTTGCGGGAAGAGCTCGAAAAAGCCCTCCAGCGTGCA
4 2 1  ------------------- + --------------------+ --------------------+ --------------------+ --------------------+ -------------------- + 4 8 0
GGCAGGAGAGAGTTAGGGGCAGTAAACGCCCTTCTCGAGCTTTTTCGGGAGGTCGCACGTU2
P S S L N P R H L R E E L E K A L Q R A
202
ATGTTGTGTGATGTGCACTGCGAGGGTGAGATTGAAAGGCTCCTCGATGACATCATAGGA
4 8 1  ------------------- + --------------------+ --------------------+ --------------------+ --------------------+ -------------------- + 5 4 0
TACAACACACTACACGTGACGCTCCCACTCTAACTTTCCGAGGAGCTACTGTAGTATCCT
M L C D V H C E G E  l E R L L D D I  I  G
AGGGTACAAGTGGTGAACTTCGCAACCCTAAATGACCTTTTAAACTTCTTCCGTTTTCTG
5 4 1   +  +  +  +  +  + 6 0 0
TCCCATGTTCACCACTTGAAGCGTTGGGATTTACTGGAAAATTTGAAGAAGGCAAAAGAC
R V Q V V N F A T L N D L L N F F R F L
TACCACGAGGAGTATCCGTCGTCTATGCATCATGCTAACCAACGCCGCGCGTTGGTCGTT
6 0 1   +  +  +  +  +  + 6 6 0
ATGGTGCTCCTCATAGGCAGCAGATACGTAGTACGATTGGTTGCGGCGCGCAACCAGCAA
Y H E E Y P S S M H H A N Q R R A L V V
ATCGACAGTGTTGCTCGCCTTTGGGATCACCCGACATGTGGAGCAACAAAGCATGCGCGG
6 6 1 -------------------- 1---------------------4----------------------1----------------------1----------------------1----------------------1- 7 2 0
TAGCTGTCACAACGAGCGGAAACCCTAGTGGGCTGTACACCTCGTTGTTTCGTACGCGCC
I D S V A R L W D H P T C G A T K H A R
GACTGGGCGGCGGCTGAACTGGTGCGTGAGTTGCGCAATGTTATTATGCTTGGGAACGGT 
7 2 1  — — — — — — — — — + — —  — — — — — 4-— — —  — — — 4- — — — — — — — — — 4- — — — — — —  — + — — — — — — --— 4- 7 8 0
CTGACCCGCCGCCGACTTGACCACGCACTCAACGCGTTACAATAATACGAACCCTTGCCA
D W A A A E L V R E L R N V I M L G N G
TGGCGTGGTGAGTATTGTGGTAACATTGACTCGCATCACTTAGATACCGAAGCTGGGAAC
7 8 1  -------------4--------------- 4-------------- 4-------------- 4-------------- 4-------------- 4- 8 4 0
ACCGCACCACTCATAACACCATTGTAACTGAGCGTAGTGAATCTATGGCTTCGACCCTTG
W R G E Y C G N I D S H H L D T E A G N
RHF FOR_________ \
GTTTTTTGTAGCGTCCAGGCTGCCAATGCGGGTACCTCTGTTGGTGGTAGTGTGGCGGTT
8 4 1  -------------4--------------- 4-------------- 4-------------- 4-------------- 4-------------- 4- 9 0 0
CAAAAAACATCGCAGGTCCGACGGTTACGCCCATGGAGACAACCACCATCACACCGCCAA
V F C S V Q A A N A G T S V G G S V A V
GTTCTCGTTAACGGGTGCACGAACACGCGTTACTGCCACACCGTTGTTGGACCTTTGGGG
9 0 1  ------------------- 4-------------- 4-------------- 4-------------- 4-------------- 4- + 9 6 0
CAAGAGCAATTGCCCACGTGCTTGTGCGCAATGACGGTGTGGCAACAACCTGGAAACCCC
V L V N G C T N T R Y C H T V V G P L G
GTGCCCTTGTGGTTGGCAGCTGCAGCGGATATTCGTCTTTTCATTGAACCCACATCAACT
9 6 1  -------------4-------------- 4-------------- 4-------------- 4-------------- 4-------------- 4- 1 0 2 0
CACGGGAACACCAACCGTCGACGTCGCCTATAAGCAGAAAAGTAACTTGGGTGTAGTTGA
V P L W L A A A A D I R L F I E P T S T
203
TCGGGTGATTATCCGCCCACTACCGGCGAGGATGACGATGGCATGTTATGCACTCACCAA
1 0 2 1  — — — — — — 1- — — — —----------4----------------------1 — — — — — 4-— — — —-------------1-__ -— —  — — — 4- 1 0 8 0
AGCCCACTAATAGGCGGGTGATGGCCGCTCCTACTGCTACCGTACAATACGTGAGTGGTT
S G D Y P P T T G E D D D G M L C T H Q
TACGGGGCTGCAAAACACGTATTGGCGGTGCGTGTAGCGAAGGGCAGTGGTTCCTCGGCT
1 0 8 1 --------------------------------------1----------------------------------------1----------------------------------------1----------------------------------------1----------------------------------------1 !■ 1 1 4 0
ATGCCCCGACGTTTTGTGCATAACCGCCACGCACATCGCTTCCCGTCACCAAGGAGCCGA ^  RHF REV
Y G A A K H V L A V R V A K G S G S S A
CCCCGCGTGGGAAACATCTTTTTACCC
GGGGCGCACCCTTTGTAGAAAAATGGG \  REV
P R V G N I F L P
204
Appendix 5: The gene sequence of D M C l
The DMCl specific primers and the restriction sites of the enzymes used during copy 
number analysis are shown.
FOR_________ \
ATGCAGCACGTGGGAACGCGGTCGGGCAAAAGTGATGCGAAGGATGCAGCGGTTTCCACG
1 ---------------------+ ------------------------+ ------------------------+ -----------------------+ --------------------- + ------------------------+ 6 0
TACGTCGTGCACCCTTGCGCCAGCCCGTTTTCACTACGCTTCCTACGTCGCCAAAGGTGC
M Q H V G T R S G K S D A K D A A V S T
LHF FOR \  PCR KO 5'
GACAACTCTACGCATGAGGACGCGGCGCACACCATCATGGAGATTGACCGCCTTACCGAG 
6 1 ------------------- —+ ———— ---------------H————------------- ---------------------------— ———+ 1 2 0
CTGTTGAGATGCGTACTCCTGCGCCGCGTGTGGTAGTACCTCTAACTGGCGGAATGGCTC
D N S T H E D A A H T I M E  I D R L T E
SadiCAGGGGGTTGCCGCGGCGGATGTCGCTAAGCTGCGGCAGGCGGGTATATTCACCGTGACT
1 2 1 ---------------------+ ------------------------+ ------------------------+ -----------------------+ --------------------- + ------------------------+ 1 8 0
GTCCCCCAACGGCGCCGCCTACAGCGATTCGACGCCGTCCGCCCATATAAGTGGCACTGA
Q G V A A A D V A K L R Q A G I  F T V T
GGGATTCACATGCAGTGCCGAAAGGATCTTGTTCTTATCAAGGGTTTGTCTGATGCCAAA
1 8 1 ------------------- + --------------------+ --------------------+ --------------------+ --------------------+  + 2 4 0
CCCTAAGTGTACGTCACGGCTTTCCTAGAACAAGAATAGTTCCCAAACAGACTACGGTTT
G I H M Q C R K D L V L I K G L S D A K
GTTGACAAAATTATCGAGGCGGCACGGAAGTTATCGGATTGCGGTTTCAGCGTTGGAACG
2 4 1  ------------------- + --------------------+ --------------------+ ------------------- + --------------------+ -------------------- + 3 0 0
CAACTGTTTTAATAGCTCCGCCGTGCCTTCAATAGCCTAACGCCAAAGTCGCAACCTTG^.,
V D K I  l E A A R K L S D C G F S V G T
GCTTACCTGCAACAGAGAGGGAGGGTGACCCGTGTAACAACTGGAAGCACGGCTCTGGAT
3 0 1  ------------------- + --------------------+ --------------------+ --------------------+ --------------------+ -------------------- + 3 6 0
CGAATGGACGTTGTCTCTCCCTCCCACTGGGCACATTGTTGACCTTCGTGCCGAGACCTA LHF REV
A Y L Q Q R G R V T R V T T G S T A L D
CAGTTGTTGGGCGGTGGCATAGAAAGCATGTCAATTACGGAGGCGTTTGGTGAGTTCCGA
3 6 1 -------------------- 1----------------------1----------------------1--------------------- 1----------------------1--------------------- 1" 4 2 0
GTCAACAACCCGCCACCGTATCTTTCGTACAGTTAATGCCTCCGCAAACCACTCAAGGCT
V  uT
Q L L G G G I E S M S I T E A F G E F R
ACCGGTAAAACGCAGATAGCACACACATTGTGCGTAACGTGCCAACTCCCCATTTCAATG
4 2 1  ------------------- + --------------------+ --------------------+ --------------------+ --------------------+ -------------------- + 4 8 0
TGGCCATTTTGCGTCTATCGTGTGTGTAACACGCATTGCACGGTTGAGGGGTAAAGTTAC
T G K T Q I A H T L C V T C Q L P I S M
205
D3____
g g g g g g g g c a a t g g t a a a g c t a t t t a t g t t g a c a c a g a g g c a a c t t t c a g a c c t g à g c g g '
481 ----------------- +------------------- +------------------+---------------- +----------------- +------------------- + 540
CCCCCCCCGTTACCATTTCGATAAATACAACTGTGTCTCCGTTGAAAGTCTGGACTCGCC
G G G N G K A I Y V D T E A T F R P E R  
 \ATTAAGCCCATCGCAGAGCGTTTTGGTCTCGACGTTGAGGCCGTACTGGGGAACATTCTC
541 ----------------- +------------------- +------------------+---------------- +----------------- +-------------------+ 600
TAATTCGGGTAGCGTCTCGCAAAACCAGAGCTGCAACTCCGGCATGACCCCTTGTAAGAG
I K P I A E R F G L D V E A V L G N I L
D2_____________ \GTGGCACGAGCTTACACGCACGAGCATCAGATGCACCTCTTGTCAATGGTTGCTGCGAAG
601  +-------------------+------------------+---------------- +----------------- +------------------- + 660
CACCGTGCTCGAATGTGCGTGCTCGTAGTCTACGTGGAGAACAGTTACCAACGACGCTTC
V A R A Y T H E H Q M H L L S M V A A K
D1______________\
ATGGTAGAGGATCAGTTCAGTCTCCTTGTTGTAGACAGTGTAACGGCTCTCTTTCGCGTG
6 6 1 ------- ----------------------------------------------- --------------------—+—------———-----H———— —+ 720
TACCATCTCCTAGTCAAGTCAGAGGAACAACATCTGTCACATTGCCGAGAGAAAGCGCAC
M V E D Q F S L L V V D S V T A L F R V
RHF FOR________ \
GATTTTTCTGGCAGAGGGGAGCTCGCGGAGCGGCAGCAGAAACTGGCCAAGATGTTGAGC
721 —------ ——— -------------- ----------------------------------------- —+——  ------ H—— ———4- 780
CTAAAAAGACCGTCTCCCCTCGAGCGCCTCGCCGTCGTCTTTGACCGGTTCTACAACTCG
D F S G R G E L A E R Q Q K L A K M L S
AACATGATTAAACTTGCGGAGGAGTATAACGTTGCTGTGTACATAACAAATCAGGTGGTT
7 8 1  ------------------- + --------------------- + ------------------- + --------------------+ ------------------- +  + 8 4 0
TTGTACTAATTTGAACGCCTCCTCATATTGCAACGACACATGTATTGTTTAGTCCACCAA
N M I K L A E E Y N V A V Y I T N Q V V
BarrfrMGCGGATCCTGGTGGCGCCTCCATGTTTGTGGCCGACCCCAAAAAGCCTATTGGAGGTCAT
8 4 1  ------------------- + ---------------------+ ------------------- + ------------------- + ------------------- +  + 9 0 0
CGCCTAGGACCACCGCGGAGGTACAAACACCGGCTGGGGTTTTTCGGATAACCTCCAGTA
A D P G G A S M F V A D P K K P I G G H
ATTCTTGCGCATGCCTCAACGACGCGACTGTCGCTGCGCAAAGGACGGGGGGATCAGCGC
9 0 1  ------------------- + --------------------+ --------------------+ --------------------+ --------------------+ -------------------- + 9 6 0
TAAGAACGCGTACGGAGTTGCTGCGCTGACAGCGACGCGTTTCCTGCCCCCCTAGTCGCGPCR KO 3 \
I L A H A S T T R L S L R K G R G D Q R
GTGTGTAAGATATATGACAGTCCGTCGTTGCCGGAGGTGGAATGTGTTTTCAGCATATCG
9 6 1 --------------------H---------------------1----------------------1--------------------- 1----------------------1----------------------!■ 1 0 2 0
CACACATTCTATATACTGTCAGGCAGCAACGGCCTCCACCTTACACAAAAGTCGTATAGC 
RHF REV
V C K I Y D S P S L P E V E C V F S I S
206
GAGCAAGGGATTGTTGACGCACGTGAG
CTCGTTCCCTAACAACTGCGTGCACTC
^  revT
E O G I V D A R E
207
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